Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024980	s-igg4	g/l (g/l)	5941	9519	0.00%
3024980	s-igg4	— (—)	2027	2797	100.00%	Distribution not available
3024980	s-igg4	g/l_______ (g/l)	154	193	0.00%
3024980	s-immunoglobuliinig,alaluokka4	g/l (g/l)	131	168	0.00%
3024980	s-immunoglobuliinig,alaluokka4	g/l_______ (g/l)	69	77	0.00%
3024980	s-igg4	g/L (g/l)	25	31	0.00%
3024980	s-igg4	G/L (g/l)	23	35	0.00%
3024980	immunoglobuliinig4	g/l_______ (g/l)	17	17	0.00%	Distribution not available
3024980	immunoglobuliinig4	g/l (g/l)	11	13	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

General symptoms and signs

2109

3936

2.73

320.62

1.7

1.5

0.73

0.79

g/l

1.46

1644

3076

Used for control exclusion in common control thyroid runs

2066

3855

2.75

318.63

1.7

1.5

0.79

g/l

0.01

1597

3020

Bronchiectasis

357

364

10.87

316.39

1.5

1.6

0.72

0.87

g/l

1.19

284

283

Gastrointestinal diseases

1065

1273

4.27

310.14

1.7

1.4

0.70

0.82

g/l

2.15

837

1010

Other diseases of pancreas

360

382

10.36

309.45

2.1

1.4

0.88

g/l

0.00

252

309

Autoimmune diseases related-to ILD

2252

5371

3.61

307.65

1.8

1.5

0.72

0.77

g/l

0.96

1776

4177

Asthma-related infections

1692

4432

3.85

307.65

1.6

0.73

0.75

g/l

0.18

1325

3467

Fever of other and unknown origin

1555

3336

4.17

307.65

1.7

1.5

0.66

0.79

g/l

5.16

1187

2615

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2180

5520

2.69

307.65

1.6

0.73

0.77

g/l

0.81

1683

4327

Pneumonia, organism unspecified

2049

5073

2.83

307.65

1.6

0.73

0.78

g/l

0.72

1582

3975

Any gastric operation

1663

1772

4.82

307.65

1.7

1.3

0.73

0.75

g/l

0.23

1281

1492

Asthma (only as main-diagnosis)

1842

2185

4.86

307.65

1.6

0.76

0.79

g/l

0.35

1428

1686

Noninfective enteritis and colitis

1271

3764

3.49

307.65

2.0

1.5

0.69

0.78

g/l

2.32

1034

2928

Immunodeficiencies

434

304

18.13

307.65

2.1

1.6

0.44

0.81

g/l

4.41

340

244

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2393

5207

3.18

307.65

1.8

1.5

0.76

g/l

0.04

1840

4096

Asthma

1861

2185

4.52

307.65

1.6

0.79

g/l

0.01

1448

1686

Second line medication for Crohn's disease

1703

4613

3.84

307.65

2.0

1.5

0.75

g/l

0.02

1327

3614

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

433

260

12.54

307.65

1.7

1.3

0.96

0.83

g/l

0.71

318

193

Influenza and pneumonia

2334

5350

2.75

307.65

1.6

0.73

0.77

g/l

0.69

1806

4194

Asthma (diagnoses ohter than nonallergic)

2094

5776

3.00

307.65

1.6

0.79

0.74

g/l

0.84

1628

4519

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1717

4287

3.60

307.65

1.7

1.5

0.82

0.77

g/l

0.69

1325

3339

IBD (strict) with PSC

248

106.59

307.65

3.4

1.3

0.85

0.59

g/l

1.54

233

Certain disorders involving the immune mechanism

821

1379

6.46

307.65

2.2

1.6

0.70

0.81

g/l

1.14

625

1077

Asthma, hospital admissions 3, pneumonia

1044

2432

4.46

307.65

1.7

1.5

0.74

0.77

g/l

0.21

804

1887

1373

3392

4.18

307.65

1.6

0.74

0.73

g/l

0.05

1086

2665

Chronic sinusitis

1180

3093

3.95

307.65

1.7

1.6

0.77

0.75

g/l

0.16

961

2377

Autoimmune diseases

2209

4244

2.69

307.65

1.7

1.5

0.76

0.79

g/l

0.50

1739

3294

Chronic lower respiratory diseases

2469

5211

2.54

307.65

1.6

0.77

0.75

g/l

0.30

1937

4048

Autoimmune diseases excluding thyroid diseases

2436

4225

3.20

307.65

1.8

1.5

0.75

0.79

g/l

0.91

1937

3281

Undetermined asthma, excluding more controls

451

535

8.95

307.65

1.7

1.5

0.89

0.81

g/l

0.46

341

422

Oral corticosteroids

3214

3765

5.20

307.65

1.9

1.3

0.76

g/l

0.00

2503

2886

Other diseases of biliary tract

473

384

13.88

307.65

3.0

1.4

0.97

0.85

g/l

0.62

377

301

Asthma, hospital admissions , main diagnosis only

1945

5865

2.96

307.65

1.6

0.77

0.75

g/l

0.39

1511

4572

Autoimmune diseases excluding thyroid diseases, strict definition

2337

4078

3.19

307.65

1.8

1.5

0.75

0.79

g/l

0.87

1868

3177

Asthma, hospital admission 2, infections

1692

4432

3.85

307.65

1.6

0.73

0.75

g/l

0.18

1325

3467

Primary Sclerosing Cholangitis, IBD and UDCA required

448

96.09

307.65

3.1

1.2

0.80

0.78

g/l

0.07

401

Asthma (only as main-diagnosis), excluding more controls

1813

2055

5.04

307.65

1.6

0.76

0.78

g/l

0.23

1411

1586

Chronic pancreatitis

605

643

10.44

307.65

2.5

1.4

0.97

0.90

g/l

0.42

427

518

Azathioprine

616

755

8.82

307.65

2.5

1.3

0.74

0.73

g/l

0.07

506

585

Systemic connective tissue disorders

1164

2455

5.00

307.65

1.9

1.4

0.76

0.72

g/l

0.36

900

1895

Asthma, excluding more controls

1808

2055

4.65

307.65

1.6

0.78

g/l

0.02

1404

1586

Examination and observation for other reasons

1366

2146

3.68

307.65

1.7

1.5

0.70

0.83

g/l

3.10

1199

1541

Undetermined asthma

451

548

8.73

307.65

1.7

1.5

0.89

0.78

g/l

0.65

341

434

ILD medications: prednisolone, methylprednisolone, prednisone

3193

3554

5.18

307.65

1.8

1.3

0.77

0.76

g/l

0.15

2494

2752

Asthma, unspecified (mode), excluding more controls

1241

1925

4.75

307.65

1.6

0.80

0.77

g/l

0.34

924

1489

Asthma (mode)

1811

2206

4.43

307.65

1.6

0.79

g/l

0.02

1414

1703

Pneumonias (Asthma/COPD co-morbidities)

2236

5476

2.72

307.65

1.6

0.73

0.77

g/l

0.85

1721

4300

Diseases of liver

1338

2477

5.76

307.65

1.7

1.6

0.80

g/l

0.04

1099

1916

Cholangitis (primary sclerosing, PSC), with reimbursement 202

362

115

60.82

307.65

3.3

1.5

0.80

0.68

g/l

0.37

329

Inflammatory bowel disease treatment related agents

3455

3910

5.08

307.65

1.9

1.3

0.77

0.76

g/l

0.08

2723

3000

ILD medications

3236

3617

4.99

307.65

1.9

1.3

0.77

0.76

g/l

0.17

2533

2803

Reimbursement for rheumatic diseases

1635

4327

3.90

307.65

2.0

1.5

0.73

0.76

g/l

0.41

1305

3374

Disorders of gallbladder, biliary tract and pancreas

2829

4313

4.23

307.65

1.9

1.4

0.76

0.77

g/l

0.28

2144

3433

Other systemic involvement of connective tissue

832

1841

4.74

307.65

2.0

1.5

0.75

0.73

g/l

0.19

647

1424

Asthma-related pneumonia

1042

2428

4.45

307.65

1.7

1.5

0.74

0.77

g/l

0.21

802

1884

Asthma, unspecified (mode)

1251

2049

4.53

307.65

1.6

1.5

0.80

0.78

g/l

0.23

929

1583

2009

3652

3.29

307.65

1.6

0.73

0.81

g/l

1.69

1552

2836

ILD medications: azathioprine

616

725

9.19

307.65

2.5

1.4

0.74

0.73

g/l

0.12

506

568

First line medication for Crohn's disease

3078

3499

4.89

307.65

1.9

1.3

0.77

g/l

0.01

2420

2707

GASTRO-related operations

1663

1772

4.82

307.65

1.7

1.3

0.73

0.75

g/l

0.23

1281

1492

Acute pancreatitis

1200

1057

12.83

307.65

1.8

1.4

0.68

0.87

g/l

3.84

818

829

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2009

3652

3.29

307.65

1.6

0.73

0.81

g/l

1.69

1552

2836

ILD medications: immunosuppressive drugs

2060

3364

5.80

307.65

1.9

1.3

0.74

0.75

g/l

0.17

1606

2605

All pneumoniae

2244

5484

2.72

307.65

1.6

0.73

0.77

g/l

0.94

1726

4306

Colitis, primary sclerosing, strict definition

243

71.64

307.65

3.2

1.3

0.87

0.63

g/l

1.53

227

Cholangitis (primary sclerosing, PSC)

596

276

27.31

307.65

2.9

1.4

0.82

0.89

g/l

0.35

509

223

Ulcerative colitis (strict) with PSC

205

116.00

307.65

3.3

1.3

0.87

0.67

g/l

0.81

193

Acute pancreatitis (for exclusion)

1200

1290

10.49

307.65

1.8

1.6

0.68

0.84

g/l

3.57

818

1027

L04AX Other immunosuppressants

1618

4506

3.73

307.65

2.0

1.5

0.75

g/l

0.02

1257

3541

Immunodeficiency with predominantly antibody defects

335

159

30.74

307.65

2.2

1.8

0.35

0.77

g/l

3.18

270

131

Other systemic involvement of connective tissue (FG)

811

1552

5.39

307.65

2.0

1.5

0.75

0.74

g/l

0.07

630

1195

Asthma-related pneumonia or sepsis

1044

2432

4.46

307.65

1.7

1.5

0.74

0.77

g/l

0.21

804

1887

Colitis, primary sclerosing

309

72.62

307.65

3.2

1.6

0.87

0.80

g/l

0.14

287

Abnormal findings on diagnostic imaging of lung

1206

3071

3.85

307.65

1.7

1.5

0.84

0.81

g/l

0.36

939

2368

5-aminosalicylic acid

668

1133

6.21

307.65

2.3

1.3

0.76

0.73

g/l

0.29

562

872

Other diseases of liver

642

1276

5.35

306.69

1.6

0.73

0.77

g/l

0.45

534

989

Abnormal findings on examination of blood, without diagnosis

1155

3144

3.43

304.22

1.8

1.6

0.84

0.83

g/l

0.05

907

2426

Fibrosis and cirrhosis of liver

373

435

9.55

299.17

1.7

1.6

0.86

0.82

g/l

0.15

318

342

Inflammatory bowel disease

924

2518

3.83

291.67

2.1

1.5

0.72

0.76

g/l

0.54

766

1937

Asthma, including avohilmo

2347

5470

2.40

285.57

1.6

0.79

0.75

g/l

0.78

1840

4253

Abnormalities of breathing

1790

3808

2.74

285.41

1.5

1.6

0.71

0.79

g/l

2.11

1394

2961

Budesonide

451

687

6.94

283.85

1.9

1.3

0.71

0.73

g/l

0.10

369

527

Other pulmonary diagnosis

1395

2209

3.22

279.05

1.6

0.73

0.79

g/l

0.96

1089

1704

Ulcerative colitis

759

1861

4.27

278.36

2.2

1.5

0.75

0.78

g/l

0.31

640

1449

Asthma/COPD (KELA code 203)

1931

5200

2.53

275.41

1.6

0.78

0.75

g/l

0.54

1524

4040

IBD patients in KELA-register

730

1775

4.32

270.90

2.2

1.5

0.73

0.78

g/l

0.44

610

1387

Excluding asthma or asthma-COPD overlap

1377

2209

3.18

269.99

1.6

0.73

0.79

g/l

0.95

1072

1704

COPD/asthma/ILD related infections

1885

3652

2.63

267.20

1.5

1.6

0.68

0.81

g/l

5.04

1475

2836

COPD/asthma related infections

1885

3652

2.63

267.20

1.5

1.6

0.68

0.81

g/l

5.04

1475

2836

Other respiratory diseases principally affecting the interstitium

545

1057

5.44

267.17

1.7

1.6

0.95

0.86

g/l

0.60

399

818

Tramadol

1598

3519

2.78

266.49

1.5

1.6

0.69

0.82

g/l

4.20

1256

2735

COPD differential diagnosis

1367

2207

3.16

265.43

1.6

0.73

0.79

g/l

0.88

1063

1703

ILD differential diagnosis

1364

2206

3.15

264.09

1.6

0.73

0.79

g/l

0.93

1061

1703

Anaemias

622

754

5.48

261.58

1.7

0.69

0.79

g/l

1.10

483

617

ILD, hospital admission 2, with pulmonary infections

350

447

8.41

258.81

1.8

1.7

0.81

0.91

g/l

0.58

261

350

Bacterial infection, other or unspecified

1172

3273

3.10

258.27

1.5

1.6

0.72

0.82

g/l

1.63

897

2543

Cholelithiasis, broad definition with cholecystitis

1574

3947

2.70

256.29

1.7

1.4

0.68

0.77

g/l

2.25

1189

3142

Pain in joint

1174

2268

3.25

255.26

1.5

1.6

0.65

0.90

g/l

9.97

929

1766

Inflammatory bowel disease, strict (require KELA)

730

1855

4.13

255.21

2.2

1.5

0.73

0.76

g/l

0.24

610

1458

Other bacterial diseases

1902

5232

2.45

254.19

1.5

1.6

0.73

0.78

g/l

0.80

1476

4080

Bacterial infection, other or unspecified, including avohilmo

1255

3558

2.96

253.88

1.5

1.6

0.72

0.81

g/l

1.64

967

2766

Other interstitial pulmonary diseases

481

883

5.78

250.91

1.7

1.6

0.88

0.85

g/l

0.19

350

694

Interstitial lung disease endpoints

481

892

5.72

248.17

1.7

1.6

0.88

0.85

g/l

0.19

350

698

Interstitial lung disease

481

892

5.72

248.17

1.7

1.6

0.88

0.85

g/l

0.19

350

698

Autoimmune hepatitis, wide definition

251

221

12.86

246.82

2.1

1.7

0.79

0.81

g/l

0.04

199

180

Asthma and opportunity respiratory infection

252

224

12.89

246.75

1.6

1.5

0.77

0.80

g/l

0.10

197

175

ILD, hospital admissions

477

884

5.73

246.35

1.7

1.6

0.88

0.85

g/l

0.18

346

692

Diseases of oesophagus, stomach and duodenum

2073

5291

2.35

245.85

1.6

0.72

0.78

g/l

1.48

1629

4107

Mucosal proctocolitis

486

923

5.63

244.94

2.5

1.5

0.79

0.80

g/l

0.05

417

722

Cough

920

2595

3.40

241.97

1.5

1.6

0.67

0.81

g/l

3.83

734

2030

Other inflammatory liver diseases

310

374

9.21

241.95

2.0

1.7

0.81

0.77

g/l

0.18

236

293

Acute sinusitis

1197

3851

2.90

238.63

1.6

0.65

0.77

g/l

4.36

951

2980

Other bacterial diseases, including avohilmo

1985

5363

2.35

238.44

1.6

0.72

0.77

g/l

1.11

1554

4181

2070

4514

2.36

237.01

1.6

0.68

0.80

g/l

4.67

1637

3494

Abdominal and pelvic pain

1786

3601

2.53

235.45

1.7

1.6

0.77

0.82

g/l

0.87

1367

2835

Other and unspecified immunodeficiencies with predominantly antibody defects

166

32.50

233.85

2.2

1.7

0.27

0.82

g/l

3.42

138

Symptoms and signs involving the digestive system and abdomen

1784

3601

2.52

233.56

1.7

1.6

0.76

0.82

g/l

1.26

1371

2835

Cholelithiasis

1478

3888

2.64

231.95

1.6

1.4

0.68

0.77

g/l

2.45

1109

3094

ILD, hospital admissions 3, with pneumonia sepsis

305

379

8.66

230.92

1.7

0.78

0.98

g/l

1.23

222

302

Any reimbursement code in KELA

1061

1590

3.41

230.75

1.7

1.4

0.73

0.77

g/l

0.55

840

1266

Ulcerative colitis, NAS

493

1007

5.21

228.41

2.3

1.6

0.76

0.77

g/l

0.04

416

779

ILD, hospital admissions 1, main diag only

430

799

5.72

221.61

1.8

1.6

0.89

0.87

g/l

0.11

314

622

Chronic rhinitis, nasopharyngitis and pharyngitis

796

2364

3.48

219.78

1.7

1.6

0.72

0.76

g/l

0.50

661

1822

L04AA Selective immunosuppressants

665

1762

3.96

219.35

1.8

1.6

0.65

0.75

g/l

1.85

525

1369

Non-allergic asthma (mode), excluding more controls

423

793

5.47

211.25

1.7

1.6

0.75

0.81

g/l

0.48

337

627

Dyspnoea

1734

5510

2.31

208.01

1.5

1.6

0.71

0.78

g/l

1.47

1347

4312

Allergic asthma (mode), excluding more controls

507

1102

4.62

207.67

1.6

0.75

0.78

g/l

0.19

427

866

Symptoms and signs involving the circulatory and respiratory systems

1780

3815

2.37

205.73

1.6

0.70

0.79

g/l

2.83

1373

2966

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

533

1263

4.45

205.25

2.3

1.6

0.77

0.78

g/l

0.05

452

983

Allergic asthma (mode)

507

1113

4.57

205.14

1.6

0.75

0.78

g/l

0.26

427

874

Non-allergic asthma (mode)

423

815

5.32

204.89

1.7

1.5

0.75

0.81

g/l

0.43

337

644

Ulcerative colitis (strict definition, require KELA)

542

1303

4.38

204.72

2.3

1.6

0.77

0.78

g/l

0.12

458

1012

Bacterial pneumonia (organism specified)

924

2810

3.05

202.28

1.6

0.69

0.81

g/l

2.37

682

2203

Enlarged lymph nodes

450

944

4.99

201.01

2.1

1.4

1.08

0.77

g/l

2.93

356

751

Chronic hepatitis, not elsewhere classified

200

174

13.27

198.86

2.0

1.7

0.67

0.77

g/l

0.35

159

137

Headache

1233

3688

2.63

198.26

1.6

1.5

0.60

0.77

g/l

9.00

978

2886

Obesity related asthma

802

2555

3.24

197.65

1.5

1.6

0.69

0.75

g/l

0.82

603

1987

Bronchitis

2012

5684

2.15

195.67

1.6

0.68

0.79

g/l

4.15

1587

4407

Bacterial pneumoniae

838

2372

3.18

195.26

1.6

0.71

0.82

g/l

1.69

627

1857

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

555

1408

4.14

194.78

2.3

1.6

0.76

0.77

g/l

0.08

468

1101

Primary biliary cholangitis, wide definition

159

19.62

194.15

2.1

2.0

0.61

0.96

g/l

1.17

133

Septicaemia

862

2610

3.09

192.79

1.6

0.77

0.84

g/l

0.68

657

2036

Medical observation and evaluation for suspected diseases and conditions

1166

2147

2.82

189.82

1.7

1.5

0.80

0.83

g/l

0.33

951

1542

Other necrotizing vasculopathies

274

381

7.82

188.96

1.7

1.6

0.74

0.81

g/l

0.35

201

310

Bacterial pneumonia, not elsewhere classified

786

2192

3.23

187.81

1.5

1.6

0.71

0.82

g/l

1.49

586

1709

Acute upper respiratory infections

1873

5238

2.17

186.39

1.6

0.68

0.79

g/l

4.00

1487

4057

Other diseases of intestines

1933

5061

2.16

185.34

1.6

0.69

0.79

g/l

3.80

1510

3947

Certain infectious and parasitic diseases

1666

3633

2.33

185.23

1.6

0.72

0.79

g/l

1.51

1296

2821

Other necrotizing vasculopathies (FG)

233

275

9.23

184.44

1.8

1.6

0.72

0.76

g/l

0.21

171

222

Finngen Rheumatological endpoints

1733

4443

2.25

183.89

1.6

0.73

0.77

g/l

0.63

1348

3455

Bacterial Sepsis

945

2767

2.89

183.86

1.6

0.76

0.83

g/l

0.82

708

2150

Opioids

1698

3906

2.28

180.99

1.6

0.69

0.80

g/l

3.88

1317

3050

Polyarthropathies

1297

3391

2.50

179.65

1.6

1.7

0.71

0.81

g/l

2.06

1014

2655

Other specified/unspecified systemic involvement of connective tissue

249

330

8.31

179.59

3.1

1.5

0.96

0.70

g/l

1.55

206

262

Nonhereditary hypogammaglobulinemia

131

28.64

178.31

2.3

1.9

0.21

0.79

g/l

1.98

102

Explicit Sepsis, including avohilmo

916

2977

2.85

178.26

1.6

0.77

0.81

g/l

0.35

703

2317

Other septicaemia, including avohilmo

777

2403

3.11

177.50

1.6

0.75

0.84

g/l

1.25

597

1868

Pain in throat and chest

1469

3731

2.36

177.29

1.6

0.71

0.79

g/l

2.48

1149

2898

Explicit Sepsis

897

2907

2.88

177.25

1.6

0.76

0.81

g/l

0.51

685

2266

Other septicaemia

762

2349

3.14

176.66

1.6

0.75

0.84

g/l

1.30

583

1824

Malaise and fatigue

945

2680

2.83

175.58

1.6

1.5

0.74

0.80

g/l

0.59

738

2094

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

558

628

4.53

174.37

1.7

1.5

0.74

0.80

g/l

0.51

438

488

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

264

384

7.37

174.28

1.8

1.6

0.95

0.79

g/l

0.74

187

301

Codeine

1595

3838

2.28

172.54

1.5

1.6

0.68

0.80

g/l

5.13

1224

2996

Other acute lower respiratory infections

1100

4225

2.53

171.04

1.6

0.71

0.79

g/l

1.45

872

3281

Infections, IBD-co-morbidities

365

462

5.74

167.94

1.7

1.6

0.63

0.79

g/l

1.69

268

362

Implicit bacterial Sepsis

813

2423

2.94

165.25

1.6

0.75

0.85

g/l

1.27

606

1889

Other diseases of pleura

857

2673

2.85

164.87

1.6

0.79

0.86

g/l

0.73

649

2062

Other specific joint derangements/joint disorders

1399

3811

2.33

164.57

1.5

1.6

0.65

0.80

g/l

6.12

1094

2996

Implicit bacterial Sepsis, including avohilmo

881

2657

2.82

164.41

1.6

0.75

0.83

g/l

1.17

665

2064

Primary biliary cholangitis (PBC)

141

17.36

162.42

1.9

0.58

0.97

g/l

1.38

117

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

424

1010

4.42

162.16

1.6

1.7

0.97

0.86

g/l

0.95

348

789

Acute upper respiratory infections of multiple and unspecified sites

1409

4624

2.26

161.11

1.5

1.6

0.65

0.79

g/l

4.41

1112

3593

Hernia of abdominal wall, postoperative

323

611

5.39

159.99

1.7

1.3

0.67

0.78

g/l

1.12

242

527

Kela reimbursement Agammaglobulinemia (D80-84)

112

32.83

159.33

2.2

1.4

0.19

0.67

g/l

3.82

Implicit Sepsis

1375

4552

2.26

158.12

1.5

1.6

0.75

0.79

g/l

0.59

1032

3567

Other noninfective gastroenteritis and colitis

585

1771

3.41

156.81

1.9

1.5

0.66

0.78

g/l

2.30

474

1383

Other soft tissue disorders, not elsewhere classified

1665

4497

2.14

156.62

1.5

1.6

0.72

0.81

g/l

2.30

1307

3498

Sicca syndrome [Sjögren]

285

506

6.03

154.73

1.6

1.5

0.60

0.68

g/l

0.54

207

395

Abnormal serum enzyme levels

642

2010

3.18

152.20

1.7

0.79

0.89

g/l

1.65

533

1574

Other diseases of upper respiratory tract

1806

4632

2.06

150.96

1.6

0.77

0.78

g/l

0.19

1433

3546

Suggestive for eosinophilic asthma

292

542

5.73

150.89

2.1

1.6

1.33

0.80

g/l

4.85

241

423

Nonalcoholic fatty liver disease

362

812

4.76

150.31

1.4

1.6

0.73

0.79

g/l

0.50

312

626

Implicit viral Sepsis, including avohilmo

641

2097

3.13

150.26

1.6

0.60

0.82

g/l

6.75

486

1647

Diseases of the respiratory system

970

1827

2.70

145.29

1.6

0.73

0.78

g/l

0.53

750

1399

Acute bronchitis

831

3123

2.67

144.84

1.6

0.68

0.79

g/l

1.69

656

2412

Nausea and vomiting

532

1550

3.43

144.35

1.7

1.5

0.66

0.80

g/l

2.60

425

1229

Cirrhosis of liver, NAS

214

309

7.57

142.93

1.5

1.6

1.06

0.86

g/l

1.03

188

239

Crohn disease

390

962

4.26

142.42

2.1

1.5

0.69

0.78

g/l

0.75

324

747

Gastro-oesophageal reflux disease

1220

4658

2.24

142.12

1.5

1.6

0.67

0.79

g/l

3.61

928

3626

Asthma and allergy, excluding more controls

306

610

5.12

142.04

1.7

1.8

0.73

0.82

g/l

0.62

263

489

Asthma and allergy

306

616

5.07

140.36

1.7

1.8

0.73

0.82

g/l

0.68

263

490

Diseases of the digestive system

865

3424

2.56

139.10

1.9

1.6

0.79

0.80

g/l

0.11

663

2649

Eosinophilic disease (BM)

108

22.01

139.00

2.1

1.3

1.50

0.66

g/l

3.65

Pain (limb, back, neck, head abdominally)

1120

2326

2.44

138.52

1.6

0.71

0.90

g/l

5.25

869

1810

Implicit Sepsis, including avohilmo

1427

4929

2.10

135.64

1.5

1.6

0.75

0.78

g/l

0.36

1068

3880

Oedema, not elsewhere classified

588

1923

3.05

131.91

1.7

1.5

0.69

0.79

g/l

1.69

469

1490

Ulcerative colitis (strict definition, all Crohn cases excluded)

404

1081

3.91

131.59

2.2

1.6

0.75

0.77

g/l

0.20

338

846

Implicit viral Sepsis

471

1392

3.49

131.42

1.6

1.7

0.61

0.82

g/l

4.52

356

1100

Viral Sepsis

472

1398

3.48

131.25

1.6

1.7

0.60

0.82

g/l

4.49

357

1105

Cholecystectomy

1239

4969

2.15

130.09

1.7

1.5

0.68

0.76

g/l

2.27

930

3899

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

931

3824

2.39

128.69

1.7

1.6

0.70

0.79

g/l

1.93

712

2932

Low back pain

1344

4364

2.11

127.84

1.6

0.70

0.80

g/l

2.96

1047

3401

Sulfasalazine

484

1485

3.33

126.67

1.6

1.3

0.62

0.74

g/l

1.81

370

1137

Intestinal infectious diseases

1635

6356

1.94

125.88

1.7

1.6

0.71

0.77

g/l

1.34

1271

4957

Pain, not elsewhere classified

539

1773

3.11

125.60

1.7

1.5

0.68

0.76

g/l

1.12

448

1384

Other diseases of blood and blood-forming organs, wide

509

1642

3.21

123.38

1.6

0.83

0.78

g/l

0.34

375

1277

Intestinal infectious diseases, including avohilmo, including avohilmo

1904

5751

1.86

122.83

1.7

1.6

0.69

0.79

g/l

3.18

1496

4463

Early onset COPD, excluding more controls

344

857

4.11

122.65

1.7

1.5

0.77

0.81

g/l

0.25

267

671

Heart failure, not strict

1252

4004

2.13

122.61

1.5

1.6

0.76

0.81

g/l

0.62

973

3095

Other special examinations and investigations of persons without complaint or reported diagnosis

1010

2147

2.41

122.24

1.6

1.5

0.75

0.83

g/l

1.34

790

1542

Dermatitis

1131

5223

2.15

122.11

1.7

1.6

0.79

0.75

g/l

0.42

866

4082

Codeine or tramadol medication

1848

5393

1.88

122.01

1.5

1.6

0.67

0.79

g/l

5.43

1417

4202

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1511

5252

1.97

119.20

1.5

1.6

0.74

0.77

g/l

0.53

1146

4111

Diseases of salivary glands

690

2672

2.65

118.73

1.8

1.6

0.75

0.74

g/l

0.11

543

2068

Irritable bowel syndrome

576

2032

2.91

118.68

1.6

0.58

0.73

g/l

3.59

455

1587

Intestinal malabsorption

186

283

7.16

118.35

2.4

1.5

0.89

0.77

g/l

0.40

132

232

Diarrhoea and gastroenteritis of presumed infectious origin

1248

5494

2.06

117.90

1.7

1.6

0.72

0.79

g/l

1.17

969

4279

Pain in limb

1381

4378

2.03

117.49

1.5

1.6

0.73

0.81

g/l

1.73

1084

3402

Condition for Implicit Sepsis (Organ dysfunction codes)

1429

5037

1.99

117.39

1.5

1.6

0.74

0.77

g/l

0.51

1073

3962

Vocal cord dysfunction

269

489

4.98

116.80

1.6

1.4

0.64

0.82

g/l

1.96

200

384

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1694

5834

1.88

116.57

1.7

1.6

0.72

0.78

g/l

1.50

1326

4536

All kidney diseases

1646

5897

1.89

115.86

1.6

0.74

0.75

g/l

0.16

1252

4636

Other ulcerative colitis

209

365

6.16

115.69

2.6

1.6

0.78

0.88

g/l

0.44

179

280

Cardiovascular diseases

1071

2531

2.28

115.62

1.6

0.70

0.74

g/l

0.48

827

2039

Other disorders of white blood cells

196

323

6.56

115.24

1.8

1.7

1.20

0.83

g/l

1.75

142

255

L04AD Calcineurin inhibitors

333

858

4.10

114.97

1.8

1.7

0.69

0.81

g/l

0.84

259

678

Unspecified jaundice

159

209

8.12

114.81

2.1

1.5

0.94

0.91

g/l

0.10

115

180

Other and unspecified dermatitis

963

4395

2.23

114.03

1.8

1.6

0.79

0.75

g/l

0.42

743

3455

Aplastic and other anaemias

791

3020

2.44

113.49

1.5

1.6

0.74

0.83

g/l

1.05

577

2353

Haemorrhage from respiratory passages

583

1846

2.85

113.36

1.7

1.6

0.81

0.86

g/l

0.44

438

1424

Covid-19 confirmed case

703

2807

2.56

112.90

1.8

1.6

0.73

0.80

g/l

0.64

526

2181

Ethmoidectomy

355

976

3.81

111.34

2.0

1.6

0.97

0.79

g/l

1.52

274

767

Complications of surgical and medical care, not elsewhere classified

1645

5951

1.87

110.87

1.5

1.6

0.71

0.77

g/l

0.92

1271

4647

Oxycodone

671

2225

2.63

110.69

1.6

0.65

0.88

g/l

5.89

503

1717

Cardiovascular diseases (excluding rheumatic etc)

1119

2985

2.18

110.64

1.6

0.73

0.72

g/l

0.08

850

2393

Other Crohn's disease

231

460

5.35

110.57

2.0

1.5

0.67

0.78

g/l

0.64

191

360

Certain infectious and parasitic diseases, including avohilmo

1077

2444

2.23

109.67

1.6

0.73

0.80

g/l

0.97

855

1868

Other heart diseases

861

2378

2.39

109.52

1.6

0.71

0.74

g/l

0.25

666

1905

FESS (DNB20)

345

944

3.83

109.00

2.0

1.7

0.99

0.79

g/l

1.79

265

742

Dental caries

515

1677

2.97

108.95

1.6

0.65

0.88

g/l

4.93

405

1293

Other arthritis (FG)

584

2174

2.75

108.54

1.5

0.69

0.77

g/l

0.93

456

1694

Other immunodeficiencies

17.66

108.39

2.4

0.67

0.89

g/l

0.36

Dermatitis and eczema

1831

6074

1.80

108.09

1.6

0.76

g/l

0.04

1427

4729

Dorsalgia

1593

4486

1.90

108.07

1.6

0.68

0.80

g/l

4.34

1242

3500

Other anaemias

730

2823

2.46

107.56

1.5

1.6

0.75

0.84

g/l

0.95

533

2195

Persons encountering health services in other circumstances, wide

1829

5219

1.82

107.53

1.6

0.78

0.77

g/l

0.06

1466

4016

Provisional assignment of new diseases of uncertain etiology

964

4469

2.18

107.23

1.8

1.5

0.72

0.76

g/l

0.48

756

3484

Other and unspecified anaemias

724

2804

2.47

107.09

1.5

1.6

0.74

0.84

g/l

1.18

528

2178

Codes for special purposes

964

4473

2.17

106.95

1.8

1.5

0.72

0.76

g/l

0.47

756

3488

Eosinophilia

108

13.30

105.82

2.1

1.7

1.50

0.78

g/l

2.15

General examination and investigation of persons without complaint and reported diagnosis

944

2147

2.31

104.97

1.6

1.5

0.67

0.83

g/l

5.07

790

1542

Vasomotor and allergic rhinitis

690

2759

2.49

104.83

1.7

1.6

0.76

0.75

g/l

0.11

579

2120

Biological medication for rheuma

457

1529

3.10

104.30

1.6

0.66

0.76

g/l

0.86

347

1201

Other heart diseases, wide

1540

5021

1.88

103.71

1.5

1.6

0.72

0.76

g/l

0.75

1181

3958

Diseases of the skin and subcutaneous tissue

1532

4069

1.91

103.68

1.6

0.75

0.78

g/l

0.55

1198

3142

Disorders of other endocrine glands

823

3625

2.28

102.11

1.6

0.71

0.73

g/l

0.19

543

2861

Other functional intestinal disorders

788

3127

2.33

101.73

1.5

1.6

0.63

0.80

g/l

5.32

602

2453

Exclusions for E4_PCOS_BROAD

429

1405

3.16

101.41

1.7

1.6

0.69

0.76

g/l

0.61

256

1117

Diagnoses used for exclusion with ILD

505

1810

2.86

101.19

1.7

1.6

0.91

0.81

g/l

0.64

374

1426

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1745

5217

1.80

99.05

1.7

1.6

0.76

0.77

g/l

0.19

1449

4014

Other specified/unspecified arthritis

521

1926

2.77

98.28

1.5

1.7

0.71

0.81

g/l

1.28

403

1516

Lower back pain or/and sciatica

1730

6140

1.77

96.97

1.6

0.67

0.78

g/l

4.40

1345

4771

Caries of dentine

458

1532

2.96

96.59

1.6

0.64

0.89

g/l

5.44

360

1178

Primary_lymphoid and hematopoietic malignant neoplasms

462

1622

2.93

96.29

1.5

1.6

0.56

0.84

g/l

6.30

342

1259

Liquid cancers

545

1960

2.69

96.19

1.5

1.6

0.59

0.85

g/l

5.91

405

1516

Other disorders involving the immune mechanism, not elsewhere classified

140

201

7.71

94.41

3.8

1.8

1.40

0.87

g/l

1.89

104

163

Abnormal results of function studies

247

590

4.39

94.33

1.8

1.6

0.74

0.77

g/l

0.17

193

466

Noninfectious colitis NAS

324

938

3.58

93.76

2.0

1.5

0.64

0.78

g/l

1.65

270

725

Disorders of lacrimal system

787

3539

2.23

92.73

1.7

1.5

0.63

0.74

g/l

2.22

605

2757

Osteoporosis

469

1539

2.87

92.69

1.7

1.5

0.70

0.76

g/l

0.47

342

1183

All influenza

478

1744

2.80

92.41

1.5

1.6

0.66

0.83

g/l

3.03

371

1379

Nasal polyp

380

1231

3.18

91.40

1.9

1.6

1.16

0.85

g/l

3.38

327

944

Functional dyspepsia

501

1892

2.71

90.68

1.7

1.5

0.67

0.76

g/l

0.97

386

1455

Persons encountering health services for specific procedures and health care

1709

5842

1.74

90.17

1.5

1.6

0.67

0.79

g/l

4.42

1334

4554

Rheumatoid arthritis

553

1925

2.59

89.68

1.6

0.70

0.81

g/l

1.53

427

1513

Endocrine, nutritional and metabolic diseases

1252

3287

1.94

89.53

1.6

0.72

0.79

g/l

1.13

947

2640

Metabolic disorders

1510

5078

1.80

89.47

1.6

0.74

0.77

g/l

0.40

1162

3974

Renal failure

755

2898

2.25

89.46

1.6

0.77

0.85

g/l

0.78

564

2237

Disorders of eyelid, lacrimal system and orbit

1391

5650

1.82

89.25

1.7

1.6

0.69

0.76

g/l

1.26

1081

4415

Parasetamol

1098

2757

2.03

89.16

1.6

1.7

0.76

0.84

g/l

1.06

843

2161

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

130

184

7.82

88.81

3.9

1.9

1.43

0.87

g/l

1.86

150

Hypertensive diseases (excluding secondary)

860

2303

2.20

88.38

1.6

0.70

0.72

g/l

0.27

644

1834

Renal tubulo-interstitial diseases

1386

5640

1.82

88.37

1.6

0.72

0.76

g/l

0.55

1050

4420

Osteopathies and chondropathies

957

4362

2.03

88.36

1.6

0.71

0.77

g/l

0.83

723

3420

Other disorders of lacrimal gland

669

2925

2.33

88.25

1.7

1.5

0.62

0.73

g/l

2.24

508

2271

Adrenocortical insufficiency

146

235

6.78

88.20

1.8

1.6

0.59

0.76

g/l

0.89

192

Disorders of thyroid, IBD co-morbidities

293

520

3.93

87.81

1.6

0.81

0.76

g/l

0.27

230

408

Persons encountering health services for examination and investigation

918

2147

2.17

87.39

1.7

1.5

0.77

0.83

g/l

0.73

745

1542

Complications of procedures, not elsewhere classified

1300

5757

1.84

87.30

1.5

1.6

0.71

0.77

g/l

0.99

1008

4487

Cardiac arrhythmias

1000

3177

2.04

87.11

1.5

1.6

0.68

0.75

g/l

1.38

767

2534

Hypothyroidism (congenital or acquired)

427

771

3.15

86.84

1.5

1.6

0.66

0.77

g/l

1.49

315

629

Viral pneumonia

283

789

3.71

86.63

1.5

1.7

0.58

0.83

g/l

4.25

204

620

6-mercaptopurine

120

159

8.08

86.19

2.3

1.4

0.71

0.67

g/l

0.14

125

Hypothyroidism, levothyroxine purchases

423

764

3.16

86.16

1.5

1.6

0.66

0.77

g/l

1.51

311

622

Hypothyroidism and >3 levothyroxin purchases

423

764

3.16

86.16

1.5

1.6

0.66

0.77

g/l

1.51

311

622

Other disorders of adrenal gland

164

302

5.85

86.02

1.8

1.6

0.57

0.76

g/l

1.20

245

Symptoms and signs involving the skin and subcutaneous tissue

1185

6059

1.87

85.97

1.8

1.5

0.77

0.74

g/l

0.36

953

4709

Other dorsopathies, not elsewhere classified

1533

4499

1.79

85.44

1.6

0.71

0.80

g/l

2.43

1197

3509

Respiratory disorders in diseases classified elsewhere

13.19

85.22

2.0

1.8

0.71

0.79

g/l

0.14

Crohn's disease NAS

194

416

4.93

85.11

2.0

1.6

0.63

0.79

g/l

1.06

166

326

Ulcerative ileocolitis

148

251

6.37

84.68

2.8

1.6

0.75

0.88

g/l

0.64

126

200

Pleural effusion

293

851

3.55

84.19

1.8

1.7

0.91

0.90

g/l

0.02

220

669

Diseases of the musculoskeletal system and connective tissue

817

1849

2.24

84.16

1.6

0.71

0.79

g/l

1.37

635

1459

Implicit fungal Sepsis, including avohilmo

192

412

4.90

83.99

1.5

1.7

0.66

0.83

g/l

1.10

136

331

Dysphagia

400

1400

2.91

83.60

1.5

0.78

0.84

g/l

0.47

294

1093

Neoplasms

1212

3361

1.91

83.56

1.7

1.5

0.73

0.78

g/l

0.85

929

2661

Idiopathic pulmonary fibrosis

176

352

5.23

83.50

1.7

1.6

0.93

0.90

g/l

0.08

133

280

Other joint disorders

1355

3875

1.84

83.33

1.5

1.7

0.72

0.80

g/l

1.82

1051

3041

Complications of medical and surgical care

1180

5778

1.86

83.21

1.5

1.6

0.72

0.76

g/l

0.56

906

4522

Spondylopathies

1178

3699

1.90

82.57

1.5

1.6

0.68

0.83

g/l

4.45

882

2873

Cholecystitis

249

657

3.89

82.39

2.1

1.4

0.76

0.84

g/l

0.48

188

511

Abnormal findings on diagnostic imaging of other body structures

309

943

3.39

82.30

1.8

1.5

0.77

0.75

g/l

0.10

234

737

Soft tissue disorders

1545

4528

1.76

82.24

1.5

1.6

0.71

0.81

g/l

3.11

1196

3521

All chronic kidney diseases

876

3429

2.06

82.23

1.8

1.6

0.79

0.81

g/l

0.13

670

2666

Symptoms and signs concerning food and fluid intake

231

579

4.12

82.05

1.8

1.5

0.88

0.81

g/l

0.23

183

471

Diverticular disease of intestine

1056

3386

1.96

82.03

1.7

1.6

0.74

0.83

g/l

1.71

851

2628

Arthropathies

1388

3889

1.82

81.77

1.5

1.7

0.73

0.81

g/l

1.57

1099

3055

Drug-induced adrenocortical insufficiency

110

10.17

81.54

2.0

1.9

0.50

0.80

g/l

1.02

Pneumonia due to other infectious organisms, not elsewhere classified

118

164

7.78

81.51

1.4

1.7

0.59

0.94

g/l

1.24

136

Tumor necrosis factor alpha inhibitors

390

1372

2.94

81.44

1.5

1.6

0.67

0.76

g/l

0.70

297

1066

Neurological diseases, wide definition

461

798

2.94

80.88

1.6

0.70

0.80

g/l

0.97

359

634

Nutritional anaemias

802

3710

2.09

80.46

1.7

1.6

0.71

0.77

g/l

0.71

636

2859

Candidiasis, including avohilmo

574

2449

2.39

80.27

1.5

1.6

0.66

0.73

g/l

1.16

450

1899

Benign neoplasm of colon, rectum, anus and anal canal

980

4294

1.95

79.86

1.7

1.6

0.69

0.82

g/l

4.24

788

3297

Anxiety disorders, excluding more controls

1325

4754

1.80

79.28

1.6

0.68

0.79

g/l

3.82

1059

3702

Alcohol-induced chronic pancreatitis

191

433

4.68

78.42

1.5

1.7

0.87

0.89

g/l

0.10

125

347

Methotrexate

239

636

3.86

78.15

1.5

1.3

0.63

0.72

g/l

0.59

176

493

Wegener granulomatosis

11.82

77.44

1.9

1.7

0.71

0.76

g/l

0.09

Constipation

1387

5415

1.75

76.93

1.5

1.6

0.66

0.79

g/l

4.84

1042

4276

Dorsopathies

1536

4536

1.73

76.41

1.6

0.70

0.80

g/l

3.10

1185

3542

Chronic kidney disease

501

1973

2.49

76.03

1.7

1.6

0.81

0.86

g/l

0.27

377

1534

Iron deficiency anaemia

703

3269

2.14

75.52

1.6

0.69

0.77

g/l

1.01

552

2527

Other diseases of pericardium

135

234

6.13

75.23

1.6

1.7

0.71

0.86

g/l

0.67

102

186

Other headache syndromes

710

3377

2.13

75.18

1.6

0.64

0.74

g/l

2.32

554

2676

Collagenous colitis

225

593

3.96

75.12

1.7

1.6

0.66

0.81

g/l

1.10

172

456

Acute renal failure

394

1452

2.78

74.99

1.5

1.6

0.77

0.88

g/l

0.74

279

1131

Other and unspecified iron deficiency

580

2555

2.31

74.80

1.6

1.5

0.67

0.78

g/l

1.42

453

1973

Mycoses

526

2236

2.40

74.27

1.6

0.70

0.77

g/l

0.94

393

1744

COPD (mode)

377

1027

2.90

74.24

1.5

0.81

0.84

g/l

0.18

297

787

Sarcoidosis

295

937

3.26

73.78

1.6

0.80

0.83

g/l

0.15

213

741

Other respiratory disorders and diseases

361

1282

2.88

73.72

1.6

0.69

0.86

g/l

2.23

273

990

Other diseases of the respiratory system

361

1282

2.88

73.72

1.6

0.69

0.86

g/l

2.23

273

990

Biological medicines for asthma

105

145

8.07

73.47

1.9

1.8

1.30

0.81

g/l

1.91

120

Hypopituitarism

218

576

3.99

72.80

1.7

0.74

0.86

g/l

0.73

118

470

Benign neoplasm of other and ill-defined parts of digestive system

351

1241

2.91

72.51

1.8

1.5

0.67

0.77

g/l

0.96

282

955

Benign neoplasm: Colon

829

3967

1.99

72.32

1.8

1.6

0.69

0.83

g/l

3.79

668

3052

Diseases of the eye and adnexa

1224

3400

1.82

72.12

1.6

0.70

0.81

g/l

2.67

951

2672

Abnormalities of heart beat

536

2250

2.34

71.75

1.5

1.6

0.69

0.79

g/l

1.44

401

1760

Other disorders of fluid, electrolyte and acid-base balance

509

2027

2.41

71.64

1.5

1.6

0.73

0.85

g/l

1.39

373

1566

Benign neoplasms

1483

4774

1.71

71.40

1.7

1.5

0.74

0.79

g/l

0.93

1138

3721

Alcohol-induced acute pancreatitis

134

244

5.96

71.35

1.4

1.7

0.76

0.90

g/l

0.57

191

Liquid cancers, including Hilmo

593

2352

2.26

71.31

1.5

1.6

0.67

0.84

g/l

2.21

446

1834

Depression medications

450

828

2.77

71.29

1.5

1.7

0.67

0.79

g/l

1.70

350

679

Bleeding

1259

5073

1.76

71.08

1.6

0.78

0.79

g/l

0.12

971

3950

Defects in the complement system

16.92

70.84

2.6

2.4

0.69

0.75

g/l

0.07

Diaphragmatic hernia

581

2627

2.25

70.79

1.6

1.5

0.72

0.77

g/l

0.54

479

2036

Anxiety disorders

1423

5814

1.70

70.31

1.6

0.68

0.77

g/l

2.94

1136

4507

Neurotic, stress-related and somatoform disorders

1411

5779

1.70

70.22

1.6

0.68

0.77

g/l

2.78

1129

4477

Fibromyalgia

215

575

3.88

70.17

1.5

1.6

0.59

0.71

g/l

1.14

170

450

Seropositive rheumatoid arthritis

398

1515

2.66

70.10

1.7

1.5

0.77

0.73

g/l

0.28

308

1169

Coagulation defects, purpura and other haemorrhagic conditions

390

1482

2.70

70.08

1.8

1.6

0.72

0.79

g/l

0.51

307

1155

Fungal Sepsis

131

238

5.86

69.57

1.5

1.7

0.64

0.85

g/l

0.95

193

Episodal and paroxysmal disorders

1613

4966

1.66

69.37

1.5

1.6

0.70

0.79

g/l

2.85

1227

3929

Total colectomy operation

137

261

5.62

69.24

2.4

1.7

1.01

0.85

g/l

0.52

114

210

Total colectomy

137

261

5.62

69.24

2.4

1.7

1.01

0.85

g/l

0.52

114

210

Rheumatoid arthritis, including avohilmo

624

2930

2.17

69.19

1.6

0.70

0.75

g/l

0.58

478

2263

Crohn's disease of large intestine

154

326

5.01

68.76

2.3

1.6

0.71

0.82

g/l

0.43

129

258

Neurological diseases

1275

3649

1.77

68.62

1.5

1.7

0.69

0.82

g/l

3.99

976

2900

Transplanted organ and tissue status

238

694

3.57

68.45

1.9

1.7

0.58

0.84

g/l

3.45

187

567

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1414

6635

1.67

68.34

1.6

0.70

0.78

g/l

1.67

1097

5180

Polymyalgia rheumatica

233

670

3.58

68.08

1.5

0.76

0.83

g/l

0.45

183

521

Erysipelas, including avohilmo

1047

4291

1.83

67.96

1.6

0.77

0.81

g/l

0.47

819

3325

Antihypertensive medication - note that there are other indications

969

2665

1.92

67.80

1.6

0.71

0.76

g/l

0.79

747

2131

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

692

2069

2.14

67.54

1.7

1.6

0.77

0.72

g/l

0.57

527

1642

Myalgia

434

1766

2.51

67.47

1.5

1.6

0.61

0.78

g/l

3.72

337

1358

COPD

603

2255

2.20

67.21

1.6

0.81

0.82

g/l

0.03

469

1733

Hepatic failure, not elsewhere classified

113

184

6.56

67.20

1.6

1.8

0.91

0.83

g/l

0.19

147

Common variable immunodeficiency

20.31

66.27

2.0

1.5

0.39

0.62

g/l

1.09

Sciatica+with lumbago

796

3645

1.96

65.94

1.4

1.6

0.59

0.82

g/l

10.44

617

2839

Mood disorders, excluding more controls

1410

4966

1.68

65.93

1.5

1.6

0.69

0.79

g/l

3.07

1098

3859

Implicit fungal Sepsis

122

219

5.94

65.67

1.5

1.7

0.66

0.88

g/l

0.91

182

SLE (Finngen)

103

156

7.03

65.63

1.6

1.7

0.50

0.86

g/l

2.02

124

Depression

1473

6020

1.65

65.57

1.5

1.6

0.68

0.78

g/l

3.03

1152

4678

Oesophageal varices

125

230

5.80

65.55

2.1

1.8

0.82

0.86

g/l

0.14

100

189

Other gastritis (incl. Duodenitis)

372

1428

2.66

65.34

1.8

1.6

0.67

0.86

g/l

3.74

304

1102

Unspecified acute lower respiratory infection

317

1124

2.90

65.17

1.6

1.7

0.70

0.82

g/l

1.16

245

891

106

8.73

64.52

1.6

1.4

0.84

0.88

g/l

0.10

Adalimumab

254

804

3.29

64.11

1.5

1.7

0.62

0.74

g/l

1.12

203

627

Ascites

159

364

4.54

64.07

1.6

1.4

0.93

0.84

g/l

0.27

122

289

Other chronic obstructive pulmonary disease

576

2176

2.20

63.95

1.6

0.81

0.83

g/l

0.09

448

1672

Chronic gastritis

400

1608

2.53

63.74

1.5

1.6

0.70

0.84

g/l

2.08

343

1235

Other intervertebral disc disorders

1181

4062

1.75

63.60

1.6

0.70

0.81

g/l

3.26

896

3157

Dialysis, with operation codes

267

874

3.16

63.50

1.5

1.7

0.61

0.87

g/l

3.41

208

693

Giant cell arteritis

112

191

6.22

63.49

1.4

1.7

0.79

0.82

g/l

0.09

151

Urticaria and erythema

638

3125

2.08

63.28

1.6

0.67

0.71

g/l

0.59

512

2448

Sleep disorders (combined)

1604

5224

1.62

62.57

1.5

1.6

0.73

0.78

g/l

1.22

1221

4111

Ulcerative enterocolitis

107

178

6.47

62.45

2.5

1.7

0.77

0.87

g/l

0.27

139

Migraine

826

3403

1.91

62.34

1.5

1.6

0.58

0.71

g/l

3.69

650

2717

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

145

317

4.76

61.96

2.1

1.7

0.87

0.95

g/l

0.31

113

249

Sleep apnoea

1411

5448

1.65

61.65

1.4

1.6

0.73

0.77

g/l

0.89

1041

4280

Persons encountering health services in other circumstances

661

3271

2.03

61.63

1.5

1.6

0.69

0.76

g/l

1.15

456

2508

Mood disorders

1539

6164

1.61

61.55

1.5

1.6

0.67

0.78

g/l

3.67

1205

4800

Chronic laryngitis and laryngotracheitis

263

869

3.11

61.37

1.5

1.6

0.72

0.80

g/l

0.52

205

671

Mood [affective] disorders

1535

6163

1.61

61.24

1.5

1.6

0.67

0.78

g/l

3.60

1203

4798

Spondyloarthritis

308

1110

2.84

61.23

1.5

0.61

0.81

g/l

3.05

228

865

Hypertension, essential

1157

3786

1.74

60.93

1.6

0.71

0.77

g/l

1.15

876

2961

ILD-related respiratory insufficiency

156

6.79

60.84

1.3

1.6

0.74

0.93

g/l

0.50

123

Viral infections characterized by skin and mucous membrane lesions

706

3634

1.97

60.68

1.6

0.67

0.78

g/l

1.44

545

2836

Allergic rhinitis

569

2679

2.13

60.59

1.6

0.78

0.72

g/l

0.73

487

2088

Malignant neoplasm of pancreas, including Hilmo

176

454

4.01

60.49

1.8

1.7

0.75

0.93

g/l

1.02

131

356

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

919

5053

1.80

60.07

1.6

0.72

0.76

g/l

0.45

709

3948

Chronic hepatitis NAS

10.85

60.06

1.9

1.7

0.72

0.82

g/l

0.18

Mycoses, including avohilmo

1399

6618

1.62

59.79

1.6

0.70

0.77

g/l

1.86

1104

5142

Atrial fibrillation and flutter

479

1329

2.36

59.59

1.5

1.6

0.73

0.80

g/l

0.80

375

1048

Heart failure,strict

716

2543

1.99

59.35

1.4

1.6

0.79

0.86

g/l

0.74

540

1951

Purpura and other haemorrhagic conditions

280

984

2.93

58.66

1.9

1.6

0.75

0.77

g/l

0.06

217

766

Childhood asthma (age<16), excluding more controls

225

520

3.45

58.62

1.5

1.8

0.68

0.83

g/l

1.22

180

415

Nephropathy related operations

254

848

3.10

58.45

1.6

1.7

0.63

0.87

g/l

2.78

196

676

Pneumocystosis

117

8.02

58.41

1.5

1.8

0.49

0.85

g/l

0.93

Pneumocystosis, including avohilmo

117

8.02

58.41

1.5

1.8

0.49

0.85

g/l

0.93

Other general symptoms and signs

133

283

4.86

57.96

2.0

1.5

0.58

0.69

g/l

0.87

100

233

Other disorders of skin and subcutaneous tissue

1080

5371

1.71

57.84

1.6

0.72

0.77

g/l

0.60

840

4186

Hypertensive diseases

1176

3918

1.71

57.64

1.6

0.71

0.77

g/l

0.76

895

3069

Childhood asthma (age<16)

225

526

3.41

57.63

1.5

1.8

0.68

0.83

g/l

1.26

180

418

Hypertension

1173

3916

1.71

57.04

1.6

0.71

0.77

g/l

0.85

892

3068

Continuous positive airway pressure

293

871

2.86

56.82

1.5

1.6

0.70

0.92

g/l

2.79

259

706

Syncope and collapse

588

2399

2.07

56.52

1.6

1.5

0.72

0.81

g/l

1.35

445

1867

Hypothyroidism, drug reimbursement

227

473

3.42

56.37

1.8

1.5

0.66

0.76

g/l

0.94

177

391

Crohn disease (strict definition, require KELA)

174

470

3.88

56.36

2.0

1.7

0.63

0.76

g/l

0.92

140

371

Osteoporosis with pathological fracture (FG)

137

309

4.59

56.25

1.7

1.4

0.68

0.67

g/l

0.01

245

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

118

236

5.26

56.23

1.6

1.8

0.63

0.96

g/l

1.61

191

Protozoal diseases, including avohilmo

104

187

6.00

56.11

1.5

1.7

0.63

0.77

g/l

0.36

151

Diseases of arteries, arterioles and capillaries (FINNGEN)

369

1005

2.58

56.06

1.7

0.86

0.82

g/l

0.19

280

792

Other antidepressants

1474

4720

1.61

55.89

1.5

1.6

0.71

0.81

g/l

2.79

1124

3700

Exposure to unspecified factor

1512

6583

1.57

55.86

1.6

0.76

g/l

0.04

1117

5193

Infections of the skin and subcutaneous tissue

934

5291

1.76

55.85

1.6

0.74

0.79

g/l

0.46

749

4110

Erysipelas

769

3577

1.87

55.78

1.6

0.76

0.83

g/l

0.77

604

2762

Crohn disease (strict definition, require KELA, min 2 HDR)

172

465

3.88

55.65

2.0

1.7

0.62

0.77

g/l

0.95

138

367

Drug-induced osteoporosis with pathological fracture

9.39

55.60

2.0

2.1

0.69

0.91

g/l

0.43

Anxiety (asthma-related co-morbidities)

975

4277

1.75

55.34

1.5

1.6

0.68

0.75

g/l

1.56

794

3355

Disorders of conjunctiva

1278

6150

1.62

54.98

1.6

0.65

0.77

g/l

5.12

1026

4781

Sleep apnoea, including avohilmo

1455

5576

1.59

54.89

1.5

1.6

0.73

0.77

g/l

0.80

1076

4384

Crohn's disease of small intestine

169

455

3.87

54.89

1.8

1.6

0.70

0.79

g/l

0.35

141

355

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

573

2846

2.05

54.87

1.8

1.5

0.77

0.72

g/l

0.53

398

2224

Other bacterial intestinal infections, including avohilmo

389

1657

2.39

54.77

1.6

1.5

0.63

0.80

g/l

3.20

303

1280

Other bacterial intestinal infections

313

1206

2.65

54.72

1.6

1.5

0.61

0.81

g/l

3.10

238

930

Protozoal diseases

101

182

5.99

54.40

1.5

1.7

0.55

0.78

g/l

0.71

149

Disorders of orbit

125

271

4.88

54.31

2.2

1.7

0.93

0.78

g/l

0.46

218

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

181

515

3.67

54.28

2.0

1.7

0.63

0.76

g/l

0.94

147

408

Heart failure and antihypertensive medication

385

1018

2.50

54.10

1.5

1.6

0.76

0.87

g/l

0.61

297

806

Other diseases of intestine

270

971

2.85

54.05

1.6

0.78

0.90

g/l

0.95

202

738

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

8.27

53.87

2.2

1.7

1.02

1.03

g/l

0.01

Systemic lupus erythematosus

103

191

5.73

53.57

1.6

1.5

0.50

0.74

g/l

1.65

160

GI-bleeding

464

2146

2.19

53.50

1.7

1.6

0.76

0.84

g/l

0.75

363

1661

Simple and mucopurulent chronic bronchitis

170

5.97

53.30

1.3

1.6

0.61

0.86

g/l

1.26

133

Rheumatism, unspecified

245

845

2.98

53.08

1.8

1.6

0.62

0.77

g/l

1.55

188

646

Care involving use of rehabilitation procedures

953

5012

1.73

53.07

1.5

1.6

0.65

0.80

g/l

6.08

722

3908

Pulmonary heart disease, diseases of pulmonary circulation

475

2226

2.17

53.02

1.6

0.77

0.83

g/l

0.45

376

1713

Other diseases of the digestive system

464

2156

2.18

52.91

1.7

1.6

0.74

0.84

g/l

1.12

365

1671

Pulmonary eosinophilia, not elsewhere classified

11.73

52.79

2.1

1.9

1.83

0.85

g/l

1.31

Respiratory insufficiency

123

267

4.71

52.56

1.4

1.5

0.75

0.88

g/l

0.64

210

Visual disturbances and blindness

796

4462

1.80

52.28

1.7

1.6

0.82

0.76

g/l

0.61

625

3470

Other/unspecified dorsalgia

561

2774

2.02

52.22

1.5

1.6

0.65

0.81

g/l

3.79

433

2165

L04AC Interleukin inhibitors

176

506

3.64

52.01

1.6

1.7

0.66

0.74

g/l

0.29

133

393

Infection due to other mycobacteria

10.26

51.47

1.5

1.4

0.65

0.68

g/l

0.10

Spondylosis

755

3235

1.84

51.20

1.5

1.6

0.69

0.85

g/l

3.27

556

2514

All anxiety disorders

990

4558

1.70

51.08

1.5

1.6

0.67

0.73

g/l

1.29

807

3547

Spondylopathies (FG)

255

922

2.83

50.63

1.6

0.58

0.75

g/l

2.09

191

712

Visual disturbances

748

4162

1.82

50.62

1.8

1.6

0.80

0.75

g/l

0.52

585

3241

Lumbar disc prolapse

910

3907

1.74

50.59

1.5

1.6

0.68

0.82

g/l

4.22

692

3038

Glomerular diseases

322

1312

2.51

50.25

1.9

1.6

0.66

0.81

g/l

1.33

240

1031

Non-Hodgkin lymphoma, all, including Hilmo

234

813

2.96

50.07

1.6

0.57

0.83

g/l

2.39

175

638

Hard cardiovascular diseases

1192

4350

1.63

49.92

1.6

0.75

0.79

g/l

0.70

929

3380

Conjunctivitis

1158

5802

1.62

49.82

1.7

1.5

0.64

0.75

g/l

3.64

940

4510

Recurrent or chronic depression

638

2302

1.95

49.79

1.5

1.6

0.71

0.80

g/l

1.48

500

1809

Depression or dysthymia

967

3073

1.73

49.75

1.5

1.7

0.73

0.85

g/l

2.39

747

2398

Symptoms and signs involving the nervous and musculoskeletal systems

858

4997

1.74

49.42

1.7

1.6

0.65

0.77

g/l

3.50

660

3914

Other pleural conditions

173

507

3.51

49.25

1.7

1.6

0.77

0.92

g/l

0.81

128

406

Percutaneous Coronary Intervention

1112

4125

1.65

49.23

1.6

0.73

0.81

g/l

1.58

861

3236

Other symptoms and signs involving the digestive system and abdomen

257

946

2.77

49.15

1.6

1.5

0.75

0.77

g/l

0.10

186

758

Voice disturbances

441

2072

2.17

49.11

1.6

1.5

0.62

0.74

g/l

2.24

347

1602

Pericarditis

174

5.69

48.90

1.4

1.8

0.69

0.84

g/l

0.64

144

Polyneuropathies and other disorders of the peripheral nervous system

355

1529

2.37

48.89

1.6

0.65

0.86

g/l

3.97

286

1188

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1426

5852

1.55

48.84

1.6

0.69

0.77

g/l

1.92

1081

4648

Nerve, nerve root and plexus disorders

1503

5918

1.54

48.82

1.6

0.71

0.77

g/l

1.40

1133

4627

COPD, hospital admission 2, with asthma infections

445

1790

2.17

48.67

1.5

1.6

0.76

0.87

g/l

1.11

344

1378

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

834

4836

1.74

48.40

1.5

1.6

0.71

0.76

g/l

0.51

638

3767

Gout

371

1383

2.33

48.35

1.5

1.8

0.77

0.97

g/l

2.03

285

1066

Infection due to other mycobacteria, including avohilmo

8.99

48.26

1.5

1.4

0.65

0.71

g/l

0.19

Explicit bacterial Sepsis, including avohilmo

200

653

3.14

47.75

1.7

0.86

0.87

g/l

0.03

149

528

Hypothyroidism, strict autoimmune

866

3282

1.74

47.56

1.5

0.67

0.76

g/l

1.92

657

2575

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

111

243

4.75

47.45

2.1

1.7

0.81

1.00

g/l

0.71

195

Heart failure, strict

758

2942

1.81

47.38

1.5

1.6

0.80

0.85

g/l

0.51

572

2280

Other and unspecified polyneuropathies, also in other diseases

314

1299

2.47

47.38

1.7

1.6

0.66

0.87

g/l

3.30

254

1005

Ischemic heart diseases

1164

4313

1.62

47.37

1.6

0.72

0.80

g/l

1.61

878

3380

Paralytic ileus and intestinal obstruction

366

1618

2.29

47.14

1.5

1.6

0.65

0.85

g/l

3.19

272

1239

Urticaria

508

2554

2.02

47.09

1.6

0.67

0.71

g/l

0.60

410

2000

Other nutritional deficiencies

1015

5698

1.64

46.97

1.4

1.6

0.70

0.75

g/l

0.90

801

4458

Coronary revascularization (ANGIO or CABG)

1103

4131

1.64

46.83

1.6

0.73

0.81

g/l

1.57

855

3240

Follow-up examination after treatment for conditions other than malignant neoplasms

550

1844

2.01

46.57

1.5

0.71

0.79

g/l

0.94

450

1338

Explicit bacterial Sepsis

194

632

3.15

46.50

1.7

0.81

0.88

g/l

0.17

143

514

Emergency coronary revascularization (for ACS)

1165

4407

1.61

46.25

1.6

0.73

0.82

g/l

1.73

903

3435

Symptoms and signs involving speech and voice

516

2625

2.00

46.24

1.6

1.5

0.64

0.76

g/l

1.70

406

2027

Later onset COPD, excluding more controls

219

561

3.02

46.14

1.3

1.4

0.84

0.86

g/l

0.06

172

431

Alcoholic liver disease

187

600

3.21

46.11

1.3

1.6

1.08

0.83

g/l

1.51

143

472

Panniculitis, unspecified

12.20

45.90

1.6

2.8

0.66

1.03

g/l

0.46

Factors influencing health status and contact with health services

373

783

2.42

45.80

1.7

0.80

0.97

g/l

1.56

300

591

Candidiasis

269

1053

2.62

45.76

1.6

0.66

0.75

g/l

0.69

203

825

Gastroduodenal ulcer

341

1478

2.33

45.74

1.5

1.7

0.75

0.90

g/l

1.81

261

1131

Bacterial intestinal infections, IBD co-morbidities

305

1266

2.46

45.67

1.6

0.61

0.79

g/l

2.76

233

981

Malignant neoplasm of pancreas

135

353

3.95

45.63

1.4

1.7

0.72

0.96

g/l

1.23

277

Atrial fibrillation and flutter with reimbursement

360

967

2.38

45.54

1.6

0.74

0.82

g/l

0.66

279

762

Any mental disorder

1520

5040

1.52

45.46

1.5

1.6

0.73

0.80

g/l

1.44

1182

3921

Disturbances of skin sensation

465

2297

2.06

45.34

1.5

0.63

0.71

g/l

1.60

368

1779

Other specified/unspecified necrotizing vasculopathies

9.53

45.18

2.1

1.9

0.61

0.84

g/l

0.48

Non-invasive ventilation

343

1281

2.34

45.17

1.6

0.70

0.84

g/l

1.01

150

1037

Insulin, combination of fast acting with intermediate-acting or long-acting

866

4682

1.69

45.12

1.8

1.6

0.82

0.80

g/l

0.17

642

3643

All-cause Heart Failure

740

2897

1.79

45.12

1.5

1.6

0.79

0.86

g/l

0.65

559

2249

Major coronary heart disease event

1156

4351

1.60

45.06

1.6

0.74

0.82

g/l

1.45

892

3394

Ulcerative rectosigmoiditis

177

561

3.26

44.66

1.9

1.5

0.68

0.80

g/l

0.74

134

430

Nonsuppurative otitis media, including avohilmo

528

2350

1.97

44.53

1.7

1.6

0.71

0.73

g/l

0.20

418

1854

Pulmonary embolism

425

2044

2.11

44.45

1.6

0.78

0.82

g/l

0.27

333

1577

Conjunctivitis (acute, non atopic), including avohilmo

1426

5700

1.52

44.42

1.6

0.73

0.80

g/l

1.68

1141

4388

COPD, hospital admissions 3, with asthma pneumonia sepsis

366

1409

2.26

44.14

1.6

1.7

0.77

0.87

g/l

0.88

286

1089

Insulin medication

866

4300

1.69

43.85

1.8

1.6

0.82

0.80

g/l

0.13

642

3353

Pulmonary heart disease

425

2058

2.10

43.66

1.6

0.78

0.82

g/l

0.25

333

1592

Other chronic obstructive pulmonary disease, including avohilmo

713

3329

1.78

43.39

1.6

0.82

0.84

g/l

0.19

554

2565

Atypical mycobacterium lung infection

11.80

43.31

1.4

1.3

0.78

0.63

g/l

0.49

Diseases of middle ear and mastoid

870

4269

1.68

43.30

1.6

0.72

0.75

g/l

0.28

670

3329

Nonsuppurative otitis media

400

1632

2.16

43.28

1.7

1.6

0.72

0.75

g/l

0.26

307

1300

Migraine without aura

346

1557

2.26

42.95

1.5

1.6

0.55

0.70

g/l

2.80

266

1257

Seropositive rheumatoid arthritis, wide

398

1894

2.14

42.93

1.7

1.5

0.77

0.74

g/l

0.17

308

1455

Alcohol use disorder, Swedish definition

792

4260

1.71

42.51

1.5

1.7

0.80

0.82

g/l

0.20

582

3319

Cerebrovascular diseases (FINNGEN)

433

1455

2.11

42.48

1.6

0.80

0.77

g/l

0.14

344

1147

Diseases of arteries, arterioles and capillaries

878

3879

1.67

42.42

1.6

0.81

0.82

g/l

0.09

679

2989

836

4492

1.68

42.01

1.5

1.7

0.81

0.82

g/l

0.05

617

3500

Intracranial trauma

801

3175

1.72

41.96

1.5

1.7

0.76

0.81

g/l

0.56

613

2528

Early onset COPD

344

1561

2.25

41.93

1.7

1.6

0.77

0.86

g/l

0.62

267

1206

Chronic diseases of tonsils and adenoids

1034

4076

1.61

41.88

1.5

1.6

0.63

0.77

g/l

4.74

830

3130

Streptococcal septicaemia, including avohilmo

166

527

3.24

41.67

1.8

1.6

0.88

0.86

g/l

0.04

121

433

Migraine with aura

399

1922

2.11

41.58

1.4

1.6

0.59

0.70

g/l

1.46

325

1529

DVT of lower extremities and pulmonary embolism

566

3059

1.86

41.57

1.6

0.76

0.80

g/l

0.33

437

2361

Other reaction to severe stress, and adjustment disorders

575

3143

1.85

41.27

1.7

1.6

0.64

0.71

g/l

1.05

450

2458

Urinary track infection

837

2462

1.72

41.00

1.6

1.5

0.58

0.65

g/l

1.65

656

1941

Concussion

706

3145

1.76

40.97

1.5

1.7

0.72

0.81

g/l

1.08

540

2503

Shoulder lesions

988

3671

1.62

40.93

1.5

1.6

0.67

0.83

g/l

3.97

774

2833

Corticotropin deficiency

10.32

40.91

1.9

2.1

0.72

0.86

g/l

0.20

Symptoms and signs involving cognition, perception, emotional state and behaviour

1356

6070

1.50

40.74

1.5

1.6

0.72

0.76

g/l

0.69

1038

4756

Temporal arteritis

166

5.32

40.68

1.5

1.7

0.79

0.83

g/l

0.08

129

Streptococcal septicaemia

161

510

3.24

40.58

1.8

1.6

0.83

0.87

g/l

0.08

116

421

Psoriatic and enteropathic arthropathies

207

755

2.81

40.56

1.5

1.6

0.60

0.75

g/l

1.52

165

587

Thrombocytopenia, unspecified

147

442

3.44

40.45

2.0

1.6

0.68

0.87

g/l

1.08

111

345

Herpesviral [herpes simplex] infections

228

877

2.67

40.32

1.6

1.7

0.79

0.73

g/l

0.21

179

689

SLE, strict definition

215

4.73

40.23

1.6

0.50

0.82

g/l

2.21

175

SLE, ICD10

215

4.73

40.23

1.6

0.50

0.82

g/l

2.21

175

Hypo-osmolality and hyponatraemia

262

1067

2.48

40.15

1.4

1.6

0.64

0.80

g/l

1.85

180

824

Enterocolitis due to Clostridium difficile

178

603

3.02

39.93

1.6

0.59

0.85

g/l

2.84

131

479

COPD, hospital admissions

574

2650

1.84

39.74

1.6

0.81

0.87

g/l

0.48

447

2031

Aspergillosis, including avohilmo

10.34

39.57

1.5

1.9

0.79

1.03

g/l

0.36

Other/unspecified seropositive rheumatoid arthritis

385

1867

2.10

39.55

1.6

0.77

0.75

g/l

0.14

300

1432

Abnormal weight loss

176

597

3.04

39.52

1.7

1.6

0.97

0.80

g/l

0.54

135

473

866

4642

1.64

39.48

1.5

1.7

0.81

g/l

0.04

641

3606

Glomerulonephritis

188

666

2.91

39.05

2.1

1.6

0.73

0.78

g/l

0.20

132

528

Adenocarcinoma and ductal carcinoma of pancreas

176

5.06

39.01

1.3

1.8

0.71

1.08

g/l

1.28

142

COPD, early/later onset

577

2674

1.83

38.98

1.6

0.81

0.87

g/l

0.46

448

2052

Diseases of the ear and mastoid process

1582

5468

1.46

38.80

1.6

0.72

0.77

g/l

0.93

1206

4308

Inflammatory diseases of the central nervous system

168

562

3.09

38.71

1.6

1.7

0.61

0.79

g/l

1.82

136

436

Benzodiazepine use

1396

6419

1.48

38.69

1.5

1.6

0.70

0.77

g/l

1.86

1063

5019

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

380

1851

2.09

38.60

1.6

0.77

0.75

g/l

0.13

297

1418

Other anxiety disorders

716

3595

1.71

38.51

1.5

1.6

0.65

0.73

g/l

1.60

596

2793

Disorders of sclera, cornea, iris and ciliary body

800

4902

1.65

38.25

1.7

1.6

0.71

0.77

g/l

0.77

623

3831

Aspergillosis

10.13

38.12

1.5

1.9

0.80

1.03

g/l

0.33

Weight loss

189

680

2.86

38.11

1.7

1.6

0.92

0.79

g/l

0.43

146

540

Other disorders of urethra and urinary system

954

4184

1.60

38.10

1.4

1.6

0.63

0.76

g/l

4.22

714

3290

Special screening examination for infectious and parasitic diseases

344

1151

2.20

38.09

1.6

1.5

0.70

0.78

g/l

0.98

289

839

Venous thromboembolism

715

4096

1.70

38.03

1.6

0.75

0.80

g/l

0.47

553

3175

Other (seronegative) rheumatoid arthritis, wide

292

1295

2.30

37.70

1.5

1.6

0.56

0.76

g/l

3.58

233

993

Acute tubulo-interstitial nephritis

836

4355

1.63

37.69

1.6

0.64

0.75

g/l

3.07

647

3414

Other diseases of lip and oral mucosa

630

3640

1.75

37.67

1.6

0.72

0.75

g/l

0.28

481

2837

Other complications of surgical and medical care, not elsewhere classified

184

658

2.87

37.52

1.4

1.6

0.62

0.77

g/l

1.22

147

514

Disorders of skin appendages

753

4542

1.67

37.49

1.6

0.66

0.75

g/l

2.21

596

3545

Gout, FINNGEN

371

1796

2.08

37.49

1.5

1.7

0.77

0.93

g/l

1.67

285

1390

Secondary hypertension

140

420

3.37

37.48

1.3

1.5

0.79

g/l

0.01

340

Other arthrosis

688

2678

1.74

37.44

1.5

1.7

0.74

0.85

g/l

1.78

531

2092

Polyarthrosis

292

1164

2.29

36.99

1.7

1.6

0.65

0.75

g/l

1.07

217

916

Hernia

1284

5767

1.49

36.98

1.7

1.6

0.77

0.75

g/l

0.19

1005

4467

Use of hypnotics and sedatives

1457

5741

1.46

36.86

1.6

0.71

0.78

g/l

1.84

1133

4469

Giant cell arteritis with polymyalgia rheumatica

181

4.87

36.81

1.5

1.7

0.79

0.87

g/l

0.22

143

Atopic dermatitis, strict definition with reimbursement

473

2422

1.90

36.72

1.6

0.73

0.72

g/l

0.10

390

1896

Benign neoplasm: Colon, unspecified

356

1726

2.10

36.64

1.8

1.6

0.67

0.86

g/l

3.06

280

1331

Malignant neoplasm of other and unspecified parts of biliary tract

7.91

36.58

2.1

1.7

0.99

0.92

g/l

0.10

Obesity and other hyperalimentation

925

5565

1.58

36.47

1.4

1.6

0.71

0.75

g/l

0.65

729

4354

Spinal stenosis

627

2651

1.76

36.35

1.5

1.6

0.72

0.88

g/l

2.85

472

2049

242

1006

2.45

36.28

1.7

1.6

0.70

0.72

g/l

0.12

169

765

Paroxysmal tachycardia

316

1202

2.21

36.26

1.6

0.77

0.76

g/l

0.08

243

940

Obesity

920

5544

1.58

36.26

1.4

1.6

0.71

0.75

g/l

0.64

724

4342

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

804

4778

1.63

36.26

1.7

1.5

0.64

0.71

g/l

1.55

664

3736

Disorders of synovium and tendon

725

3709

1.67

35.88

1.6

0.64

0.81

g/l

5.47

552

2878

Other or unspecified ileus, impaction or obstruction

255

1089

2.38

35.84

1.4

1.6

0.63

0.88

g/l

3.20

182

832

Other viral diseases, including avohilmo

601

3440

1.75

35.83

1.5

1.6

0.59

0.75

g/l

4.88

472

2706

Drug-induced cataract

136

5.58

35.83

1.9

1.8

0.48

0.87

g/l

1.84

112

Polyarteritis nodosa and related conditions

7.62

35.81

1.8

1.49

0.82

g/l

1.07

Pain in thoracic spine

245

1031

2.42

35.71

1.5

0.65

0.82

g/l

1.18

199

799

COPD related to multimorbidity

491

2242

1.87

35.69

1.5

1.6

0.79

0.88

g/l

0.83

376

1710

Cervical disc disorders

482

2617

1.86

35.54

1.6

0.65

0.86

g/l

5.69

363

2036

Ovarian cyst

475

1415

1.94

35.53

1.4

1.5

0.59

0.63

g/l

0.50

371

1094

Diabetes mellitus

1405

5599

1.46

35.48

1.7

1.6

0.73

0.76

g/l

0.36

1055

4405

Viral pneumonia (unknown virus, not influenza)

138

434

3.28

35.37

1.5

1.8

0.56

0.85

g/l

3.40

351

Sequelae of external causes of morbidity and mortality

388

1967

2.00

35.32

1.5

1.6

0.74

0.80

g/l

0.35

297

1519

Diabetes, varying definitions

1397

5592

1.46

35.22

1.7

1.6

0.73

0.76

g/l

0.36

1048

4398

Other arrhythmias

866

4073

1.60

35.21

1.5

1.6

0.69

0.76

g/l

1.21

648

3207

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1299

5612

1.47

35.06

1.7

1.6

0.79

0.76

g/l

0.35

993

4387

Insulin, fast-acting

521

2910

1.81

34.99

1.9

1.6

0.79

0.81

g/l

0.11

389

2287

Insulin, intermediate and long-acting

740

4382

1.64

34.95

1.8

1.6

0.82

0.80

g/l

0.13

559

3415

Seronegative rheumatoid arthritis

174

627

2.83

34.90

1.4

1.5

0.52

0.71

g/l

2.02

130

472

Zoster [herpes zoster], including avohilmo

703

4113

1.67

34.87

1.7

1.6

0.68

0.78

g/l

1.19

548

3206

UC patients in KELA-register (code 208), prior to 1994

100

258

4.06

34.75

2.3

1.7

0.80

0.88

g/l

0.20

211

Cutaneous abscess, furuncle and carbuncle

415

2171

1.94

34.46

1.6

0.73

0.78

g/l

0.26

330

1707

Hypokalaemia

201

785

2.62

34.46

1.6

0.82

0.77

g/l

0.21

153

613

Systemic sclerosis (FG)

112

5.96

34.35

1.6

1.8

0.50

0.69

g/l

0.60

Hypermobility syndrome

121

358

3.51

34.29

1.6

1.5

0.45

0.56

g/l

1.32

287

Gastric ulcer

232

970

2.43

34.25

1.5

1.6

0.78

0.87

g/l

0.56

181

746

Other medical care

649

3230

1.70

34.24

1.4

1.6

0.72

0.81

g/l

1.09

501

2488

All influenza (not pneumonia)

238

1008

2.41

34.22

1.4

1.6

0.73

0.84

g/l

0.70

181

791

Suppurative and unspecified otitis media

565

2866

1.77

34.20

1.6

0.73

g/l

0.04

442

2262

Herpesviral [herpes simplex] infections, including avohilmo

409

2138

1.94

34.05

1.5

1.6

0.76

0.71

g/l

0.31

319

1653

Intestinal stricture

430

2286

1.91

33.95

1.5

1.6

0.66

0.83

g/l

3.24

325

1757

Multiple myeloma, including Hilmo

210

4.35

33.85

1.5

1.8

0.36

1.00

g/l

5.51

171

Drug-induced osteoporosis

7.46

33.73

2.2

1.8

0.54

0.77

g/l

0.56

Symptoms and signs involving the urinary system

1025

5113

1.52

33.63

1.6

0.78

g/l

0.05

786

3965

Other symptoms and signs involving the nervous and musculoskeletal systems

603

3553

1.72

33.61

1.7

1.6

0.62

0.76

g/l

4.15

450

2765

Disorders of oesophagus in diseases classified elsewhere

101

6.21

33.48

1.7

1.2

0.68

0.75

g/l

0.21

Nonorganic sleeping disorders, excluding more controls

323

1564

2.10

33.40

1.5

1.6

0.65

0.76

g/l

1.46

252

1227

Allergic conjunctivitis

833

5116

1.58

33.39

1.7

1.5

0.63

0.70

g/l

1.62

690

3991

Other and unspecified disorders of white blood cells

227

4.19

33.10

1.5

1.7

0.76

0.82

g/l

0.15

183

Type 2 diabetes

1320

5283

1.45

33.07

1.7

1.6

0.73

0.75

g/l

0.32

1001

4140

Heart failure and coronary heart disease

503

1946

1.83

32.87

1.4

1.6

0.74

0.93

g/l

3.28

385

1488

Acute suppurative otitis media

433

2166

1.89

32.84

1.7

1.6

0.74

0.72

g/l

0.08

341

1723

Other inflammation of eyelid, including avohilmo

651

3948

1.67

32.53

1.5

0.72

g/l

0.02

519

3081

COPD, hospital admissions 1, only main diagnosis

417

1898

1.91

32.41

1.4

1.7

0.72

0.88

g/l

2.43

325

1458

Convulsions, not elsewhere classified

309

1472

2.10

32.14

1.4

1.6

0.64

0.82

g/l

3.47

239

1152

Somatoform disorder

266

1215

2.23

32.08

1.5

1.6

0.67

0.76

g/l

0.79

202

928

Mixed connective tissue disease

6.78

32.04

2.0

1.3

0.81

0.51

g/l

0.83

Pain and other conditions associated with female genital organs and menstrual cycle

309

1234

2.12

32.00

1.4

1.5

0.66

0.65

g/l

0.08

235

972

Pneumonia due to Streptococcus pneumoniae

220

4.15

31.85

1.9

1.8

0.62

0.93

g/l

1.24

181

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

922

5534

1.53

31.79

1.5

1.6

0.68

0.74

g/l

1.01

705

4331

Adverse effects, not elsewhere classified

325

1611

2.05

31.64

1.7

1.6

0.65

0.72

g/l

0.74

263

1264

Psychiatric diseases

1295

4484

1.46

31.55

1.5

1.6

0.70

0.81

g/l

2.97

1001

3500

Colectomy operation

248

1109

2.28

31.50

2.0

1.6

0.97

0.82

g/l

0.90

196

858

Polypectomy (DHB20)

132

434

3.14

31.49

2.4

1.7

1.10

0.86

g/l

1.35

118

343

Other and unspecified effects of external causes

430

2345

1.86

31.42

1.6

0.71

0.72

g/l

0.06

347

1834

Temporomandibular joint disorders, including avohilmo

663

3947

1.64

31.28

1.6

1.5

0.61

0.68

g/l

1.38

501

3117

Glomerular disorders in diseases classified elsewhere

192

770

2.55

31.25

1.5

1.6

0.60

0.84

g/l

2.78

144

610

Insulin, fast-acting or short human

522

3019

1.75

31.15

1.9

1.6

0.79

0.82

g/l

0.14

390

2368

Disorders of the thyroid gland

1247

5620

1.45

31.13

1.6

0.71

0.75

g/l

0.59

930

4436

Enteropathic arthropathies

123

5.41

31.06

1.9

2.0

0.50

0.80

g/l

1.21

101

Disorders of lens

871

3485

1.56

30.99

1.6

0.70

0.81

g/l

2.29

654

2768

Need for other prophylactic measures

122

387

3.27

30.95

1.6

1.8

0.52

0.83

g/l

3.37

117

311

Personal history of allergy to drugs, medicaments and biological substances

7.07

30.87

1.9

1.8

1.02

0.83

g/l

0.41

Disorders of lipoprotein metabolism and other lipidaemias

1055

4313

1.50

30.79

1.6

0.78

0.79

g/l

0.15

826

3359

Multiple myeloma and malignant plasma cell neoplasms

239

3.95

30.78

1.5

1.7

0.35

0.89

g/l

5.32

189

Viral hepatitis, IBD co-morbidity

225

4.01

30.73

1.5

1.7

0.81

0.77

g/l

0.15

178

Migraine with aura and triptan purchases

271

1269

2.17

30.72

1.4

1.6

0.59

0.68

g/l

0.58

221

996

Thyroiditis, ILD-related definition

182

717

2.59

30.71

1.7

1.5

0.67

0.73

g/l

0.37

139

560

Idiopathic thrombocytopenic purpura

185

4.44

30.44

1.9

1.7

0.90

0.82

g/l

0.19

148

Other specified/unspecified inflammatory spondylopathies

103

298

3.58

30.24

1.7

1.8

0.48

0.79

g/l

2.84

231

Sequelae with surgical and medical care as external cause

302

1482

2.07

30.24

1.6

0.78

0.81

g/l

0.11

234

1140

Pruritus

187

753

2.53

30.15

1.6

1.5

0.75

0.71

g/l

0.21

154

580

Rotator cuff syndrome

769

3356

1.59

30.13

1.5

1.6

0.69

0.85

g/l

2.78

608

2594

Agranulocytosis

189

766

2.53

30.12

1.4

1.6

0.53

0.78

g/l

3.25

138

590

Cervicalgia

293

1424

2.09

30.05

1.7

1.6

0.69

0.83

g/l

1.78

236

1099

Other inflammation of eyelid

232

1031

2.29

29.97

1.5

1.6

0.76

g/l

0.00

184

808

Deviated nasal septum

427

2355

1.83

29.91

1.7

1.6

0.83

0.84

g/l

0.03

325

1782

Non-selective monoamine reuptake inhibitors

495

2735

1.75

29.85

1.5

1.6

0.64

0.80

g/l

3.22

375

2143

Other disorders of eye and adnexa

245

1116

2.24

29.84

1.6

0.57

0.75

g/l

3.40

197

861

Exposure to other specified factors

1121

6671

1.45

29.72

1.6

0.75

0.76

g/l

0.10

883

5205

Other diseases of hard tissues of teeth

683

2153

1.66

29.71

1.6

0.78

0.85

g/l

0.75

513

1658

Congenital malformations, deformations and chromosomal abnormalities

835

5189

1.54

29.71

1.5

1.6

0.67

0.74

g/l

1.41

638

4067

Other CVD (FINNGEN)

160

443

2.80

29.70

1.4

0.61

0.77

g/l

1.49

109

341

Other abnormal immunological findings in serum

117

5.45

29.69

1.9

1.6

1.03

0.70

g/l

0.58

Non-follicular lymphoma

154

569

2.78

29.63

1.6

0.48

0.88

g/l

6.59

113

448

Migraine without aura and triptan purchases

279

1341

2.12

29.57

1.5

1.6

0.52

0.68

g/l

3.44

217

1056

Selective serotonin reuptake inhibitors

1305

4762

1.43

29.57

1.5

1.6

0.72

0.81

g/l

1.89

1000

3737

Other diseases of urinary system

1293

5103

1.43

29.50

1.6

0.70

0.79

g/l

2.05

982

4023

Subjective visual disturbances

374

1994

1.90

29.41

1.7

1.5

0.70

0.75

g/l

0.34

292

1536

Dizziness and giddiness

997

5251

1.49

29.39

1.5

1.6

0.71

0.75

g/l

0.65

772

4115

Pollen allergy

327

1645

1.99

29.31

1.7

1.6

0.81

0.70

g/l

1.01

288

1293

Viral pneumonia (known virus, not influenza)

149

4.79

29.28

1.5

1.7

0.70

0.81

g/l

0.30

121

Other viral diseases

459

2601

1.78

29.20

1.6

0.60

0.76

g/l

3.79

360

2055

Non-ischemic cardiomyopathy

386

1631

1.90

29.12

1.4

1.6

0.84

0.87

g/l

0.18

298

1256

Heartburn

166

642

2.63

29.07

1.4

0.67

0.81

g/l

0.87

126

505

Chronic apical periodontitis

1489

6032

1.39

29.06

1.5

1.6

0.73

0.76

g/l

0.46

1137

4720

Systemic lupus erythematosus, unspecified

184

4.35

28.91

1.4

1.7

0.48

0.78

g/l

1.93

148

Other diseases of stomach and duodenum

110

341

3.32

28.89

1.4

0.62

0.84

g/l

1.44

268

Crohn disease (strict definition, all UC cases excluded)

111

347

3.32

28.88

1.7

1.6

0.64

0.77

g/l

0.59

270

Cervicobrachial syndrome

311

1568

2.01

28.84

1.6

0.64

0.80

g/l

1.82

260

1209

Arthrosis

860

3063

1.55

28.84

1.5

1.6

0.79

0.82

g/l

0.32

666

2391

Congenital malformations of the respiratory system, including avohilmo

132

5.12

28.79

1.7

1.8

0.61

0.73

g/l

0.30

113

Enthesopathies of lower limb, excluding foot

329

1693

1.97

28.77

1.6

0.64

0.81

g/l

2.83

276

1308

Pneumonia derived septicemia

185

4.28

28.59

1.9

0.58

0.87

g/l

1.48

155

Type 2 diabetes, wide definition

902

3769

1.52

28.48

1.7

1.5

0.79

0.81

g/l

0.11

713

3001

Iridocyclitis

340

1777

1.94

28.46

1.7

1.6

0.64

0.78

g/l

2.16

268

1393

Papulosquamous disorders

550

3312

1.68

28.40

1.6

0.75

0.78

g/l

0.20

433

2559

Vasculitis limited to skin, not elsewhere classified

145

4.79

28.37

1.7

1.8

0.77

0.88

g/l

0.25

117

Other diseases of gallbladder

177

4.31

28.37

1.6

1.5

0.74

0.84

g/l

0.47

149

Internal derangement of knee

480

2756

1.74

28.36

1.5

1.7

0.74

0.83

g/l

1.12

365

2165

Valvular heart disease excluding rheumatic fever

576

2470

1.68

28.30

1.5

1.6

0.77

0.83

g/l

0.68

420

1930

COPD-related respiratory insufficiency

161

622

2.64

28.29

1.4

1.6

0.68

0.89

g/l

2.08

123

490

Non-rheumatic valve diseases

571

2443

1.68

28.21

1.5

1.6

0.77

0.83

g/l

0.65

416

1908

Other diseases of anus and rectum

377

2036

1.86

28.04

1.5

1.6

0.76

0.84

g/l

0.70

291

1572

Care involving dialysis

142

519

2.81

27.96

1.4

1.7

0.58

0.91

g/l

2.75

110

414

Other metabolic disorders

217

966

2.29

27.96

1.9

1.6

0.68

0.72

g/l

0.29

157

749

Genitourinary diseases

768

2448

1.58

27.90

1.6

1.7

0.82

0.85

g/l

0.24

609

1921

Persons encountering health services for specific procedures, not carried out

162

634

2.62

27.84

1.4

1.7

0.69

0.81

g/l

0.80

141

498

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1243

5214

1.42

27.82

1.7

1.6

0.75

0.77

g/l

0.25

925

4098

Exophthalmic conditions

7.44

27.70

2.3

1.9

1.35

0.83

g/l

0.67

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

239

3.75

27.57

2.0

1.6

0.94

0.98

g/l

0.11

189

Other and unspecified vasculitis limited to skin

133

4.92

27.46

1.7

1.8

0.82

0.87

g/l

0.09

106

Atopic dermatitis

824

4342

1.52

27.38

1.5

1.6

0.71

0.72

g/l

0.18

669

3420

Volume depletion

141

518

2.78

27.37

1.4

1.6

0.68

0.86

g/l

1.00

102

396

Ulcerative proctitis

119

400

3.07

27.35

1.8

1.6

0.64

0.83

g/l

1.36

316

Heart failure and bmi 25plus

411

1506

1.84

27.21

1.4

1.6

0.84

0.87

g/l

0.13

300

1119

Cystitis

1078

4437

1.45

27.16

1.6

0.66

0.76

g/l

2.65

842

3498

Portal vein thrombosis

5.95

27.04

2.3

1.7

0.66

0.89

g/l

0.60

Other viral diseases, not elsewhere classified, including avohilmo

421

2375

1.78

26.99

1.5

1.7

0.60

0.75

g/l

3.20

340

1874

Systemic sclerosis

139

4.79

26.98

1.6

0.50

0.75

g/l

0.94

118

Hypothyroidism, other/unspecified

1137

5252

1.43

26.88

1.6

1.5

0.68

0.74

g/l

1.36

848

4145

Postviral fatigue syndrome

8.08

26.84

2.1

1.5

0.52

0.47

g/l

0.17

Coeliac disease

196

852

2.35

26.76

2.0

1.6

0.71

0.73

g/l

0.12

147

663

Other and unspecified tonsillitis

466

2248

1.74

26.75

1.5

1.7

0.78

0.81

g/l

0.17

369

1749

Benign neoplasm: Pancreas

165

4.41

26.70

1.7

0.50

0.86

g/l

2.03

131

Gonarthrosis [arthrosis of knee](FG)

849

3229

1.52

26.69

1.5

0.77

0.81

g/l

0.47

671

2504

Other skin changes

280

1400

2.03

26.68

1.9

1.5

0.64

0.79

g/l

2.06

214

1068

Haemorrhoids and perianal venous thrombosis

415

2335

1.78

26.65

1.6

0.71

0.84

g/l

1.83

304

1807

Cardiomyopathy

226

1043

2.20

26.55

1.5

1.6

0.77

0.89

g/l

0.84

172

818

Unspecified kidney failure

144

544

2.70

26.49

1.3

1.6

0.63

0.91

g/l

3.02

114

431

Other symptoms and signs involving the circulatory and respiratory systems

111

365

3.12

26.42

1.5

1.6

0.63

0.83

g/l

1.32

295

Other enthesopathies

398

2236

1.80

26.39

1.7

1.6

0.63

0.82

g/l

4.09

319

1748

Gout, idiopatic and unspecified

317

1664

1.93

26.19

1.5

1.7

0.74

0.93

g/l

2.17

241

1302

Other diseases of arteries and capillaries

141

531

2.71

26.16

1.7

0.75

0.83

g/l

0.18

110

419

Type 2 diabetes, definitions combined

1220

5059

1.41

26.06

1.7

1.6

0.75

0.76

g/l

0.06

927

3970

Acquired haemolytic anaemia

131

4.82

26.01

2.1

1.6

0.72

0.84

g/l

0.29

109

Other viral diseases, not elsewhere classified

298

1533

1.97

25.96

1.6

1.7

0.62

0.81

g/l

3.01

239

1220

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

153

604

2.59

25.85

1.5

0.63

0.73

g/l

0.63

118

475

Substance abuse, excluding more controls

723

3944

1.54

25.82

1.4

1.7

0.76

0.82

g/l

0.66

550

3063

Obesity due to excess calories

666

4299

1.56

25.81

1.3

1.6

0.73

0.74

g/l

0.09

520

3358

Localized swelling, mass and lump of skin and subcutaneous tissue

439

2559

1.73

25.66

2.2

1.5

1.03

0.76

g/l

2.86

374

1977

Ulcer of lower limb, not elsewhere classified

203

911

2.27

25.66

1.3

1.6

0.84

0.89

g/l

0.14

162

704

Suppurative and necrotic conditions of lower respiratory tract

102

326

3.23

25.59

1.5

1.6

0.75

0.88

g/l

0.51

258

Other specified/unspecified soft tissue disorders

228

3.70

25.54

1.5

1.7

0.58

0.87

g/l

1.61

181

Other external causes of accidental injury

1062

3695

1.45

25.42

1.6

0.72

0.78

g/l

1.00

834

2893

Fissure and fistula of anal and rectal regions

316

1675

1.91

25.34

1.4

1.6

0.60

0.84

g/l

5.03

235

1290

Diseases of spleen

103

5.37

25.34

1.7

1.9

0.68

0.85

g/l

0.40

Type 2 diabetes, strict (exclude DM1)

1225

5113

1.40

25.23

1.7

1.6

0.75

0.76

g/l

0.07

932

4003

Disease of hard tissues of teeth, NOS

649

2131

1.61

25.22

1.6

0.79

0.85

g/l

0.62

493

1641

Congenital malformations of the respiratory system

119

5.04

25.21

1.7

1.8

0.68

0.75

g/l

0.13

102

Malignant neoplasm of digestive organs, including Hilmo

542

2434

1.65

25.18

1.7

1.6

0.89

0.86

g/l

0.14

410

1902

Unspecified chronic bronchitis

142

4.50

25.16

1.4

1.6

0.85

0.80

g/l

0.08

113

Inflammatory diseases of female pelvic organs

813

3727

1.50

24.91

1.5

0.61

0.62

g/l

0.14

632

2914

Triptan medication for migraine, single purchase ok

1051

5009

1.43

24.90

1.6

0.65

0.73

g/l

2.00

818

3920

Migraine, single triptan purchase ok & required. ICD-code if available is included

1051

5009

1.43

24.90

1.6

0.65

0.73

g/l

2.00

818

3920

Myocarditis

261

3.47

24.85

1.6

1.5

1.06

0.78

g/l

0.68

212

Ocular pain

155

629

2.53

24.77

1.6

1.7

0.60

0.72

g/l

1.23

124

484

Hypoparathyroidism

188

3.98

24.66

2.3

1.7

0.63

0.78

g/l

0.40

152

Falls/tendency to fall

1422

5234

1.37

24.58

1.5

1.6

0.72

0.77

g/l

1.01

1110

4070

Hypothyreosis and Thyroxine purchase for inclusion criteria

1168

5490

1.40

24.53

1.6

1.5

0.68

0.74

g/l

1.50

869

4328

Pure hypercholesterolaemia

920

4011

1.46

24.53

1.5

1.6

0.83

0.81

g/l

0.24

728

3119

Behavioural syndromes associated with physiological disturbances and physical factors

1261

6210

1.38

24.47

1.5

1.6

0.70

0.77

g/l

2.08

986

4849

Triptan medication for migraine, min. 3 purchases

791

3966

1.50

24.46

1.5

1.6

0.63

0.66

g/l

0.40

630

3108

Other encephalitis

163

4.24

24.46

1.4

1.8

0.46

0.85

g/l

2.16

130

Personal history of allergy to analgesic agent

8.72

24.42

1.7

1.2

1.12

0.64

g/l

1.97

Non-Hodgkin lymphoma, all

198

3.85

24.40

1.5

1.6

0.79

0.99

g/l

0.41

160

Acute and subacute iridocyclitis

282

1461

1.96

24.34

1.6

0.63

0.80

g/l

2.25

219

1144

Diabetes medication

1361

5838

1.37

24.32

1.7

1.6

0.75

0.76

g/l

0.01

1030

4588

Type 2 diabetes, definitions combined, including avohilmo

1222

5099

1.39

24.28

1.7

1.6

0.75

0.76

g/l

0.08

926

3994

Diseases of oral cavity, salivary glands and jaws

658

2156

1.58

24.06

1.6

0.75

0.85

g/l

1.32

509

1661

Multiple myeloma

123

4.74

24.03

1.4

1.8

0.32

1.02

g/l

3.64

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

123

4.74

24.03

1.4

1.8

0.32

1.02

g/l

3.64

Stomatitis and related lesions

300

1595

1.91

23.95

1.5

1.6

0.75

0.74

g/l

0.01

244

1243

Haemolytic anaemias

197

3.85

23.89

2.3

1.7

0.79

0.85

g/l

0.12

159

Dermatitis due to substances taken internally

319

3.16

23.85

1.6

1.7

0.58

0.78

g/l

0.89

251

Disorders of parathyroid gland

255

1269

2.01

23.79

1.7

1.5

0.74

0.76

g/l

0.08

186

967

Fall on same level

1518

6050

1.34

23.75

1.5

1.6

0.72

0.77

g/l

0.94

1191

4715

Benign neoplasm: Stomach

149

606

2.51

23.69

2.0

1.6

0.67

0.80

g/l

0.92

129

462

Anterior Iridocyclitis

296

1573

1.91

23.68

1.6

0.63

0.78

g/l

2.04

230

1227

Ankylosing spondylitis

145

583

2.54

23.62

1.6

1.7

0.60

0.88

g/l

2.62

108

459

Soft tissue disorders related to use, overuse and pressure

353

1981

1.80

23.60

1.5

1.6

0.69

0.85

g/l

2.70

289

1533

Obesity, other/unspecified

483

2954

1.65

23.59

1.5

1.6

0.69

0.71

g/l

0.16

404

2308

Panhypopituitarism

114

4.96

23.52

1.9

1.8

0.66

0.84

g/l

0.55

Hypogonadotropic hypogonadism

243

3.54

23.45

1.6

1.8

0.84

0.89

g/l

0.13

194

STROKE

684

3011

1.54

23.44

1.6

0.81

0.80

g/l

0.11

543

2351

Other and unspecified urticaria

299

1601

1.90

23.38

1.6

0.66

0.72

g/l

0.59

231

1249

Benign neoplasm: Transverse colon

167

720

2.37

23.34

1.9

1.6

0.60

0.87

g/l

2.95

138

557

Encephalitis

178

3.99

23.28

1.4

1.7

0.45

0.82

g/l

2.25

143

Nephrotic syndrome

192

3.86

23.23

2.6

1.6

0.79

0.71

g/l

0.15

154

Disorders of mineral metabolism

139

553

2.57

23.16

1.6

1.7

0.73

0.81

g/l

0.31

435

Ischaemic heart disease, wide definition

941

4040

1.44

23.03

1.6

0.74

0.83

g/l

1.74

708

3157

Other diseases of oesophagus

132

513

2.62

23.02

1.5

0.74

0.87

g/l

0.83

102

397

Accidents

1045

3695

1.42

22.99

1.6

0.72

0.78

g/l

0.98

824

2893

Acetic acid derivatives and related substances

334

921

1.89

22.87

1.5

1.7

0.70

0.85

g/l

1.84

261

723

Reactive arthropathies, FINNGEN

118

436

2.77

22.82

1.4

1.6

0.54

0.75

g/l

1.74

332

Postprocedural disorders of digestive system, not elsewhere classified

185

3.88

22.79

1.8

1.5

0.87

0.77

g/l

0.23

147

Otitis media, unspecified

187

781

2.24

22.78

1.5

1.7

0.75

0.76

g/l

0.04

139

651

Recurrent aphthous stomatitis , including avohilmo

223

1090

2.08

22.76

1.5

1.6

0.71

0.74

g/l

0.16

182

839

Gout, unspecified

258

1327

1.97

22.75

1.6

1.7

0.70

0.92

g/l

2.48

198

1050

Systemic sclerosis, icd10

155

4.22

22.69

1.6

1.8

0.50

0.83

g/l

1.34

128

Zoster [herpes zoster]

251

1281

1.99

22.65

1.6

0.51

0.78

g/l

4.96

197

991

Excessive, frequent and irregular menstruation

465

1473

1.70

22.63

1.5

0.53

0.65

g/l

2.25

343

1143

Extracorporeal dialysis

109

389

2.89

22.59

1.4

1.7

0.53

0.88

g/l

2.22

310

Exclusions for E4_PCOS_CONSORTIUM

962

4230

1.43

22.39

1.6

1.5

0.64

0.68

g/l

0.60

682

3362

Diabetes, insulin treatment (Kela reimbursement)

1293

5686

1.36

22.35

1.7

1.6

0.75

0.77

g/l

0.28

969

4464

Adenocarcinoma of pancreas

135

4.38

22.27

1.4

1.6

0.73

0.97

g/l

0.53

111

Pneumococcal septicemia

199

3.71

22.03

2.0

1.8

0.60

0.83

g/l

1.02

161

Sleep disorders

1199

6073

1.37

21.94

1.6

0.70

0.77

g/l

1.81

939

4734

Radiculopathy

199

945

2.13

21.87

1.5

1.6

0.66

0.87

g/l

2.09

152

729

Psoriasis

393

2330

1.71

21.72

1.5

1.6

0.74

0.78

g/l

0.28

311

1805

Reactive arthropathies

138

566

2.49

21.58

1.4

1.7

0.53

0.78

g/l

3.00

101

435

Misadventures to patients during surgical and medical care

205

991

2.10

21.57

1.5

1.6

0.71

0.79

g/l

0.57

150

771

Paralytic ileus

166

3.91

21.28

1.5

1.7

0.54

0.96

g/l

2.25

134

Seropositive rheumatoid arthritis, strict definition

212

1044

2.06

21.24

1.6

0.88

0.74

g/l

0.81

169

800

Irregular menses

638

3172

1.52

21.17

1.6

1.5

0.56

0.61

g/l

1.28

506

2504

Insomnia

1178

6049

1.36

21.14

1.6

0.70

0.76

g/l

1.37

924

4717

Injuries to the abdomen, lower back, lumbar spine and pelvis

517

3256

1.58

21.00

1.5

1.6

0.78

0.79

g/l

0.02

407

2519

Personality disorders, excluding more controls

345

1987

1.75

20.98

1.5

1.6

0.70

0.75

g/l

0.41

260

1551

Persons with potential health hazards related to communicable diseases

538

3442

1.56

20.94

1.7

1.6

0.64

0.73

g/l

1.43

381

2733

Diseases of tongue

344

2.92

20.88

1.7

1.6

0.66

0.87

g/l

1.17

270

Conjunctivitis (acute, non atopic)

403

2420

1.68

20.86

1.7

1.6

0.67

0.76

g/l

1.22

315

1903

Diseases of pulp and periapical tissues, including avohilmo

1323

5114

1.34

20.72

1.6

0.76

0.77

g/l

0.24

1025

3990

Myositis

131

4.29

20.50

1.2

1.9

0.55

0.96

g/l

1.91

112

External causes of morbidity and mortality

828

2870

1.45

20.41

1.6

0.71

0.78

g/l

1.07

640

2256

Injuries to the ankle and foot

978

6051

1.39

20.39

1.6

0.75

g/l

0.01

789

4700

Disorders of optic nerve and visual pathways

154

681

2.31

20.37

1.6

1.7

0.61

0.72

g/l

0.68

122

540

Meniscus derangement

631

2776

1.52

20.32

1.5

1.7

0.77

0.85

g/l

0.95

471

2167

Other CVD

237

1232

1.95

20.28

1.6

0.68

0.87

g/l

2.26

168

961

Viral and other specified intestinal infections, including avohilmo

389

2250

1.68

20.28

1.8

1.6

0.69

0.76

g/l

0.46

302

1771

Complications of internal orthopaedic prosthetic devices, implants and grafts

261

1403

1.88

20.18

1.4

1.6

0.71

0.84

g/l

1.46

199

1077

Benign neoplasm: Small intestine

226

3.39

20.13

1.5

1.8

0.75

0.87

g/l

0.24

181

Lung cancer and mesothelioma

165

629

2.25

20.13

1.2

1.4

0.71

0.83

g/l

0.74

115

485

Cellulitis

311

1766

1.78

20.12

1.6

0.70

0.80

g/l

0.91

261

1383

Postprocedural endocrine and metabolic disorders, not elsewhere classified

184

878

2.13

20.09

1.9

1.6

0.66

0.71

g/l

0.32

136

684

Missing teeth due to accident, extraction or parodontitis

769

4795

1.44

20.01

1.6

0.70

0.80

g/l

1.97

581

3733

Injuries to the knee and lower leg

1529

6346

1.31

20.01

1.5

1.6

0.71

0.77

g/l

1.05

1210

4929

Psoriatic arthropathies

153

681

2.29

19.90

1.4

1.7

0.65

0.81

g/l

1.14

117

529

Faecal incontinence

114

444

2.61

19.85

1.3

1.4

0.59

0.73

g/l

0.89

338

Senile cataract

731

3042

1.47

19.83

1.5

1.6

0.72

0.83

g/l

1.69

550

2419

Panic disorder

226

1167

1.96

19.81

1.5

1.6

0.65

0.74

g/l

0.72

180

905

Coronary atherosclerosis

737

3193

1.46

19.76

1.6

0.74

0.85

g/l

1.32

557

2488

Diseases of the myoneural junction and muscle

172

805

2.17

19.75

1.6

0.62

0.84

g/l

2.69

135

628

Vascular disorders of the intestines

300

2.99

19.74

1.5

1.6

0.82

0.98

g/l

0.59

232

Other infectious diseases

115

452

2.60

19.73

1.5

1.6

0.58

0.83

g/l

2.20

357

Hyperlipidaemia, other/unspecified

442

2477

1.62

19.69

1.5

1.6

0.67

0.86

g/l

3.73

344

1921

Gonarthrosis

711

2730

1.48

19.67

1.5

1.7

0.77

0.84

g/l

1.03

558

2134

Other peripheral vascular diseases

125

512

2.49

19.66

1.4

1.6

0.62

0.74

g/l

0.70

101

406

Deforming dorsopathies

348

2051

1.71

19.64

1.6

0.67

0.82

g/l

1.87

270

1592

Secondary right heart disease

195

3.54

19.60

1.6

1.7

0.70

0.90

g/l

0.63

157

Coxibs

326

954

1.81

19.59

1.4

1.7

0.73

0.85

g/l

1.12

249

753

Other infectious diseases, including avohilmo

135

574

2.40

19.54

1.6

0.62

0.84

g/l

2.06

100

451

Other pulmonary heart/vessel disease

225

3.34

19.51

1.6

1.7

0.71

0.88

g/l

0.56

180

Nonorganic sleeping disorders

323

1872

1.75

19.49

1.5

1.6

0.65

0.74

g/l

1.01

252

1459

Other/unspecified rheumatoid arthritis

159

725

2.23

19.49

1.5

0.55

0.79

g/l

2.83

128

542

Dentofacial anomalies [including malocclusion]

952

5404

1.39

19.48

1.5

1.6

0.63

0.73

g/l

3.23

715

4256

Hernia of abdominal wall

571

3797

1.52

19.46

1.6

0.77

0.82

g/l

0.45

445

2942

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

358

2105

1.69

19.43

1.4

1.6

0.67

0.73

g/l

0.60

274

1649

Emphysema

341

2.84

19.42

1.5

1.6

0.93

0.92

g/l

0.03

273

Gingivitis and periodontal diseases

1236

4771

1.34

19.41

1.6

0.74

0.79

g/l

1.07

985

3666

Etanercept

119

482

2.53

19.24

1.6

1.7

0.84

0.72

g/l

0.26

384

Other and unspecified drugs and medicaments

135

580

2.38

19.13

1.4

1.7

0.64

0.75

g/l

0.63

108

451

Lung diseases due to external agents

171

808

2.15

19.13

1.5

1.7

0.73

0.87

g/l

0.80

129

644

Cytomegalovirus infection, IBD co-morbidity

143

4.03

19.11

1.3

1.6

0.45

0.75

g/l

1.31

116

Hyperkinetic disorders, excluding more controls

197

912

2.04

19.11

1.5

1.8

0.66

0.75

g/l

0.62

158

721

Dental operations

684

2380

1.49

19.00

1.6

0.77

0.83

g/l

0.69

513

1878

Hypotension

198

992

2.02

18.89

1.5

1.6

0.67

0.89

g/l

2.21

137

770

Secondary and unspecified malignant neoplasm of lymph nodes

121

498

2.48

18.84

1.4

1.6

0.59

0.90

g/l

2.26

391

Dermatographic urticaria

117

476

2.52

18.73

1.9

1.6

0.66

0.70

g/l

0.16

372

Coxarthrosis [arthrosis of hip](FG)

572

2607

1.52

18.66

1.4

1.5

0.77

0.82

g/l

0.47

463

2007

Polyarthritis, unspecified

197

3.46

18.61

1.8

0.76

0.86

g/l

0.24

160

Malignant neoplasm, wide definition

1111

4807

1.35

18.57

1.5

1.6

0.71

0.77

g/l

0.90

850

3763

Malignant neoplasm, including Hilmo

1109

4801

1.35

18.54

1.5

1.6

0.71

0.77

g/l

0.88

848

3757

Algoneurodystrophy

198

3.45

18.51

1.5

1.7

0.65

0.72

g/l

0.17

159

Disorders of muscles

146

658

2.26

18.44

1.3

1.6

0.65

0.83

g/l

1.37

112

507

Elevated blood glucose level

125

528

2.41

18.40

2.1

1.6

0.91

0.79

g/l

0.50

411

Injuries to the head

1431

6554

1.30

18.34

1.6

0.75

0.76

g/l

0.10

1115

5109

Dermatopolymyositis (FG)

5.68

18.30

1.2

2.0

0.43

0.78

g/l

0.86

Acute pharyngitis

215

1112

1.94

18.20

1.4

1.7

0.86

0.81

g/l

0.14

161

875

Gout, strict definition

219

1154

1.92

18.10

1.4

1.7

0.65

0.92

g/l

3.31

166

904

Cluster headache, strict

226

3.24

18.08

1.3

1.8

0.62

0.83

g/l

1.10

181

Diffuse large B-cell lymphoma, including Hilmo

257

3.08

18.06

1.5

1.8

0.56

0.94

g/l

2.29

210

Diffuse large B-cell lymphoma

257

3.08

18.06

1.5

1.8

0.56

0.94

g/l

2.29

210

Diffuse large B-cell lymphoma, helper endpoint

257

3.08

18.06

1.5

1.8

0.56

0.94

g/l

2.29

210

Substance use, excluding alcohol

290

1668

1.76

18.03

1.4

1.7

0.67

0.77

g/l

0.69

223

1316

Diplopia

187

936

2.03

18.01

1.8

1.6

0.82

0.78

g/l

0.18

141

726

Other neurological diseases

857

4801

1.39

18.00

1.6

0.71

0.79

g/l

1.75

653

3721

Disorders of calcium metabolism

380

2.66

17.87

1.5

1.7

0.81

0.86

g/l

0.13

301

Tuberculosis, IBD comorbidity

312

2.84

17.86

1.8

1.7

0.87

0.86

g/l

0.02

248

Pyogenic arthritis

369

2.68

17.80

1.4

1.8

0.73

0.85

g/l

0.55

293

Unknown and unspecified causes of morbidity

369

2.68

17.78

1.4

1.5

0.48

0.77

g/l

3.81

300

Other coagulation defects

120

507

2.42

17.70

1.8

1.6

0.63

0.75

g/l

0.67

101

398

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

209

3.31

17.65

1.8

1.7

0.60

0.82

g/l

1.14

168

Other disorders of bone

272

1546

1.78

17.63

1.5

1.6

0.77

0.76

g/l

0.05

220

1218

Atopic dermatitis, strict definition

421

2617

1.59

17.63

1.5

1.6

0.68

0.71

g/l

0.40

348

2050

Small fibre neuropathy

185

3.48

17.58

1.7

1.6

0.66

0.81

g/l

0.53

149

Benign neoplasm: Duodenum

147

3.83

17.58

1.4

1.6

0.76

0.80

g/l

0.05

118

Open wound of lower leg

218

1160

1.91

17.54

1.4

1.6

0.83

0.79

g/l

0.10

171

904

Chronic iridocyclitis

305

2.86

17.53

1.7

0.58

0.79

g/l

1.13

241

Chronic ulcer of skin, not elsewhere classified

372

2.66

17.53

1.9

1.6

0.93

0.89

g/l

0.10

297

Cytomegaloviral disease, including avohilmo

157

3.73

17.49

1.3

1.6

0.47

0.77

g/l

1.41

127

Tuberculosis, wide, including avohilmo

338

2.74

17.48

1.8

1.6

0.86

0.84

g/l

0.05

270

Dental caries, including avohilmo

856

3144

1.40

17.42

1.6

0.76

0.80

g/l

0.50

645

2447

Abnormal findings on diagnostic imaging of central nervous system

323

2.80

17.40

1.9

1.6

0.69

0.78

g/l

0.28

260

Coxarthrosis

540

2311

1.52

17.37

1.4

1.6

0.78

0.86

g/l

0.85

437

1804

Adjustment and management of implanted device

200

1037

1.95

17.34

1.5

1.7

0.78

0.86

g/l

0.59

149

798

Fracture of rib(s), sternum and thoracic spine

377

2353

1.62

17.14

1.5

1.6

0.79

0.84

g/l

0.30

306

1810

Malignant neoplasm of digestive organs

455

2247

1.56

17.09

1.7

1.6

0.90

0.87

g/l

0.15

337

1757

Cytomegaloviral disease

155

3.71

17.06

1.3

1.7

0.45

0.77

g/l

1.54

125

Hepatocellular carcinoma, including Hilmo

127

3.98

17.02

2.1

1.7

0.82

1.12

g/l

0.78

103

Other and unspecified coagulation defects

350

2.70

16.99

1.8

1.6

0.67

0.70

g/l

0.11

274

Retention of urine

390

1972

1.61

16.98

1.6

1.7

0.85

0.87

g/l

0.13

291

1521

Diseases of external ear

454

2966

1.54

16.92

1.6

0.73

0.80

g/l

0.75

345

2306

Other disorders of skin and subcutaneous tissue, not elsewhere classified

189

971

1.97

16.90

1.9

1.6

0.86

0.82

g/l

0.18

143

752

Polyuria

275

1589

1.75

16.83

1.5

1.6

0.78

0.84

g/l

0.36

216

1227

Injuries to the thorax

560

3823

1.47

16.75

1.6

0.79

0.82

g/l

0.25

455

2937

Diseases of peritoneum

142

661

2.19

16.64

1.4

1.6

0.58

0.80

g/l

2.07

112

516

Lymphoid leukaemia

308

2.79

16.63

1.4

1.6

0.41

0.85

g/l

4.01

243

Raynaud syndrome

139

643

2.20

16.58

1.4

1.7

0.61

0.72

g/l

0.82

109

510

Acute generalized exanthematous pustulosis

287

2.87

16.55

1.5

1.6

0.56

0.77

g/l

0.79

226

Tuberculosis, wide

331

2.70

16.52

1.8

1.6

0.86

0.84

g/l

0.05

263

Cluster headache, wide

244

3.04

16.50

1.3

1.8

0.61

0.81

g/l

1.11

195

Injury, poisoning and certain other consequences of external causes

664

2304

1.45

16.44

1.7

1.6

0.68

0.78

g/l

1.57

516

1775

Ankylosing spondylitis, ICD10

142

666

2.18

16.38

1.6

0.60

0.80

g/l

1.67

108

522

Disorders of vestibular function (Vertigo)

560

3740

1.47

16.38

1.4

1.6

0.66

0.77

g/l

2.11

425

2916

Other disorders of kidney and ureter

176

893

2.00

16.36

1.4

1.6

0.70

0.81

g/l

0.79

139

699

Other abnormalities of plasma proteins

4.97

16.32

2.1

1.8

1.59

0.90

g/l

0.40

Chronic tubulo-interstitial nephritis

189

3.32

16.23

1.3

1.7

0.90

0.80

g/l

0.20

154

Pyothorax

241

3.03

16.22

1.6

1.7

0.78

0.85

g/l

0.17

188

Other noninfective disorders of lymphatic vessels and lymph nodes

210

3.19

16.18

1.6

0.77

0.80

g/l

0.05

168

Other and unspecified visual disturbances

156

762

2.08

16.14

1.8

1.6

0.92

0.75

g/l

0.63

126

583

Iron deficiency anaemia secondary to blood loss (chronic)

190

994

1.93

16.11

1.7

1.5

0.69

0.79

g/l

0.62

150

754

Dermatopolymyositis

4.93

16.10

1.3

1.7

0.53

0.77

g/l

0.57

Other enthesopathy of foot (+metatarsalgia)

142

670

2.15

16.07

1.6

1.5

0.58

0.77

g/l

1.95

115

523

Benign neoplasm of major salivary glands

133

612

2.21

16.07

2.2

1.6

0.95

0.81

g/l

0.56

107

483

Oesophagitis

280

2.85

16.07

1.4

0.71

0.86

g/l

0.59

219

Benign neoplasm: salivary glands, exclude unknown (D119)

124

555

2.28

16.04

2.3

1.6

0.97

0.81

g/l

0.68

100

438

Golimumab

276

2.89

16.02

1.5

1.8

0.62

0.77

g/l

0.72

224

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

408

1631

1.59

16.02

1.5

0.56

0.59

g/l

0.34

323

1303

Oter anti-inflammatory and antirheumatic agents, non-steroids

236

701

1.86

15.98

1.6

0.79

0.89

g/l

0.59

183

540

Other cataract

511

2550

1.50

15.97

1.8

1.6

0.72

0.82

g/l

1.22

384

2029

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

120

4.02

15.97

1.4

0.69

0.59

g/l

0.25

Menorrhagia

386

1341

1.62

15.94

1.5

0.56

0.63

g/l

1.05

282

1035

Hyperkalaemia

293

2.78

15.85

1.6

1.8

0.65

0.95

g/l

1.54

237

ILD medications: pirfenidone

7.59

15.85

1.3

0.47

1.15

g/l

1.84

Generalized skin eruption due to drugs and medicaments

250

2.97

15.84

1.6

0.58

0.76

g/l

0.55

195

Other and unspecified types of non-Hodgkin lymphoma, hilmo

218

3.11

15.82

1.6

1.7

0.54

0.92

g/l

1.94

175

Atherosclerosis, excluding cerebral and coronary sclerosis

404

2033

1.57

15.82

1.7

1.6

0.86

0.87

g/l

0.03

319

1563

Caries of dentine, including avohilmo

922

3482

1.36

15.74

1.5

1.6

0.70

0.80

g/l

1.90

699

2731

Psoriasis vulgaris

254

1465

1.76

15.73

1.6

0.79

0.80

g/l

0.05

204

1148

Injuries to the wrist and hand

1289

6663

1.29

15.71

1.5

1.6

0.73

0.76

g/l

0.63

1014

5191

Trochanteric bursitis

182

949

1.94

15.61

1.6

1.5

0.63

0.77

g/l

1.38

151

726

Viral infections of the central nervous system, including avohilmo

121

543

2.27

15.59

1.5

1.7

0.50

0.76

g/l

3.20

425

Fentanyl

111

478

2.35

15.56

1.6

1.5

0.59

0.90

g/l

3.17

372

Other obstetric conditions, not elsewhere classified

415

1684

1.57

15.42

1.5

0.55

0.59

g/l

0.46

330

1343

Phlebitis and thrombophlebitis (not including DVT)

278

1652

1.70

15.42

1.6

0.70

0.78

g/l

0.72

222

1295

Other disorders of ear

1134

5631

1.31

15.41

1.6

0.71

0.78

g/l

1.36

859

4421

Superficial injury of lower leg

347

2181

1.61

15.40

1.4

1.6

0.67

0.75

g/l

0.87

279

1694

Pneumothorax

373

2.54

15.39

1.4

1.6

0.85

0.88

g/l

0.11

303

Asthma mixed form (mode), excluding more controls

190

3.21

15.35

1.5

0.64

0.84

g/l

1.04

148

Major coronary heart disease event excluding revascularizations

646

3007

1.43

15.29

1.6

0.78

0.88

g/l

1.30

498

2320

Mental and behavioural disorders due to psychoactive substance use

746

4984

1.38

15.26

1.4

1.7

0.76

0.81

g/l

0.51

564

3876

Pyoderma gangrenosum

5.63

15.18

1.2

1.9

0.56

0.77

g/l

0.38

Unspecified/other endometriosis

129

587

2.18

15.15

1.5

1.6

0.54

0.61

g/l

0.43

107

457

Metatarsalgia

132

620

2.16

15.15

1.7

1.6

0.58

0.78

g/l

1.94

107

478

Fenamates

174

599

2.00

15.13

1.6

1.5

0.78

0.86

g/l

0.41

146

476

Other meningitis

4.29

15.10

1.9

1.4

0.57

0.60

g/l

0.09

Substance abuse

723

4885

1.38

15.10

1.4

1.7

0.76

0.81

g/l

0.44

550

3799

Rare circulating lymphoid malignancy, including Hilmo

148

3.56

15.09

1.8

1.6

0.38

0.86

g/l

2.39

121

Endocarditis

183

3.26

15.02

1.4

1.6

0.78

0.82

g/l

0.09

154

Other and unspecified acquired haemolytic anaemias

5.87

15.02

2.6

2.0

0.82

0.95

g/l

0.15

Chronic lymphocytic leukaemia

139

3.63

15.00

1.2

1.6

0.28

0.99

g/l

5.02

114

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

139

3.63

15.00

1.2

1.6

0.28

0.99

g/l

5.02

114

Chronic lymphocytic leukaemia, helper endpoint

139

3.63

15.00

1.2

1.6

0.28

0.99

g/l

5.02

114

Paracetamol or NSAID medication

199

520

1.95

14.98

1.7

1.8

0.80

0.93

g/l

0.61

156

430

Secondary uncertain malignant neoplasm

160

810

2.00

14.98

1.4

1.6

0.66

0.83

g/l

1.09

124

630

Disorders of plasma-protein metabolism, not elsewhere classified

6.63

14.95

2.0

1.4

0.79

0.71

g/l

0.13

Polycystic ovarian syndrome, consortium definition

858

3640

1.36

14.94

1.5

0.58

0.62

g/l

0.69

665

2851

Endometriosis

378

1388

1.59

14.93

1.5

0.67

0.63

g/l

0.37

294

1072

Dental pulpitis, including avohilmo

1191

5925

1.29

14.92

1.5

1.6

0.75

g/l

0.09

916

4632

Benign neoplasm: Rectum, anus and anal canal

239

1377

1.76

14.86

1.6

0.72

0.84

g/l

1.24

193

1066

Sacroiliitis, not elsewhere classified

298

2.71

14.86

1.4

1.9

0.54

0.71

g/l

0.92

234

Viral infections of the central nervous system

112

497

2.30

14.85

1.5

1.7

0.50

0.77

g/l

3.01

388

Presence of other functional implants

665

3250

1.41

14.83

1.5

1.6

0.72

0.81

g/l

1.09

433

2584

Neuralgia and neuritis, unspecified

293

2.72

14.78

1.3

1.7

0.58

0.85

g/l

1.03

228

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

137

660

2.11

14.76

1.8

1.6

0.78

0.80

g/l

0.04

112

524

Other embolism and thrombosis

166

857

1.96

14.72

1.8

1.6

0.89

0.80

g/l

0.35

123

675

Other and unspecified rosacea

137

661

2.11

14.72

1.4

1.6

0.63

0.74

g/l

0.59

114

512

Benign neoplasm: Ascending colon

179

948

1.91

14.72

1.9

1.6

0.73

0.83

g/l

0.73

151

729

Other autoimmune haemolytic anaemias

5.06

14.71

2.6

1.8

0.85

0.88

g/l

0.03

Disorders of ocular muscles, binocular movement, accommodation and refraction

625

4426

1.41

14.70

1.5

1.6

0.67

0.75

g/l

1.03

479

3469

Peripheral artery disease

432

2257

1.52

14.69

1.7

1.6

0.87

g/l

0.02

345

1731

Hypertensive heart and/or renal disease

274

1183

1.70

14.67

1.4

1.6

0.77

0.92

g/l

1.16

213

895

Malignant neoplasm of liver and intrahepatic bile ducts

141

3.57

14.67

2.2

1.6

0.77

1.00

g/l

0.54

116

Cardiomyopathy, other and unspecified

103

443

2.37

14.65

1.4

1.6

0.63

0.86

g/l

1.84

357

Rosacea

184

986

1.89

14.61

1.5

1.6

0.65

0.73

g/l

0.54

150

760

Asthma mixed form (mode)

196

3.11

14.59

1.5

0.64

0.83

g/l

1.04

153

Unspecified privation

151

758

2.02

14.55

1.7

0.82

0.78

g/l

0.11

129

597

Acute laryngitis and tracheitis

168

864

1.94

14.34

1.5

1.8

0.66

0.80

g/l

1.28

125

682

Keratitis

452

3060

1.49

14.30

1.8

1.6

0.75

0.78

g/l

0.20

341

2368

Dipeptidyl peptidase 4 (DPP-4) inhibitors

619

3459

1.41

14.29

1.7

1.6

0.79

0.83

g/l

0.40

486

2683

Carrier of infectious disease

169

3.32

14.27

1.9

1.8

1.01

0.79

g/l

0.42

134

Otitis externa

306

1903

1.62

14.26

1.5

1.6

0.67

0.76

g/l

0.92

245

1502

Fibroblastic disorders

253

1498

1.70

14.24

1.5

1.6

0.70

0.89

g/l

2.65

199

1159

Myocardial infarction

511

2451

1.47

14.21

1.6

0.79

0.91

g/l

1.25

399

1895

Myelodysplastic syndrome, including Hilmo

125

3.70

14.20

1.4

1.8

0.87

1.01

g/l

0.23

104

Other/unspecified reactive arthropathies

106

469

2.31

14.19

1.4

1.6

0.56

0.78

g/l

1.83

367

Other (not insulin) diabetes medications

1176

5378

1.29

14.18

1.6

0.75

0.76

g/l

0.02

894

4206

Other/unspecified cytomegaloviral diseases

126

3.74

14.15

1.3

1.6

0.47

0.77

g/l

1.16

106

Congenital malformations of the musculoskeletal system, not elsewhere classified

108

4.00

14.10

1.4

0.70

0.58

g/l

0.29

Invasive ventilation

106

470

2.30

14.10

1.3

1.7

0.57

0.86

g/l

2.14

376

Cerebral palsy and other paralytic syndromes

157

808

1.97

14.09

1.5

1.6

0.69

0.79

g/l

0.48

123

636

Generalized anxiety disorder

226

1301

1.75

14.05

1.5

1.6

0.64

0.74

g/l

1.00

186

1009

Malignant neoplasm

1045

4703

1.31

14.04

1.5

1.6

0.70

0.77

g/l

1.30

790

3685

Scleritis and episcleritis

101

440

2.35

14.03

1.7

0.74

g/l

0.00

355

Malignant neoplasm

1047

4715

1.31

14.01

1.5

1.6

0.70

0.76

g/l

1.14

792

3693

Allergic urticaria

124

588

2.15

13.96

1.5

1.7

0.71

0.72

g/l

0.04

108

462

Benign neoplasm: Caecum

141

702

2.04

13.92

1.9

1.6

0.75

0.86

g/l

0.47

109

542

Barrett oesophagus

268

2.75

13.92

2.0

1.5

0.89

0.91

g/l

0.06

208

Infliximab

147

3.47

13.87

1.6

1.8

0.73

0.76

g/l

0.04

116

CR(E)ST syndrome

4.42

13.81

1.3

0.32

0.55

g/l

1.89

Oxicams

247

808

1.75

13.79

1.7

1.6

0.70

0.86

g/l

1.71

200

630

Viral and other specified intestinal infections

273

1622

1.66

13.79

1.9

1.6

0.72

0.78

g/l

0.24

203

1279

Chronic nephritic syndrome

237

2.87

13.71

2.0

1.6

0.57

0.77

g/l

0.96

189

Umbilical hernia

331

2118

1.58

13.68

1.7

1.6

0.83

0.85

g/l

0.11

260

1653

Postprocedural disorders of nervous system

112

515

2.22

13.66

1.6

1.7

0.62

0.71

g/l

0.51

413

Cardiac murmurs and other cardiac sounds

122

572

2.14

13.65

1.4

1.6

0.72

0.76

g/l

0.16

465

Rash and other nonspecific skin eruption

134

661

2.06

13.59

1.6

0.53

0.74

g/l

2.78

107

524

Diabetes insipidus

5.18

13.57

2.0

1.8

0.70

0.85

g/l

0.21

Benign neoplasm: Rectum

214

1229

1.76

13.53

1.5

1.6

0.70

0.83

g/l

1.29

175

946

Bronchitis, not specified as acute or chronic

109

497

2.23

13.52

1.6

0.73

0.80

g/l

0.27

391

Diseases of inner ear

631

4381

1.39

13.48

1.4

1.6

0.66

0.79

g/l

2.70

478

3409

Ehlers-Danlos syndrome, including avohilmo

4.35

13.44

1.5

0.70

0.46

g/l

0.73

Calcific aortic valvular stenosis

282

1676

1.63

13.42

1.5

1.6

0.84

0.88

g/l

0.24

217

1295

Calcific aortic valvular stenosis, operated

282

1676

1.63

13.42

1.5

1.6

0.84

0.88

g/l

0.24

217

1295

Operations 2 for CAVS

281

1669

1.63

13.40

1.5

1.6

0.84

0.88

g/l

0.23

216

1288

Calcific aortic valvular stenosis, diagnosis (helper)

281

1669

1.63

13.40

1.5

1.6

0.84

0.88

g/l

0.23

216

1288

Cluster headache, strict, including avohilmo

369

2.44

13.36

1.3

1.8

0.55

0.75

g/l

1.61

291

Abscess of anal and rectal regions

121

579

2.12

13.31

1.6

0.79

0.85

g/l

0.24

455

Mouth breathing

493

3440

1.44

13.26

1.6

0.77

0.83

g/l

0.57

374

2685

Meningitis

328

2.53

13.25

1.9

1.7

0.69

0.84

g/l

0.67

263

Intestinal adhesions without obstruction

102

457

2.27

13.21

1.8

1.7

0.66

0.91

g/l

1.30

357

Unspecified haematuria

465

2603

1.46

13.20

1.7

1.6

0.80

0.84

g/l

0.31

374

2004

Ventral hernia

274

1691

1.63

13.20

1.5

1.6

0.67

0.78

g/l

1.29

216

1301

Artificial opening status

305

2.58

13.17

1.6

1.8

0.89

g/l

0.01

250

Acute peritonitis

371

2.42

13.16

1.5

1.7

0.63

0.89

g/l

1.41

297

Other follicular disorders

119

569

2.13

13.16

1.8

1.7

0.74

0.76

g/l

0.07

444

Calcific aortic valvular stenosis, including rheumatic fever

281

1675

1.62

13.16

1.5

1.6

0.84

0.88

g/l

0.22

216

1293

Other and unspecified nerve root and plexus disorders, also in other diseases

267

1641

1.64

13.10

1.7

1.6

0.73

0.77

g/l

0.25

173

1278

Tongue abnormality

373

2.41

13.03

1.7

1.8

0.66

0.81

g/l

0.68

302

Abnormal findings in nipple discharge synovial fluid wound secretions

4.22

13.01

1.7

1.8

0.66

0.78

g/l

0.26

Abscess of lung

4.04

12.98

1.3

1.7

0.62

0.87

g/l

0.54

Phobic anxiety disorders

190

1066

1.80

12.93

1.7

0.74

g/l

0.00

150

831

Other or ill-defined heart diseases

309

2.54

12.80

1.7

0.83

0.82

g/l

0.03

245

Diseases of pulp and periapical tissues and dental caries

738

2795

1.36

12.77

1.6

0.72

0.81

g/l

1.34

555

2166

Other retinal disorders

720

4070

1.35

12.72

1.5

1.6

0.77

0.80

g/l

0.20

540

3173

Cluster headache, wide,, including avohilmo

385

2.37

12.62

1.3

1.7

0.55

0.76

g/l

1.88

304

Abnormal findings on examination of urine, without diagnosis

271

2.65

12.59

1.6

0.79

g/l

0.01

216

Benign neoplasm of other and unspecified endocrine glands

178

992

1.82

12.54

1.5

1.6

0.72

0.77

g/l

0.32

136

770

Conduction disorders

308

1573

1.58

12.51

1.5

1.6

0.79

0.88

g/l

0.66

216

1235

Other postsurgical states

418

2.29

12.46

1.7

1.6

0.71

0.84

g/l

0.44

342

Procreative management

453

2586

1.45

12.42

1.6

0.67

0.73

g/l

0.84

335

2013

Postmenopausal osteoporosis with pathological fracture

302

2.53

12.39

1.4

1.5

0.63

0.71

g/l

0.14

234

Cardiomyopathy (excluding other)

146

768

1.92

12.32

1.5

1.7

0.77

0.92

g/l

0.78

114

614

Other disorders of optic [2nd] nerve and visual pathways

414

2.29

12.32

1.6

1.7

0.66

0.79

g/l

0.49

332

Erythema multiforme

133

3.43

12.32

1.4

1.8

0.64

0.82

g/l

0.48

112

Disorders of choroid and retina

935

5067

1.30

12.31

1.6

0.77

0.79

g/l

0.17

713

3951

Cardiomyopathies, Primary/intrinsic

141

734

1.94

12.28

1.5

1.7

0.77

0.95

g/l

1.02

111

589

Lichen simplex chronicus and prurigo

383

2.34

12.28

1.3

1.6

1.00

0.78

g/l

0.81

302

Carpal tunnel syndrome

717

4659

1.34

12.28

1.6

0.69

0.77

g/l

1.35

554

3645

Hypertensive Heart Disease

240

1094

1.68

12.27

1.4

1.6

0.73

0.92

g/l

1.67

184

827

Acute lymphadenitis

422

2.27

12.22

2.4

1.7

0.99

0.74

g/l

0.54

342

Isolated proteinuria

191

2.98

12.22

1.5

0.67

0.79

g/l

0.44

153

Bullous disorders

317

2.48

12.17

1.7

0.83

0.85

g/l

0.04

251

Colonic or urogenital fistula

330

2169

1.53

12.16

1.4

1.6

0.60

0.80

g/l

4.18

249

1686

Post-traumatic stress disorder

119

586

2.06

12.16

1.5

1.7

0.60

0.71

g/l

0.80

452

Marginal zone B-cell lymphoma, including Hilmo

4.08

12.16

1.7

1.6

0.37

1.00

g/l

2.21

Aortic aneurysm

236

1404

1.66

12.15

1.8

1.7

0.97

0.93

g/l

0.13

166

1100

Thyroiditis

106

501

2.16

12.12

1.6

1.7

0.71

g/l

0.01

394

Cardiodefibrillation

362

2419

1.50

12.12

1.4

1.7

0.85

0.88

g/l

0.18

259

1872

Problems related to lifestyle

141

738

1.94

12.11

1.4

1.6

0.73

0.74

g/l

0.03

104

568

Other bursopathies

156

844

1.87

12.08

1.5

1.6

0.79

0.85

g/l

0.30

117

651

Disorders of vitreous body

575

3987

1.38

12.03

1.6

0.73

0.78

g/l

0.57

460

3101

Disorders of vitreous body and globe

590

4084

1.37

12.01

1.6

0.73

0.78

g/l

0.50

474

3182

Cerebral cysts

369

2.35

11.95

1.8

1.7

0.72

0.75

g/l

0.11

297

Other aneurysm

272

2.58

11.94

1.8

1.6

1.21

0.87

g/l

0.52

216

Unspecific neurodegenerative disorder

163

1974

0.56

11.94

1.4

1.6

0.67

0.86

g/l

1.64

122

1502

Osteonecrosis

395

2.30

11.89

1.3

1.7

0.52

0.82

g/l

2.35

312

Hyperparathyroidism

188

1068

1.76

11.89

1.4

1.5

0.77

0.75

g/l

0.04

143

811

Vitamin B12 deficiency anaemia

108

517

2.11

11.88

1.9

1.6

0.81

0.83

g/l

0.08

400

Unspecified fall

611

4425

1.36

11.88

1.6

0.68

0.80

g/l

2.51

463

3457

Psoriatic arthropathies, ICD10

151

815

1.88

11.85

1.4

1.7

0.65

0.76

g/l

0.76

116

635

Covid-19 suspected case

282

1801

1.58

11.85

1.7

1.6

0.67

0.75

g/l

0.73

246

1402

Combined immunodeficiencies

5.16

11.84

1.6

1.3

0.28

0.66

g/l

2.20

Pleural plaque

427

2.23

11.82

1.4

1.7

0.87

1.06

g/l

0.80

336

Autoimmune hyperthyroidism

334

2.40

11.77

1.7

1.6

0.74

0.76

g/l

0.07

262

Angina pectoris

583

2814

1.38

11.69

1.6

0.77

0.88

g/l

1.51

421

2182

Artrosis, including avohilmo

979

4183

1.29

11.65

1.5

1.6

0.77

g/l

0.06

766

3240

Nummular dermatitis

108

522

2.10

11.64

1.9

1.6

1.02

0.88

g/l

0.51

412

Other specified and unspecified disorders of eye and adnexa

230

2.72

11.60

1.7

1.8

0.57

0.77

g/l

0.91

188

Arthropathic psoriasis

157

864

1.84

11.58

1.3

1.6

0.65

0.77

g/l

0.97

121

674

Spontaneous rupture of synovium and tendon

100

470

2.16

11.58

1.6

0.62

0.83

g/l

1.45

367

Endometriosis of pelvic peritoneum

194

1027

1.73

11.57

1.5

0.65

0.63

g/l

0.09

136

805

Abnormal involuntary movements

173

981

1.79

11.53

1.5

1.6

0.66

0.78

g/l

1.00

143

769

Spondylolisthesis/Spondylolysis

205

1218

1.70

11.53

1.8

1.6

0.72

0.82

g/l

0.61

157

945

Pacemaker

350

2183

1.50

11.52

1.5

1.6

0.77

0.86

g/l

0.82

251

1684

Other specified and unspecified retinal disorders

197

2.86

11.52

1.6

1.7

0.56

0.85

g/l

1.44

159

Autonomic disorders

139

3.27

11.49

1.4

1.7

0.62

0.76

g/l

0.39

115

Atypical facial pain

320

2.42

11.48

1.8

1.6

0.70

g/l

0.01

254

Cutaneous lupus erythematosus

124

3.41

11.47

1.5

1.8

0.78

0.83

g/l

0.10

104

Disorders resulting from impaired renal tubular function

226

2.73

11.45

1.3

1.7

0.58

0.86

g/l

1.11

183

Synovial cyst of popliteal space [Baker]

389

2.27

11.40

1.3

1.7

0.61

0.85

g/l

1.72

299

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

116

571

2.03

11.35

1.4

1.8

0.56

0.71

g/l

0.99

465

Brachial plexus disorders

135

714

1.92

11.30

1.4

1.6

0.52

0.72

g/l

2.56

562

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

359

2410

1.48

11.29

1.5

1.6

0.64

0.70

g/l

0.58

291

1893

Superficial injury of abdomen, lower back and pelvis

203

1211

1.69

11.27

1.5

1.6

0.73

0.78

g/l

0.30

160

950

Benign neoplasm: Descending colon

430

2.20

11.27

1.6

0.66

0.88

g/l

1.13

337

Other psoriatic arthropathies

145

786

1.87

11.25

1.4

1.7

0.65

0.75

g/l

0.68

110

613

Anaemia in chronic diseases classified elsewhere

126

3.36

11.19

1.5

1.8

0.71

0.84

g/l

0.25

101

Viral warts

140

752

1.89

11.17

1.6

1.7

0.62

0.71

g/l

0.60

107

583

Childhood allergy (age < 16)

194

937

1.72

11.17

1.5

1.6

0.67

0.69

g/l

0.13

161

743

Other specified/unspecified bacterial intestinal infections

406

2.23

11.15

1.6

1.7

0.64

0.81

g/l

0.91

326

Arthropathies in other diseases classified elsewhere

195

2.84

11.15

1.4

1.9

0.64

0.91

g/l

0.95

156

Ehlers-Danlos syndrome

4.24

11.15

1.5

0.71

0.49

g/l

0.56

Other disorders of eyelid

464

3120

1.41

11.14

1.6

1.5

0.78

0.79

g/l

0.05

362

2426

Sacrococcygeal disorders, not elsewhere classified

168

2.99

11.12

2.0

1.7

0.69

0.77

g/l

0.23

130

Amyloidosis

107

3.56

11.09

1.4

1.7

0.61

0.93

g/l

0.67

Viral warts, including avohilmo

287

1871

1.55

11.05

1.7

1.6

0.68

0.76

g/l

0.71

223

1471

Dermatophytosis

175

1009

1.76

11.03

1.6

0.69

0.84

g/l

1.18

135

798

Otalgia

121

622

1.98

11.03

1.9

1.6

0.65

0.73

g/l

0.42

489

Failure and rejection of transplanted organs and tissues

3.89

11.02

1.5

0.58

0.71

g/l

0.24

Injuries to the shoulder and upper arm

1036

6368

1.26

11.02

1.6

0.74

0.79

g/l

0.72

813

4952

Other congenital malformations

128

671

1.94

11.00

1.4

1.6

0.75

0.69

g/l

0.25

102

540

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

164

924

1.79

10.98

1.6

1.7

0.71

0.70

g/l

0.03

127

747

Myocardial infarction, strict

454

2274

1.42

10.88

1.6

0.78

0.92

g/l

1.65

356

1753

Disorders of continuity of bone

139

752

1.87

10.86

1.4

1.6

0.61

0.73

g/l

0.85

102

582

Abnormalities of gait and mobility

142

773

1.86

10.86

1.6

0.75

0.86

g/l

0.80

112

610

Kidney transplant status

373

2.28

10.84

1.6

1.7

0.48

0.84

g/l

2.69

299

Other localized connective tissue disorders

109

3.52

10.82

2.4

1.9

1.15

0.84

g/l

0.43

Other abnormal findings of blood chemistry

280

2.48

10.80

1.8

1.7

0.56

0.78

g/l

1.16

222

Neuromuscular dysfunction of bladder

115

585

1.99

10.80

1.3

1.6

0.80

0.83

g/l

0.10

465

Tonsillectomy and adenotomy

727

3860

1.32

10.77

1.5

1.6

0.53

0.74

g/l

10.12

578

3013

Congenital malformations and deformations of the musculoskeletal system

134

716

1.89

10.71

1.7

0.69

0.70

g/l

0.04

102

584

Cervicocranial syndrome

127

670

1.92

10.70

1.5

1.6

0.67

0.77

g/l

0.61

521

Disturbance of activity and attention

195

1140

1.69

10.66

1.5

1.7

0.68

0.70

g/l

0.10

156

907

Prurigo nodularis

125

3.30

10.64

1.1

1.6

1.14

0.78

g/l

0.71

107

Disorders of pituitary gland, other and/or unspecified

5.84

10.61

3.3

1.3

0.79

0.48

g/l

0.71

Hepatocellular carcinoma

3.72

10.60

2.3

1.7

0.62

1.20

g/l

1.73

Tuberculosis

270

2.48

10.59

1.7

0.86

0.87

g/l

0.04

215

Preparatory care for dialysis

265

2.51

10.58

1.3

1.7

0.59

0.82

g/l

1.10

209

Smoking dependency

122

639

1.94

10.56

1.3

1.6

0.65

0.79

g/l

0.45

496

Hyperhidrosis

157

2.99

10.52

1.4

0.63

0.77

g/l

0.60

127

Other and unspecified disorders of vitreous body

479

3397

1.39

10.48

1.6

0.73

0.77

g/l

0.40

386

2640

Benign paroxysmal vertigo

331

2249

1.48

10.46

1.4

1.6

0.66

0.76

g/l

1.23

250

1740

Calculus of kidney and ureter

332

2257

1.48

10.46

1.6

0.93

0.85

g/l

0.52

261

1764

Idiopathic gout

109

551

2.01

10.43

1.4

1.6

0.86

0.87

g/l

0.04

435

Adhesive capsulitis of shoulder

188

1123

1.69

10.42

1.5

1.6

0.59

0.83

g/l

4.68

150

873

Mental and behavioural disorders due to tobacco

122

642

1.93

10.42

1.3

1.6

0.65

0.80

g/l

0.46

499

Intracranial injury

694

4956

1.31

10.39

1.6

0.75

0.79

g/l

0.46

536

3850

Disorder of lipoprotein metabolism, unspecified

140

770

1.84

10.36

1.4

1.7

0.80

0.86

g/l

0.26

117

593

Personality disorders

345

2370

1.47

10.32

1.5

1.6

0.70

0.72

g/l

0.12

260

1851

Erythema nodosum

170

2.90

10.32

1.8

1.7

0.73

0.77

g/l

0.07

139

Other disorders of veins

469

3345

1.39

10.31

1.4

1.5

0.76

0.73

g/l

0.23

363

2625

Duodenal ulcer

108

546

2.00

10.31

1.4

1.6

0.69

0.87

g/l

1.49

433

Agoraphobia

210

2.68

10.25

1.5

2.0

0.67

0.79

g/l

0.50

162

Disorders of adult personality and behaviour

365

2538

1.45

10.24

1.5

1.6

0.74

0.72

g/l

0.13

275

1991

Thyrotoxicosis, other and/or unspecified

237

1507

1.59

10.23

1.6

0.78

0.72

g/l

0.38

183

1162

Appendectomy

778

5775

1.29

10.22

1.4

1.6

0.59

0.76

g/l

7.50

595

4510

Episcleritis

364

2.24

10.15

1.7

0.78

0.73

g/l

0.14

295

Supplementary factors related to causes of morbidity and mortality classified elsewhere

379

2659

1.44

10.13

1.7

1.6

0.74

0.78

g/l

0.28

285

2070

Poisoning by drugs, medicaments and biological substances

304

2046

1.50

10.11

1.5

1.6

0.69

0.73

g/l

0.32

240

1607

Autoimmune thyroiditis

109

3.42

10.10

1.8

1.7

0.62

0.74

g/l

0.25

AV-block

165

815

1.74

10.02

1.5

1.6

0.83

0.90

g/l

0.27

118

643

Speech therapy

294

1969

1.50

10.01

1.5

1.6

0.73

0.78

g/l

0.41

268

1513

Caries of enamel

1187

6334

1.23

10.00

1.6

0.73

0.76

g/l

0.48

1002

4869

Other/unspecified enthesopathies, not elsewhere classified

100

498

2.03

10.00

1.9

1.6

0.70

0.85

g/l

0.68

387

Maternal care for other conditions predominantly related to pregnancy

261

1661

1.54

9.99

1.4

1.5

0.59

0.61

g/l

0.15

207

1309

Hypothyroidism, strict autoimmune, 3 medication purchases required

947

5068

1.26

9.96

1.5

0.68

0.73

g/l

1.14

724

4000

Vascular diseases of the intestine

173

2.83

9.95

1.6

1.8

0.91

g/l

0.01

136

Other/unspecified enthesopathies of lower limb, excluding foot

479

2.06

9.94

1.4

1.7

0.68

0.84

g/l

0.97

383

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

293

1707

1.51

9.89

1.5

1.7

0.63

0.72

g/l

0.96

236

1354

Ganglion

239

1535

1.57

9.88

1.5

1.6

0.60

0.76

g/l

2.28

191

1204

Fracture of lumbar spine and pelvis

235

1500

1.57

9.86

1.6

0.82

0.78

g/l

0.17

182

1147

Alzheimer disease, including avohilmo

131

1609

0.56

9.82

1.5

1.6

0.69

0.88

g/l

1.55

103

1227

Type 1 diabetes

303

2048

1.49

9.79

1.7

1.6

0.75

0.80

g/l

0.18

231

1617

Acute posthaemorrhagic anaemia

153

2.93

9.75

1.9

1.6

0.62

0.75

g/l

0.39

121

Nonspecific lymphadenitis

416

2.13

9.75

1.6

1.01

0.73

g/l

1.03

337

Benign neoplasm: Sigmoid colon

208

1298

1.62

9.75

1.8

1.6

0.71

0.84

g/l

1.26

164

1005

Any event in cancer register

1096

5182

1.24

9.75

1.5

1.6

0.71

0.76

g/l

0.63

834

4071

Female infertility

312

1254

1.50

9.70

1.5

0.53

0.64

g/l

1.77

248

982

Juvenile arthritis (FINNGEN)

301

2.34

9.69

1.6

0.64

0.65

g/l

0.01

238

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

113

587

1.92

9.66

1.6

1.7

0.85

0.88

g/l

0.09

456

Optic neuritis

302

2.34

9.64

1.6

1.7

0.56

0.72

g/l

0.91

237

Dystonia

359

2.21

9.64

1.4

1.6

0.70

0.75

g/l

0.12

277

Other acute viral hepatitis

3.61

9.63

1.7

2.0

0.93

0.80

g/l

0.24

Trigger finger

168

996

1.70

9.63

1.6

0.66

0.78

g/l

1.08

134

778

Adult respiratory distress syndrome

4.17

9.62

1.4

1.8

0.58

0.94

g/l

0.66

Haemorrhage, not elsewhere classified

171

2.80

9.59

1.7

1.4

0.62

0.86

g/l

0.80

139

Other extrapyramidal and movement disorders in other diseases

282

1891

1.50

9.57

1.6

0.65

0.78

g/l

1.74

228

1456

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

260

2.44

9.54

1.4

2.0

0.59

0.68

g/l

0.24

212

Nail disorders

118

633

1.89

9.54

1.3

1.6

0.57

0.79

g/l

2.29

491

Allergic purpura

172

2.80

9.53

1.7

1.4

0.99

0.67

g/l

0.58

136

Chronic suppurative otitis media, including avohilmo

104

535

1.97

9.53

1.9

1.7

0.64

0.81

g/l

1.26

426

Extreme obesity with alveolar hypoventilation

242

2.49

9.51

1.4

1.6

0.83

0.85

g/l

0.03

187

Type 1 diabetes, wide definition, subgroup 1

236

1524

1.56

9.50

1.6

0.70

0.81

g/l

0.44

186

1231

Hyperkinetic disorders

201

1221

1.62

9.48

1.5

1.7

0.69

g/l

0.04

162

980

Demyelinating diseases of the central nervous system

120

649

1.88

9.47

1.5

1.7

0.57

0.70

g/l

0.98

515

Other disorders of conjunctiva

162

956

1.71

9.46

1.5

1.6

0.63

0.82

g/l

1.85

120

741

Disorders of lacrimal system and orbit in diseases classified elsewhere

140

3.01

9.44

1.7

1.3

0.64

0.68

g/l

0.12

119

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

4.10

9.44

1.3

1.9

0.40

0.90

g/l

1.54

Hypercalcemia

249

2.46

9.43

1.6

1.8

0.91

0.84

g/l

0.12

195

Vitamin deficiency, wide

292

2.34

9.43

1.5

1.7

0.69

0.80

g/l

0.35

227

Vitamin deficiency

292

2.34

9.43

1.5

1.7

0.69

0.80

g/l

0.35

227

Other congenital malformations, including avohilmo

172

1034

1.68

9.37

1.4

1.7

0.80

0.70

g/l

0.57

136

818

KRA_PSY_EATING, excluding more controls

100

505

1.98

9.36

1.5

1.7

0.60

0.66

g/l

0.33

397

Other juvenile arthritis

281

2.36

9.34

1.6

1.8

0.60

0.68

g/l

0.19

224

Benign neoplasm: Parotid gland

491

2.01

9.32

1.8

1.6

0.85

0.83

g/l

0.04

391

Infective dermatitis

136

768

1.79

9.30

1.5

1.6

0.76

0.80

g/l

0.15

597

Urolithiasis

349

2452

1.43

9.30

1.6

0.92

0.85

g/l

0.39

269

1909

Unstable angina pectoris

339

1848

1.45

9.30

1.5

1.6

0.71

0.92

g/l

4.53

272

1417

Female infertility, cervical, vaginal, other or unspecified origin

287

1225

1.51

9.27

1.5

0.51

0.64

g/l

2.55

229

960

Any death

698

3786

1.29

9.26

1.3

1.7

0.80

0.83

g/l

0.23

531

2913

Myocardial infarction, without ST-elevation

379

2434

1.41

9.22

1.6

0.76

0.88

g/l

1.44

310

1870

Noninflammatory disorders of female genital tract

415

1481

1.41

9.18

1.5

0.59

0.65

g/l

0.76

316

1149

Pure hyperglyceridaemia

137

3.01

9.18

1.5

2.0

0.74

0.92

g/l

0.39

111

Superficial injury of wrist and hand

273

1836

1.50

9.17

1.7

1.6

0.79

0.76

g/l

0.17

225

1450

Amyloidosis, other/unspecified

3.60

9.16

1.4

1.8

0.62

0.92

g/l

0.48

Sequelae of other external causes

367

2.16

9.13

1.5

1.6

0.69

0.82

g/l

0.50

293

Impingement syndrome of shoulder

252

1670

1.52

9.08

1.6

0.63

0.88

g/l

5.02

206

1302

Benign neoplasm: other/unspecified salivary gland

138

2.98

9.05

3.2

1.7

1.24

0.81

g/l

0.87

111

Squamous cell neoplasms and carcinomas of the skin

454

2.02

9.05

1.6

1.8

0.89

0.92

g/l

0.06

348

Perforation of tympanic membrane

118

644

1.85

9.04

1.7

1.6

0.89

0.76

g/l

0.38

514

Other and unspecified follicular disorders

280

2.33

8.97

2.3

1.8

0.98

0.82

g/l

0.36

221

Other noninflammatory disorders of vulva and perineum

115

624

1.86

8.97

1.4

1.5

0.60

0.68

g/l

0.45

484

Other demyelinating diseases of the central nervous system

268

2.37

8.95

1.6

1.7

0.59

0.73

g/l

0.55

207

Abnormal blood-pressure reading, without diagnosis

255

2.39

8.95

1.6

0.54

0.82

g/l

2.23

207

Presence of cardiac and vascular implants and grafts

425

2273

1.38

8.85

1.5

1.6

0.77

0.90

g/l

1.65

329

1794

Cramp and spasm

320

2.23

8.84

1.8

1.7

0.83

0.80

g/l

0.07

257

Amiodarone users

111

599

1.88

8.83

1.2

1.7

0.72

0.91

g/l

1.27

475

Chorioretinal inflammation

168

2.75

8.82

1.8

1.6

0.51

0.74

g/l

1.01

138

Degenerative diseases of the nervous system

138

1682

0.59

8.78

1.4

1.6

0.66

0.87

g/l

1.95

108

1286

Other nonthrombocytopenic purpura

4.44

8.78

2.4

1.3

0.86

0.70

g/l

0.34

Subacute thyroiditis

209

2.54

8.78

1.6

1.7

0.69

0.81

g/l

0.33

175

Other diseases of blood and blood-forming organs

413

2.06

8.77

1.7

0.81

0.83

g/l

0.04

327

Solid cancers, including Hilmo

998

4719

1.24

8.75

1.5

1.6

0.73

0.77

g/l

0.43

766

3695

Persistent mood disorders

222

1444

1.55

8.75

1.4

1.6

0.61

0.78

g/l

2.19

185

1102

Poisoning by medicine

273

1855

1.48

8.74

1.5

1.6

0.66

0.74

g/l

0.72

212

1453

Acute bronchiolitis

414

2.02

8.73

1.6

1.8

0.78

0.83

g/l

0.13

348

Other disorders of patella

194

1225

1.60

8.71

1.4

1.7

0.71

0.76

g/l

0.33

156

958

Visual impairment including blindness (binocular or monocular)

374

2.11

8.70

1.5

1.6

0.84

0.78

g/l

0.10

295

Other symptoms and signs involving cognitive functions and awareness

504

3362

1.33

8.65

1.5

1.6

0.79

0.81

g/l

0.12

380

2599

Infections with a predominantly sexual mode of transmission

374

2690

1.40

8.63

1.6

0.68

0.70

g/l

0.17

303

2079

Use of anticholinesterases

126

1675

0.58

8.62

1.5

1.6

0.70

0.88

g/l

1.11

1282

N06DA Anticholinesterases

126

1675

0.58

8.62

1.5

1.6

0.70

0.88

g/l

1.11

1282

Other and unspecified iridocyclitis

304

2.25

8.62

2.0

1.7

0.63

0.79

g/l

0.63

244

Other obstructive and reflux uropathy

235

2.43

8.61

1.6

1.7

0.93

0.77

g/l

0.38

186

Unspecified nephritic syndrome

126

3.02

8.60

2.1

1.7

0.69

0.74

g/l

0.12

101

391

2551

1.39

8.55

1.5

1.6

0.82

0.81

g/l

0.06

301

1954

Other noninflammatory disorders of vagina

486

1.96

8.52

1.3

1.6

0.53

0.67

g/l

0.76

379

Erosion of teeth , including avohilmo

340

2420

1.41

8.49

1.5

1.6

0.70

0.74

g/l

0.27

267

1894

Other disorders of the musculoskeletal system and connective tissue

174

1078

1.63

8.49

1.4

1.6

0.78

0.77

g/l

0.02

129

836

Non-allergic asthma

102

543

1.90

8.46

1.8

1.7

0.78

0.82

g/l

0.12

416

Alzheimer disease

107

1373

0.55

8.46

1.5

1.6

0.66

0.89

g/l

1.75

1050

Respiratory tuberculosis, confirmed and not-confirmed

243

2.38

8.45

1.8

1.7

0.87

g/l

0.01

195

Respiratory tuberculosis

243

2.38

8.45

1.8

1.7

0.87

g/l

0.01

195

Alcohol abuse, main dg, excluding more controls

177

1102

1.62

8.45

1.6

1.7

0.85

g/l

0.01

138

859

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

358

2573

1.40

8.44

1.4

1.6

0.67

0.71

g/l

0.37

274

2015

Any dementia

163

1815

0.62

8.41

1.6

0.74

0.86

g/l

0.67

121

1389

Primary adrenocortical insufficiency

3.68

8.39

1.8

1.9

0.59

0.71

g/l

0.18

Other and unspecified myopathies

524

1.91

8.38

1.7

0.65

0.87

g/l

1.62

417

Dermatophytosis, including avohilmo

763

5971

1.26

8.36

1.6

0.73

0.78

g/l

0.71

611

4636

Benign neoplasm: Pituitary gland, craniopharyngeal duct

354

2.13

8.36

1.5

1.7

0.85

0.79

g/l

0.14

284

Special screening examination for other diseases and disorders

118

660

1.80

8.32

1.5

0.74

0.83

g/l

0.42

475

Viral hepatitis, including avohilmo

107

583

1.86

8.31

1.5

1.7

0.76

0.80

g/l

0.17

455

Vasomotor rhinitis (mode)

463

1.97

8.31

2.2

1.6

0.73

0.79

g/l

0.18

362

DVT of lower extremities

198

1271

1.57

8.30

1.6

0.81

0.80

g/l

0.04

147

993

Tubulo-interstitial nephritis, not specified as acute or chronic

368

2.09

8.28

1.7

1.6

0.80

0.79

g/l

0.02

296

Speech and linguistic disorders, excluding more controls

104

525

1.88

8.27

1.2

1.9

0.55

0.83

g/l

3.57

422

Scar conditions and fibrosis of skin

265

2.31

8.25

1.3

1.7

0.53

0.80

g/l

1.70

209

Dialysis

253

2.34

8.22

1.3

1.8

0.40

0.82

g/l

3.63

201

Hordeolum and other deep inflammation of eyelid

410

2.03

8.22

1.7

0.54

0.80

g/l

2.55

326

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

483

3603

1.33

8.22

1.6

0.72

0.73

g/l

0.02

401

2810

Acute gastritis

396

2.05

8.21

1.7

1.5

0.65

0.80

g/l

0.90

306

Pneumonitis due to solids and liquids

424

2.00

8.16

1.5

1.7

0.60

0.90

g/l

1.97

338

Specific personality disorders

293

2047

1.44

8.14

1.4

1.6

0.73

0.72

g/l

0.05

224

1604

Amenorrhoea

447

1.97

8.06

1.9

1.6

0.52

0.66

g/l

0.85

352

Later onset COPD

234

1250

1.51

8.05

1.4

1.6

0.87

0.90

g/l

0.11

182

954

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

362

2629

1.39

8.04

1.3

1.6

0.63

0.76

g/l

2.33

291

2057

Hypersensitivity pneumonitis due to organic dust

3.37

8.03

1.3

1.7

0.59

0.79

g/l

0.47

Benign neoplasm of mouth and pharynx

129

751

1.74

8.01

2.0

1.6

0.85

0.80

g/l

0.16

108

581

Inflammation of lacrimal passages (acute and unspecified)

3.35

8.01

2.6

1.6

0.65

0.77

g/l

0.22

Other viral hepatitis

484

1.93

7.99

1.5

1.7

0.74

0.80

g/l

0.28

386

Iron deficiency

213

2.45

7.98

1.4

1.7

0.39

0.67

g/l

1.87

170

Pemphigoid

132

2.87

7.91

1.8

1.6

0.82

g/l

0.01

106

Allergic contact dermatitis

156

958

1.64

7.91

1.4

1.6

0.67

0.72

g/l

0.18

123

743

Appendicitis, broad definition

865

6320

1.23

7.88

1.5

1.6

0.68

0.77

g/l

1.38

651

4943

Other shoulder lesions

112

629

1.80

7.88

1.5

1.6

0.60

0.81

g/l

1.96

489

Diseases of appendix

871

6348

1.23

7.85

1.5

1.6

0.68

0.77

g/l

1.44

656

4967

Ankylosing spondylitis, strict definition

330

2.13

7.84

1.7

1.8

0.64

0.81

g/l

0.56

265

Transport accidents

537

3440

1.30

7.83

1.7

1.6

0.71

0.77

g/l

1.01

427

2696

Other viral hepatitis, including avohilmo

523

1.88

7.82

1.5

1.7

0.74

0.79

g/l

0.20

413

Olecranon bursitis

363

2.07

7.82

1.4

1.6

0.80

0.91

g/l

0.36

286

Viral hepatitis

101

552

1.86

7.80

1.5

1.7

0.76

0.81

g/l

0.19

436

Allergic colitis

150

2.74

7.80

1.5

1.4

0.53

0.64

g/l

0.58

127

Lesion of ulnar nerve

170

1072

1.60

7.75

1.5

1.6

0.74

0.81

g/l

0.38

132

845

Seborrhoeic keratosis

264

1827

1.45

7.74

1.5

0.66

0.79

g/l

1.58

216

1409

Fracture of foot, except ankle

300

2127

1.42

7.71

1.6

0.79

0.75

g/l

0.14

238

1656

Epilepsy

326

2336

1.40

7.70

1.5

1.7

0.69

0.83

g/l

2.06

257

1845

Restless leg syndrome

169

1067

1.60

7.67

1.8

1.6

0.62

0.77

g/l

1.79

140

826

Conductive and sensorineural hearing loss

866

4676

1.23

7.67

1.7

1.5

0.72

0.79

g/l

1.22

644

3666

Symptoms and signs involving emotional state

199

2.47

7.65

1.5

1.8

0.77

0.83

g/l

0.11

163

Thyrotoxicosis

283

1989

1.43

7.64

1.6

0.83

0.70

g/l

1.01

219

1529

Infections with a predominantly sexual mode of transmission, including avohilmo

486

3395

1.32

7.64

1.5

1.6

0.66

0.72

g/l

0.70

386

2659

Thoracic aortic aneurysm

157

975

1.63

7.63

1.9

1.7

0.88

0.93

g/l

0.16

104

774

Graves ophthalmopathy, strict

135

2.82

7.63

1.7

1.5

0.67

0.68

g/l

0.01

114

Other problems related to primary support group, including family circumstances

153

919

1.64

7.59

1.6

1.7

0.70

0.71

g/l

0.03

126

733

Extrapyramidal and movement disorders

407

3039

1.35

7.59

1.7

1.6

0.64

0.80

g/l

3.12

318

2354

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

352

2571

1.38

7.58

1.5

1.6

0.78

0.82

g/l

0.25

276

1991

Striking against or struck by other objects

412

3079

1.34

7.56

1.6

0.78

0.80

g/l

0.09

306

2409

Cyst of kidney

423

1.97

7.55

1.5

1.6

0.83

0.86

g/l

0.08

332

Other hearing loss

270

1825

1.44

7.52

1.7

1.6

0.69

0.83

g/l

1.72

195

1403

Mental and behavioural disorders due to alcohol

575

4287

1.28

7.51

1.5

1.7

0.78

0.83

g/l

0.39

428

3329

Unspecified misadventure during surgical and medical care

342

2.08

7.51

1.6

0.95

0.82

g/l

0.41

270

Type of accident

341

2483

1.38

7.49

1.8

1.6

0.75

0.78

g/l

0.25

255

1936

Chronic suppurative otitis media

404

1.98

7.45

2.0

1.7

0.68

0.78

g/l

0.49

324

Dementia

210

2132

0.67

7.45

1.4

1.6

0.75

0.85

g/l

0.61

153

1624

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

107

605

1.79

7.40

1.4

1.6

0.70

0.82

g/l

0.58

474

Viral meningitis, including avohilmo

259

2.25

7.38

1.5

1.8

0.54

0.75

g/l

1.18

214

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

497

1.88

7.38

1.6

0.54

0.76

g/l

1.53

386

Vulvovaginal ulceration/inflammation in other diseases

483

1.89

7.37

1.6

0.68

0.60

g/l

0.37

380

Right bundle-branch block

190

2.46

7.37

1.2

1.7

0.80

0.89

g/l

0.21

149

Chronic periodontitis, including avohilmo

1153

6174

1.19

7.36

1.5

1.6

0.71

0.77

g/l

1.38

921

4771

Acute appendicitis, no complications

655

5195

1.26

7.34

1.5

1.6

0.69

0.77

g/l

0.79

494

4064

Other female pelvic inflammatory diseases

175

1126

1.57

7.34

1.4

1.5

0.69

0.65

g/l

0.13

131

868

Lichen planus

141

862

1.65

7.32

1.8

1.5

0.67

0.77

g/l

0.62

110

664

Other disorders of nervous system

428

1.94

7.32

1.4

1.7

0.42

0.85

g/l

5.95

346

Other misadventures during surgical and medical care

144

2.71

7.30

1.6

1.8

0.69

0.82

g/l

0.26

114

Oral lichen planus, including avohilmo , including avohilmo

478

1.89

7.29

1.6

0.54

0.74

g/l

1.75

363

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

106

601

1.79

7.27

1.6

0.60

0.65

g/l

0.19

465

Sensorineural hearing loss

808

4376

1.23

7.27

1.7

1.5

0.71

0.80

g/l

1.60

598

3426

Inflammatory disease of uterus

164

1043

1.59

7.25

1.4

1.5

0.58

0.63

g/l

0.43

119

809

Acute myeloid leukaemia and myelodysplastic syndromes

100

3.06

7.24

1.6

1.7

0.80

0.97

g/l

0.27

Skin changes due to chronic exposure to nonionizing radiation

356

2371

1.37

7.22

1.5

1.6

0.85

0.82

g/l

0.14

272

1807

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

128

2.81

7.21

1.5

1.7

0.47

0.78

g/l

1.17

107

conjunctival haemorrhage

473

1.88

7.18

1.6

0.65

0.85

g/l

1.13

377

Otitis externa, unspecified

144

890

1.63

7.18

1.3

1.6

0.60

0.74

g/l

1.71

113

702

Viral meningitis

243

2.27

7.17

1.5

1.8

0.53

0.74

g/l

1.08

201

Hodgkin lymphoma, hilmo

169

2.54

7.15

1.5

1.6

0.70

0.80

g/l

0.25

132

Biguanides

1085

5479

1.20

7.14

1.6

0.74

0.77

g/l

0.42

837

4272

Strabismus

311

2245

1.39

7.11

1.6

0.75

g/l

0.00

237

1760

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

107

2.99

7.10

2.2

0.49

0.83

g/l

1.11

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

106

606

1.77

7.08

1.6

0.60

0.61

g/l

0.05

476

Other bullous disorders

164

2.56

7.08

1.7

1.6

0.78

0.76

g/l

0.05

135

Dementia in Alzheimer disease

780

0.43

7.05

1.2

1.5

0.56

0.86

g/l

0.86

592

Osteonecrosis due to drugs

3.40

7.05

1.4

1.7

0.66

0.90

g/l

0.38

Hidradenitis suppurativa

284

2.16

7.04

1.3

1.7

0.41

0.74

g/l

3.12

225

Peritonsillar abscess

214

1450

1.49

7.04

1.4

1.7

0.65

0.77

g/l

1.03

162

1122

Other disorders starting during childhood or adolecense, excluding more controls

327

2.04

7.04

1.4

1.8

0.55

0.79

g/l

1.74

269

Any dementia, excluding more controls

152

1634

0.64

7.02

1.6

0.76

0.88

g/l

0.61

112

1240

Familial hypercholesterolemia

141

872

1.63

7.00

1.8

1.7

0.66

0.82

g/l

1.40

114

674

Valvular operations

134

818

1.65

7.00

1.6

1.7

0.91

0.87

g/l

0.13

106

657

Decubitus ulcer and pressure area

304

2.10

6.99

1.7

1.6

0.80

0.92

g/l

0.35

243

Other renal tubulo-interstitial diseases

136

2.71

6.96

2.2

1.8

0.68

0.76

g/l

0.14

112

Periodontitis

1150

6182

1.19

6.96

1.5

1.6

0.71

0.77

g/l

1.36

921

4777

Endometriosis of rectovaginal septum and vagina

450

1.89

6.94

2.0

1.6

0.63

0.67

g/l

0.17

348

Respiratory tuberculosis, confirmed, including avohilmo

3.18

6.92

1.2

1.7

0.92

0.87

g/l

0.07

Tinnitus

263

1861

1.42

6.90

1.7

1.6

0.77

0.80

g/l

0.18

198

1454

Bell's palsy

136

838

1.64

6.88

1.5

1.6

0.61

0.77

g/l

1.33

105

649

Hypoplasia of dental enamel

3.18

6.88

1.5

0.39

0.75

g/l

1.27

Achilles tendinitis

118

701

1.70

6.87

1.8

1.6

0.61

0.87

g/l

2.49

103

553

Dementia, including avohilmo

237

2309

0.70

6.86

1.5

1.6

0.75

0.84

g/l

0.62

178

1748

Gluteal tendinitis

254

2.20

6.85

1.5

1.7

0.59

0.81

g/l

0.97

198

Trigeminal neuralgia

368

1.98

6.85

2.0

1.6

0.60

0.76

g/l

0.85

296

Viral encephalitis, not elsewhere classified/unspecified

126

2.77

6.84

1.5

1.7

0.49

0.78

g/l

1.06

105

Other and unspecified diseases of blood and blood-forming organs

149

2.61

6.84

1.7

0.92

0.82

g/l

0.16

116

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

214

1460

1.48

6.83

1.5

0.51

0.63

g/l

1.72

161

1126

Stenosis and insufficiency of lacrimal passages

100

569

1.78

6.80

1.6

0.61

0.77

g/l

1.01

436

Acute appendicitis

804

6133

1.22

6.79

1.5

1.6

0.68

0.77

g/l

1.19

609

4796

Other disorders of bladder

126

764

1.66

6.79

1.4

1.6

0.72

0.90

g/l

1.18

595

Tuberculosis of other organs, strict, including avohilmo

104

2.95

6.79

1.6

0.75

0.80

g/l

0.08

Mantle cell lymphoma, including Hilmo

3.60

6.78

1.6

1.7

0.39

1.06

g/l

1.84

Localized scleroderma [morphea]

3.31

6.77

2.0

1.6

0.83

0.68

g/l

0.25

Other and unspecified primary disorders of muscles

4.21

6.73

1.7

1.4

0.41

0.71

g/l

1.09

Lung transplant status

3.77

6.73

1.2

1.9

0.43

0.96

g/l

1.13

Dissection of aorta

150

2.58

6.73

1.6

1.7

0.71

0.89

g/l

0.56

117

Lung transplantation

3.77

6.73

1.2

1.9

0.43

0.96

g/l

1.13

Carbimazole or st.post thyroidectomy, condition for graves disease

237

1654

1.44

6.73

1.8

1.6

0.79

0.70

g/l

0.70

180

1270

Other/unspecified synovitis and tenosynovitis

123

743

1.67

6.73

1.5

1.6

0.52

0.80

g/l

3.53

579

Dislocation, sprain and strain of joints and ligaments of knee

722

5313

1.23

6.71

1.5

1.6

0.68

0.76

g/l

1.59

565

4138

Abnormality of white blood cells, not elsewhere classified

3.73

6.70

1.3

1.9

0.44

0.90

g/l

0.97

Other sleep disorders

129

790

1.65

6.70

1.4

1.6

0.65

0.83

g/l

1.65

100

630

Other keratitis

142

891

1.61

6.69

1.6

0.52

0.77

g/l

4.01

107

705

Papilloedema, unspecified

139

2.65

6.69

1.4

1.9

0.62

0.79

g/l

0.41

112

Immunodeficiency associated with other major defects

8.41

6.69

1.4

1.9

0.72

0.77

g/l

—

Acute nephritic syndrome

122

2.78

6.67

2.2

1.5

0.86

0.70

g/l

0.33

Diseases of male genital organs

574

2271

1.28

6.67

1.7

1.8

0.86

0.95

g/l

1.09

446

1774

Other maternal disorders predominantly related to pregnancy

631

3153

1.26

6.64

1.4

1.5

0.60

0.61

g/l

0.14

501

2466

Other disorders of central nervous system

3.36

6.64

1.5

0.64

0.70

g/l

0.10

Other dialysis

194

2.37

6.64

1.3

1.8

0.52

0.88

g/l

1.94

156

Personal history of other diseases and conditions

139

865

1.61

6.63

1.4

1.6

0.56

0.69

g/l

1.34

110

703

Atrophic disorders of skin

176

1162

1.53

6.62

1.6

0.63

0.71

g/l

0.68

142

895

Benign neoplasm: Adrenal gland

523

1.80

6.61

1.4

1.6

0.67

0.86

g/l

1.17

406

Cerebrovascular diseases

771

4373

1.23

6.60

1.6

0.84

0.80

g/l

0.43

616

3357

Graves ophthalmopathy

158

2.53

6.59

1.7

1.5

0.65

0.71

g/l

0.18

132

Other and unspecified vaccines and biological substances

4.14

6.56

2.2

1.4

0.40

0.45

g/l

0.11

Plantar fascial fibromatosis

108

635

1.72

6.55

1.5

1.6

0.73

0.80

g/l

0.30

492

Other and unspecified mood [affective] disorders

517

1.80

6.55

1.3

1.8

0.65

0.72

g/l

0.37

402

Use of pramipexole

225

1564

1.45

6.53

1.6

0.68

0.79

g/l

1.00

179

1199

Anti-inflammatory and antirheumatic products, non-steroids

291

1043

1.41

6.53

1.8

1.7

0.83

0.86

g/l

0.12

227

833

Ulcer of oesophagus

341

1.99

6.46

1.3

1.5

0.68

0.90

g/l

1.37

271

Osteitis due to dental implant

4.24

6.45

1.3

2.2

0.71

0.99

g/l

0.27

Hallux valgus (acquired)

312

1631

1.37

6.43

1.5

1.6

0.65

0.75

g/l

1.13

239

1286

Amputation

534

1.78

6.43

1.4

1.6

1.09

0.89

g/l

0.31

420

Disorders of tooth development and eruption

177

952

1.52

6.41

1.8

1.6

0.68

0.81

g/l

0.90

134

749

Tuberculosis of other organs, strict

102

2.90

6.41

1.7

1.6

0.73

0.77

g/l

0.07

Acne

137

857

1.60

6.40

1.5

1.7

0.64

0.73

g/l

0.62

110

679

Use of other anti-dementia drugs

1231

0.57

6.37

1.7

1.5

0.69

0.89

g/l

1.23

952

Use of memantine

1231

0.57

6.37

1.7

1.5

0.69

0.89

g/l

1.23

952

Thyrotropin deficiency

3.37

6.37

1.5

1.4

0.71

0.50

g/l

0.49

Osteomyelitis

378

1.93

6.36

1.5

1.6

0.87

g/l

0.00

299

Other and unspecified aplastic anaemias

3.46

6.36

1.4

1.9

0.65

0.80

g/l

0.27

Actinic keratosis

339

2300

1.35

6.36

1.5

1.6

0.87

0.83

g/l

0.18

257

1753

Statin medication

795

3676

1.22

6.35

1.6

0.76

0.75

g/l

0.05

606

2828

Other superficial mycoses

137

2.61

6.34

1.8

0.79

g/l

0.01

108

Other infective otitis externa

393

1.91

6.33

1.4

1.6

0.71

0.80

g/l

0.32

316

Lichen ruber planus, wide definition including periferal and oral lichen planus

248

1766

1.41

6.32

1.9

1.6

0.63

0.75

g/l

1.33

195

1364

Tuberculosis of other organs

3.00

6.32

1.7

0.75

0.82

g/l

0.12

Abdominal aortic aneurysm (AAA)

439

1.84

6.29

1.8

1.6

1.10

0.93

g/l

0.33

349

Other congenital malformations, not elsewhere classified

3.45

6.26

1.7

1.5

0.92

0.61

g/l

0.40

Complications following infusion, transfusion and therapeutic injection

3.21

6.23

1.9

1.3

0.81

0.69

g/l

0.18

Anosmia

3.05

6.22

1.3

1.4

0.99

0.89

g/l

0.12

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

157

1026

1.54

6.22

1.5

1.6

0.85

0.83

g/l

0.04

122

804

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

504

1.79

6.21

1.6

0.60

0.62

g/l

0.06

392

Nonischemic cardiomyopathy

103

608

1.71

6.17

1.5

1.7

0.79

0.89

g/l

0.32

487

Convalescence

327

1.98

6.14

1.5

1.7

0.69

0.77

g/l

0.31

251

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

176

2.38

6.12

1.4

1.8

0.48

0.62

g/l

0.74

142

Anogenital herpesviral [herpes simplex] infection, including avohilmo

138

880

1.58

6.11

1.4

1.7

0.65

0.66

g/l

0.03

113

694

Drug-induced neutropenia

463

1.82

6.10

1.5

1.7

0.62

0.78

g/l

0.72

363

Injuries to the neck

271

1974

1.38

6.06

1.4

1.6

0.59

0.76

g/l

3.75

221

1546

Benign neoplasm of eye and adnexa

116

711

1.65

6.06

1.7

1.6

0.75

0.81

g/l

0.10

558

Other diseases of peritoneum

261

2.10

6.05

1.3

1.6

0.51

0.80

g/l

2.05

211

Recurrent dislocation of patella

336

1.96

6.04

1.3

1.9

0.88

0.68

g/l

0.59

264

Exclusion endpoint for clefts

153

2.48

6.01

1.3

1.8

0.67

0.80

g/l

0.29

127

Residual foreign body in soft tissue

316

1.99

6.00

1.5

1.7

0.73

0.86

g/l

0.54

246

Event of undetermined intent

488

1.79

5.98

1.4

1.7

0.82

0.78

g/l

0.13

388

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

488

1.78

5.97

1.3

1.7

0.58

0.73

g/l

0.94

387

Excessive attrition of teeth

718

5864

1.22

5.96

1.5

1.6

0.71

0.74

g/l

0.33

571

4591

Bacterial, viral and other infectious agents, including avohilmo

114

699

1.65

5.96

1.4

1.7

0.73

0.78

g/l

0.15

547

Certolizumab pegol

124

2.65

5.95

1.5

1.6

0.77

0.66

g/l

0.21

103

Paralytic strabismus

423

1.84

5.95

1.7

0.62

0.88

g/l

2.11

332

Mature T/NK-cell lymphomas, hilmo

3.29

5.94

1.3

1.7

0.72

0.95

g/l

0.23

Pleural plaque with presence of asbestos

352

1.92

5.93

1.3

1.6

0.97

1.02

g/l

0.13

274

Superficial injury of head

263

1911

1.38

5.92

1.6

0.66

0.76

g/l

1.23

220

1489

Dronedarone medication

148

2.48

5.91

1.2

1.5

0.62

0.80

g/l

0.55

117

Abnormal findings in cerebrospinal fluid

6.79

5.91

2.4

1.3

0.63

0.45

g/l

—

Ptosis of eyelid

112

685

1.65

5.90

1.8

1.6

0.74

0.79

g/l

0.30

530

Other abnormal uterine and vaginal bleeding

223

1124

1.43

5.90

1.4

1.5

0.64

0.65

g/l

0.05

165

861

Respiratory tuberculosis, confirmed

3.01

5.89

1.2

1.7

0.95

0.87

g/l

0.09

Other and unspecified injuries of lower leg

587

1.71

5.89

1.5

1.6

0.71

0.77

g/l

0.24

453

Other specified and unspecified disorders of eyelid

3.09

5.87

2.0

1.8

0.63

0.88

g/l

0.60

Acne vulgaris

107

647

1.67

5.86

1.4

1.7

0.67

0.70

g/l

0.12

508

Palmar fascial fibromatosis [Dupuytren]

133

849

1.58

5.86

1.4

1.7

0.69

0.99

g/l

3.50

659

IgA nephropathy (IgA glomerulonephritis)

155

2.45

5.86

1.5

1.8

0.64

0.89

g/l

0.56

123

Other surgical follow-up care

205

2.23

5.86

1.4

1.7

0.51

0.82

g/l

1.81

158

Vitamin D deficiency

125

2.63

5.86

1.3

1.6

0.60

0.65

g/l

0.09

Spirochaetal infections, other/unspecified

104

626

1.68

5.85

1.4

1.6

0.59

0.78

g/l

1.58

482

Suicide or other Intentional self-harm

283

2089

1.36

5.84

1.5

1.6

0.69

0.75

g/l

0.43

219

1637

Hemiplegia

285

2.03

5.83

1.5

1.6

0.74

0.81

g/l

0.16

224

Ingrowing nail

391

1.87

5.79

1.4

1.7

0.62

0.75

g/l

0.69

309

Achalasia of cardia

2.98

5.78

1.2

1.3

0.45

0.70

g/l

1.01

Degeneration of macula and posterior pole

440

2656

1.28

5.75

1.5

1.6

0.75

0.82

g/l

0.54

333

2060

Open wound of ankle and foot

126

799

1.59

5.75

1.4

1.6

0.87

0.82

g/l

0.13

621

Fracture at wrist and hand level

404

3132

1.29

5.75

1.5

1.7

0.72

0.81

g/l

0.81

295

2438

Other and unspecified local infections of skin and subcutaneous tissue

114

706

1.63

5.74

1.7

1.6

0.67

0.79

g/l

0.70

565

Lesion of lateral popliteal nerve

308

1.98

5.72

1.4

1.6

0.85

0.82

g/l

0.06

243

Dislocation, sprain and strain of joints and ligaments at neck level

189

1308

1.46

5.70

1.5

1.6

0.58

0.74

g/l

2.84

156

1014

Arterial embolism and thrombosis

260

2.06

5.69

1.6

1.7

1.11

0.90

g/l

0.22

209

Visual field defects

510

1.74

5.69

1.7

1.6

0.67

0.82

g/l

0.77

399

Myeloid leukaemia

145

2.46

5.67

1.9

1.6

0.86

0.84

g/l

0.03

114

Other and unspecified glaucoma

358

1.89

5.65

1.6

0.68

0.88

g/l

0.83

278

Adenomyosis (Endometriosis of uterus)

133

857

1.56

5.61

1.3

1.5

0.66

g/l

0.02

107

662

Mantle cell lymphoma

3.95

5.60

1.6

2.0

0.38

1.14

g/l

—

Superficial injury of ankle and foot

154

1028

1.51

5.58

1.6

0.68

0.75

g/l

0.49

126

809

Social phobias

106

649

1.65

5.58

1.7

0.77

0.79

g/l

0.06

502

Intrahepatic Cholestasis of Pregnancy (ICP)

521

1.73

5.58

1.6

0.60

g/l

0.01

413

Deficiency of other B group vitamins

2.78

5.57

1.8

0.79

0.86

g/l

0.08

Disorders of refraction and accommodation

336

2552

1.32

5.57

1.3

1.6

0.59

0.75

g/l

3.64

251

2014

Haemorrhage in early pregnancy

302

2202

1.34

5.56

1.4

1.5

0.57

0.61

g/l

0.45

239

1721

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.90

5.56

1.2

1.7

0.95

0.86

g/l

0.11

Other and unspecified psoriasis

440

1.79

5.56

1.4

1.6

0.78

0.76

g/l

0.04

348

Peripheral artery operations in Hilmo

110

681

1.63

5.52

1.6

1.32

0.90

g/l

0.79

538

Anogenital herpesviral [herpes simplex] infection

471

1.76

5.50

1.5

1.8

0.70

0.69

g/l

0.06

371

Alcohol use disorder, ICD-based

450

3569

1.27

5.49

1.4

1.7

0.76

0.86

g/l

1.36

329

2778

Charcot foot

100

2.77

5.49

1.3

1.5

0.64

0.67

g/l

0.07

Chondropathies

178

1228

1.46

5.48

1.6

0.77

0.76

g/l

0.05

139

955

Exposure to other and unspecified inanimate mechanical forces

592

1.67

5.47

1.7

0.65

0.81

g/l

1.08

467

Female genital prolapse

274

1115

1.37

5.45

1.6

1.4

0.56

0.63

g/l

0.85

196

863

Solid cancers

927

4600

1.18

5.45

1.5

1.6

0.73

0.77

g/l

0.57

708

3601

Chondrocostal junction syndrome [Tietze]

225

2.12

5.44

1.4

1.7

0.77

0.73

g/l

0.09

179

Monoamine oxidase A inhibitors

125

803

1.57

5.41

1.4

1.6

0.75

0.82

g/l

0.29

101

622

Artificial joint operation, meniscal resection

983

5357

1.18

5.41

1.6

0.78

0.79

g/l

0.05

765

4148

Other local infections of skin and subcutaneous tissue

119

757

1.59

5.39

1.6

0.68

0.81

g/l

0.88

102

603

Excessive vomiting in pregnancy

587

1.67

5.38

1.4

1.6

0.53

0.62

g/l

0.70

462

Campylobacter enteritis

174

2.29

5.38

1.5

1.9

0.66

0.85

g/l

0.60

142

Glucagon-like peptide-1 (GLP-1) analogues

349

2690

1.30

5.37

1.4

1.6

0.67

0.80

g/l

1.97

267

2092

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

349

2690

1.30

5.37

1.4

1.6

0.67

0.80

g/l

1.97

267

2092

Other nonscarring hair loss

3.38

5.36

1.5

1.4

0.38

0.49

g/l

0.39

Other hammer toe(s) (acquired)

152

925

1.50

5.36

1.5

1.6

0.67

0.77

g/l

0.70

123

725

Hypersplenism

5.79

5.36

1.3

2.5

0.44

1.03

g/l

—

Other superficial mycoses, including avohilmo

130

845

1.55

5.36

1.5

1.7

0.70

0.73

g/l

0.13

106

667

Endometriosis ASRM stages 1,2

197

1391

1.43

5.36

1.5

0.65

0.62

g/l

0.14

137

1082

Myelodysplastic syndrome

3.48

5.35

1.3

1.9

0.66

1.07

g/l

0.60

Injuries to unspecified part of trunk, limb or body region

115

727

1.60

5.35

1.6

0.65

0.79

g/l

0.73

575

Radial styloid tenosynovitis [de Quervain]

352

1.87

5.30

1.6

1.7

0.47

0.79

g/l

2.84

281

Alzheimer’s disease, strict definition

1140

0.60

5.26

1.3

1.6

0.54

0.89

g/l

3.79

878

Other and unspecified abdominal hernia

208

2.15

5.26

1.3

1.5

0.90

0.76

g/l

0.30

170

Testicular dysfunction

311

1.93

5.25

1.7

1.6

0.54

0.95

g/l

4.21

242

Oral lichen planus

157

2.34

5.24

1.9

1.7

0.55

0.81

g/l

1.08

133

Malignant neoplasm of small intestine, including Hilmo

157

2.33

5.23

1.4

1.8

0.94

0.96

g/l

0.04

130

Propionic acid derivatives

281

1043

1.36

5.22

1.7

0.75

0.86

g/l

0.81

221

833

Cardiomyopathy, Hypertrophic obstructive

2.74

5.22

1.3

1.8

0.59

0.80

g/l

0.44

Disorders of iron metabolism

103

2.69

5.21

1.4

1.9

0.49

0.77

g/l

0.86

Mental and behavioural disorders due to sedatives or hypnotics

509

1.71

5.21

1.3

1.8

0.62

0.80

g/l

0.94

406

Malignant neoplasm of breast

262

2265

0.74

5.21

1.3

1.5

0.64

0.65

g/l

0.06

198

1783

248

2.03

5.20

1.7

1.6

0.93

0.73

g/l

0.51

193

Seronegative juvenile rheumatoid arthritis

133

2.47

5.20

1.2

1.4

0.48

0.56

g/l

0.30

111

Malignant neoplasm of breast, HER2-negative

262

2263

0.74

5.17

1.3

1.5

0.64

0.65

g/l

0.06

198

1781

All dysplastic lesions of the vagina

158

2.32

5.16

1.4

1.5

0.47

0.68

g/l

0.75

129

Explicit fungal Sepsis, including avohilmo

3.91

5.16

1.4

2.1

1.04

1.05

g/l

—

Testicular hypofunction

285

1.97

5.16

1.7

0.56

0.98

g/l

3.96

223

therapeutic use

158

2.32

5.16

1.6

1.4

0.86

0.78

g/l

0.19

127

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.64

5.14

1.7

2.1

1.42

1.20

g/l

0.09

Hypertensive Renal Disease

158

2.31

5.14

1.6

1.4

0.88

0.83

g/l

0.08

126

Uterine polyps

269

1161

1.36

5.14

1.5

1.4

0.65

0.63

g/l

0.14

209

895

Congenital malformations of the urinary system

415

1.78

5.11

1.4

1.8

0.58

0.79

g/l

1.30

333

Other bursitis of elbow

3.68

5.11

2.1

2.0

0.72

0.94

g/l

0.26

Carcinoma in situ of skin of other and unspecified parts of face

407

1.78

5.11

1.3

1.4

0.80

0.88

g/l

0.20

322

Schizophrenia

1332

0.60

5.10

1.2

1.7

0.54

0.79

g/l

2.02

1045

Oligomenorrhoea

211

2.12

5.08

1.9

1.7

0.48

0.60

g/l

0.49

168

Gonarthrosis,primary

935

4808

1.17

5.08

1.5

1.6

0.78

0.79

g/l

0.15

744

3723

Artificial joint re-operation

379

1.81

5.07

1.4

1.7

1.04

0.87

g/l

0.48

300

Other disorders of glucose regulation and pancreatic internal secretion

566

1.66

5.07

2.1

1.6

1.04

0.77

g/l

0.71

445

Mental and behavioural disorders due to alcohol, excluding acute intoxication

477

3813

1.24

5.05

1.4

1.7

0.78

0.86

g/l

0.87

351

2979

Use of donepezil

1026

0.55

5.03

1.6

1.5

0.67

0.86

g/l

0.91

791

Other otitis externa (chronic)

454

1.74

5.03

1.3

1.6

0.50

0.77

g/l

2.73

362

Impetigo

330

1.87

5.02

1.6

0.77

0.71

g/l

0.13

268

Eustachian salpingitis and obstruction

107

677

1.60

5.00

1.9

1.7

0.75

0.74

g/l

0.02

535

Biomechanical lesions, not elsewhere classified

302

1.91

5.00

1.2

1.7

0.72

0.81

g/l

0.29

241

Other erythematous conditions

213

2.10

4.98

1.6

1.7

0.67

0.79

g/l

0.45

169

Follicular lymphoma, hilmo

247

2.01

4.97

1.6

1.8

0.38

0.87

g/l

2.91

196

Viral conjunctivitis, including avohilmo

261

1.98

4.96

1.6

1.7

0.56

0.79

g/l

1.25

214

Melanocytic naevi

349

2722

1.29

4.94

1.7

1.6

0.64

0.73

g/l

1.01

283

2123

Chronic periodontitis, complicated

607

4901

1.21

4.93

1.5

1.6

0.73

0.79

g/l

0.82

486

3793

Benign neoplasm of meninges

104

656

1.60

4.92

1.6

0.70

0.77

g/l

0.36

500

Necrosis of pulp, including avohilmo

677

5603

1.20

4.90

1.4

1.6

0.71

0.76

g/l

0.76

517

4390

Other and unspecified nail disorders

143

2.36

4.89

1.3

1.7

0.51

0.83

g/l

1.23

116

Bipolar affective disorders

211

1533

1.38

4.89

1.5

1.6

0.76

g/l

0.00

176

1183

Heterophoria

595

1.63

4.89

1.7

0.73

0.75

g/l

0.08

460

Mixed conductive and sensorineural hearing loss

117

760

1.55

4.87

1.6

1.5

0.70

0.83

g/l

0.87

589

Medicines for HER+ breast cancer

223

2806

0.74

4.87

1.4

1.5

0.64

0.65

g/l

0.04

164

2193

Acute nasopharyngitis (common cold)

128

841

1.52

4.86

1.7

0.74

0.86

g/l

0.52

645

Congenital malformations of the urinary system, including avohilmo

444

1.73

4.86

1.4

1.7

0.63

0.80

g/l

0.83

355

Disorders of optic nerve, not elsewhere classified

113

2.53

4.84

1.3

1.7

0.58

0.76

g/l

0.51

Lateral epicondylitis

137

922

1.50

4.83

1.6

0.63

0.80

g/l

1.58

110

715

Acne, including avohilmo

256

1548

1.34

4.81

1.6

0.62

0.72

g/l

1.27

211

1230

Polyp of the female genital tract

281

1195

1.34

4.81

1.4

1.5

0.65

0.63

g/l

0.13

218

921

Varicella [chickenpox]

357

1.82

4.81

1.2

1.7

0.91

0.85

g/l

0.08

282

Other salmonella infections, including avohilmo

257

1.97

4.80

1.7

1.6

0.61

0.83

g/l

1.23

204

Superficial injury of hip and thigh

147

1004

1.47

4.80

1.5

1.6

0.93

0.79

g/l

0.37

109

772

Malignant neoplasm of breast, including Hilmo

273

2301

0.76

4.79

1.3

1.5

0.63

0.65

g/l

0.14

208

1810

Malignant neoplasm of breast, HER2-negative, including Hilmo

273

2301

0.76

4.79

1.3

1.5

0.63

0.65

g/l

0.14

208

1810

Other strabismus

247

1839

1.35

4.78

1.6

0.78

0.75

g/l

0.13

185

1440

Diabetic maculopathy, excluding more controls

114

740

1.55

4.77

1.5

1.6

0.93

0.85

g/l

0.13

585

Other and unspecified erythematous conditions

190

2.14

4.77

1.7

0.62

0.79

g/l

0.75

156

Ischaemic Stroke, excluding all haemorrhages

535

3222

1.23

4.76

1.6

0.89

0.83

g/l

0.54

421

2471

Other condition

166

1164

1.44

4.75

1.7

1.6

0.75

0.79

g/l

0.21

132

916

Thyrotoxicosis with diffuse goitre

149

1024

1.47

4.74

1.8

1.6

0.82

0.70

g/l

0.81

109

799

Sequelae of injuries, of poisoning and of other consequences of external causes

261

1970

1.33

4.74

1.4

1.6

0.72

0.77

g/l

0.31

196

1541

Juvenile rheumatoid arthirtis

139

2.35

4.73

1.4

1.9

0.49

0.78

g/l

0.83

117

Other specified/unspecified dorsopathies

171

2.19

4.71

1.5

1.8

0.61

0.85

g/l

0.83

134

Malnutrition

127

2.41

4.69

1.6

1.7

0.62

0.74

g/l

0.31

109

Pain associated with micturition

126

840

1.51

4.67

1.5

0.63

0.76

g/l

1.22

649

Stroke, excluding SAH

577

3440

1.21

4.67

1.5

1.6

0.89

0.82

g/l

0.59

458

2631

Prolonged pregnancy

1112

0.61

4.66

1.3

1.6

0.58

0.61

g/l

0.15

878

Pleural plaque without asbestos

159

2.23

4.65

1.5

1.6

0.73

1.01

g/l

0.94

129

Hypocalcemia

134

2.36

4.64

1.6

1.8

0.64

0.83

g/l

0.48

107

Scoliosis

526

1.65

4.63

1.4

1.6

0.64

0.75

g/l

0.51

413

Malignant neoplasm of breast, ER-positive, including Hilmo

191

1953

0.72

4.61

1.4

1.5

0.68

0.66

g/l

0.09

139

1531

LSIL lesion of the vagina

2.67

4.61

1.4

1.6

0.51

0.68

g/l

0.36

Other symptoms and signs involving the urinary system

105

675

1.57

4.60

1.6

0.61

0.87

g/l

2.69

528

Other specified and unspecified personality disorders

105

676

1.57

4.59

1.4

1.7

0.77

0.74

g/l

0.11

532

Emotionally unstable personality disorder

146

1007

1.46

4.58

1.5

1.6

0.69

0.70

g/l

0.04

111

792

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

195

1416

1.39

4.58

1.5

1.6

0.67

0.74

g/l

0.51

146

1110

Abrasion of teeth

402

3223

1.25

4.56

1.5

1.6

0.65

0.74

g/l

1.45

313

2503

Malignant neoplasm of breast, HER-positive

191

1951

0.73

4.56

1.4

1.5

0.68

0.66

g/l

0.09

139

1529

Disorders of psychological development

146

933

1.46

4.55

1.3

1.8

0.58

0.77

g/l

2.41

117

745

Other noninflammatory disorders of uterus, except cervix

197

947

1.39

4.55

1.5

0.66

0.65

g/l

0.02

155

728

Urethritis and urethral syndrome

129

2.37

4.54

1.4

1.7

0.46

0.79

g/l

2.03

107

MS-disease / Multiple Sclerosis

537

1.64

4.54

1.4

1.7

0.53

0.68

g/l

0.94

429

Sub-endpoint used in defining T1D endpoints

305

2327

1.29

4.54

1.7

1.6

0.74

0.80

g/l

0.28

235

1838

Discitis, unspecified

2.70

4.53

1.3

1.7

0.88

1.03

g/l

0.21

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

256

1.94

4.52

1.9

1.7

0.62

0.81

g/l

0.85

209

Hypertrophic cardiomyopathy

256

1.94

4.52

1.4

1.7

0.72

0.85

g/l

0.34

206

Contusion of toe(s) without damage to nail

168

2.18

4.50

1.3

1.6

0.48

0.72

g/l

1.21

136

Obsessive-compulsive disorder

469

1.68

4.49

1.5

1.8

0.59

0.79

g/l

1.44

361

Injuries to the hip and thigh

484

3548

1.23

4.49

1.5

1.6

0.81

0.80

g/l

0.08

389

2741

Desensitization to allergens

440

1.70

4.47

1.5

1.8

0.66

0.67

g/l

0.04

346

Malignant neoplasm of thyroid gland, including Hilmo

493

1.66

4.47

2.0

1.6

0.77

0.75

g/l

0.06

388

Respiratory tuberculosis, not confirmed, including avohilmo

175

2.14

4.46

2.1

1.7

0.77

0.87

g/l

0.19

140

Benign neoplasm: Cerebral meninges

594

1.60

4.45

1.7

1.6

0.74

0.76

g/l

0.09

454

Other peripheral vertigo

595

1.59

4.43

1.6

0.55

0.79

g/l

2.79

463

Morphin

2.59

4.41

1.5

1.4

1.08

0.94

g/l

0.16

Emotional disorders starting during childhood or adolecense, excluding more controls

291

1.85

4.41

1.3

1.9

0.61

0.79

g/l

0.94

237

Hypertrophic disorders of skin

397

1.73

4.39

1.6

0.60

0.75

g/l

0.85

314

Myeloproliferative diseases

480

1.66

4.39

1.7

1.6

0.79

0.86

g/l

0.28

375

Female infertility, associated with anovulation

503

1.64

4.38

1.5

1.6

0.58

0.61

g/l

0.13

398

Flat foot [pes planus] (acquired)

612

1.58

4.38

1.3

1.8

0.72

0.76

g/l

0.12

480

Type 1 diabetes, wide definition

240

1810

1.33

4.38

1.6

0.70

0.79

g/l

0.35

188

1439

Spinal enthesopathy

2.84

4.38

1.3

1.7

0.49

0.98

g/l

1.41

Spasmodic torticollis

197

2.06

4.37

1.6

1.8

0.51

0.76

g/l

0.89

157

Dilated cardiomyopathy

115

764

1.52

4.37

1.6

0.80

0.90

g/l

0.39

604

Hydronephrosis

109

717

1.53

4.33

2.6

1.6

1.01

0.83

g/l

0.59

570

Other specified/unspecified hearing loss

537

1.61

4.29

1.7

1.6

0.67

0.87

g/l

1.31

420

Malignant neoplasm of endocrine gland, including Hilmo

561

1.60

4.28

1.9

1.6

0.78

g/l

0.01

436

Neovascular glaucoma

212

2.01

4.28

1.5

1.6

0.42

0.84

g/l

2.95

170

Presbycusis

102

654

1.55

4.28

1.9

1.5

0.59

0.90

g/l

3.01

504

Lichen planus, including avohilmo

197

1450

1.37

4.28

1.9

1.6

0.67

0.76

g/l

0.72

155

1109

Explicit fungal Sepsis

4.01

4.27

1.4

2.1

1.04

1.07

g/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

444

1.67

4.27

1.5

1.7

0.56

0.71

g/l

1.01

368

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

189

1341

1.38

4.24

1.5

1.7

0.70

0.80

g/l

0.65

149

1073

Respiratory tuberculosis, not confirmed

172

2.12

4.24

2.1

1.7

0.75

0.88

g/l

0.24

137

Vertical strabismus

220

1.98

4.24

1.3

1.6

0.96

0.89

g/l

0.10

179

Alcohol abuse, main dg

177

1283

1.39

4.24

1.6

1.7

0.85

0.81

g/l

0.15

138

1003

Other endocrine disorders

384

1.72

4.23

1.4

1.7

0.71

0.80

g/l

0.25

320

Transient ischemic attack

490

3212

1.22

4.23

1.5

1.6

0.74

0.81

g/l

0.90

380

2468

Deep endometriosis

634

1.56

4.22

1.8

1.6

0.59

g/l

0.00

494

Sleep disorders, other/unspecified

277

1.87

4.22

1.4

1.8

0.79

0.75

g/l

0.07

217

Brain meningioma, including Hilmo

306

1.82

4.20

1.5

1.7

0.49

0.83

g/l

2.75

239

Disorder of the sleep-wake schedule

128

2.32

4.18

1.4

1.7

0.63

0.79

g/l

0.46

102

Persons encountering health services in circumstances related to reproduction

677

3846

1.18

4.15

1.5

1.6

0.71

0.75

g/l

0.53

527

3012

Open wound of wrist and hand

505

4046

1.21

4.15

1.5

1.7

0.78

0.83

g/l

0.54

407

3144

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

229

1.95

4.13

2.5

1.7

0.97

0.81

g/l

0.22

183

Other congenital malformations of the digestive system, including avohilmo

394

1.71

4.13

1.7

1.6

0.74

0.76

g/l

0.05

320

Background retinopathy and retinal vascular changes

116

2.37

4.12

1.9

1.8

0.60

0.82

g/l

0.50

Diabetic neuropathy

120

812

1.48

4.10

1.8

1.7

0.68

0.84

g/l

1.26

609

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

171

1240

1.39

4.09

1.4

1.7

0.87

0.86

g/l

0.03

120

965

Fall on same level involving ice and snow

636

5392

1.18

4.08

1.6

0.72

0.76

g/l

0.37

499

4212

Benign neoplasm: Tongue

162

2.13

4.07

2.4

1.7

0.80

0.79

g/l

0.01

135

Bacterial, viral and other infectious agents

100

656

1.54

4.07

1.4

1.6

0.75

0.80

g/l

0.14

510

Injury of unspecified body region

506

1.62

4.06

1.6

1.7

0.67

0.80

g/l

0.47

405

Follicular cysts of skin and subcutaneous tissue

196

1455

1.35

4.05

1.6

0.66

0.80

g/l

1.60

149

1130

Other contact dermatitis

522

1.60

4.05

1.5

1.7

0.67

0.75

g/l

0.38

411

Other/unspecified disorders of vestibular function

238

1.92

4.04

1.1

1.7

0.85

0.79

g/l

0.13

192

Benign lipomatous neoplasm of other sites/unspecified

499

1.62

4.04

1.5

1.6

0.63

0.83

g/l

0.96

397

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

198

1430

1.35

4.03

1.4

1.7

0.72

0.79

g/l

0.40

155

1143

Malignant neoplasm of small intestine

111

2.38

4.02

1.6

2.0

1.13

1.05

g/l

0.09

Other eating disorders

362

1.73

4.02

1.5

1.7

0.74

0.66

g/l

0.34

280

Mixed and other personality disorders

634

1.54

4.02

1.5

1.7

0.83

0.76

g/l

0.27

505

Medical abortion

654

2993

1.19

4.01

1.5

0.59

0.62

g/l

0.32

516

2322

Chronic Coagulation defects

150

2.17

4.00

1.8

0.46

0.74

g/l

1.33

125

Other and unspecified disorders of skin and subcutaneous tissue

378

1.71

3.99

2.0

1.7

0.90

0.83

g/l

0.17

299

Postmenopausal bleeding

237

935

1.33

3.99

1.4

1.5

0.63

0.66

g/l

0.23

180

718

Alzheimer’s disease (Late onset)

1032

0.64

3.98

1.4

1.6

0.55

0.89

g/l

3.33

790

Malignant neoplasm of thyroid gland

448

1.65

3.95

1.9

1.6

0.75

0.77

g/l

0.07

353

Other other unspecified disorders of the circulatory system

212

1.96

3.94

2.0

1.6

0.68

0.83

g/l

0.47

169

Glaucoma

542

3858

1.20

3.92

1.5

1.6

0.70

0.80

g/l

1.02

390

3017

Suppurative otitis media, unspecified

138

2.21

3.91

1.6

1.9

0.94

0.75

g/l

0.20

115

Lichen simplex chronicus

192

2.01

3.90

1.5

1.6

0.95

0.82

g/l

0.27

156

Salpingitis and oophoritis

180

1328

1.36

3.90

1.5

0.63

0.65

g/l

0.11

144

1020

Meralgia paraesthetica

213

1.95

3.89

1.6

1.7

0.88

0.78

g/l

0.20

170

Ménière disease

599

1.55

3.88

1.9

1.6

0.71

0.81

g/l

0.59

455

Isolated proteinuria with specified morphological lesion

2.75

3.87

2.3

1.4

0.55

0.63

g/l

0.25

Familial hypercholesterolemia, with ischemic heart disease

458

1.63

3.86

1.8

1.7

0.77

0.99

g/l

1.06

369

Benign neoplasm of middle ear and respiratory system

474

1.62

3.86

2.1

1.6

1.04

0.87

g/l

0.33

370

Other symptoms and signs involving general sensations and perceptions

242

1.88

3.85

1.2

1.8

0.51

0.88

g/l

3.01

192

L02BG Aromatase inhibitors

178

2358

0.74

3.83

1.4

1.5

0.65

0.64

g/l

0.04

129

1830

Torsion of ovary, ovarian pedicle and fallopian tube

133

2.22

3.83

1.1

1.8

0.37

0.68

g/l

1.95

111

Chronic mastoiditis

133

2.22

3.83

2.3

1.6

0.71

0.78

g/l

0.13

111

Brain meningioma

301

1.78

3.82

1.5

1.7

0.50

0.84

g/l

2.72

235

Unspecified dementia

447

0.44

3.82

1.3

1.5

1.09

0.89

g/l

0.17

348

Endometriosis of ovary

159

1085

1.39

3.81

1.5

0.63

0.64

g/l

0.05

125

841

Examination and encounter for administrative purposes

445

1.63

3.79

1.3

1.5

0.97

0.85

g/l

0.28

319

Papillary adenocarcinoma of thyroid gland

339

1.73

3.79

2.1

1.7

0.72

0.75

g/l

0.08

268

Benign neoplasm: Skin of eyelid, including canthus

149

1072

1.40

3.78

1.8

1.5

0.81

0.75

g/l

0.25

122

824

Corneal ulcer

198

1490

1.34

3.77

1.8

1.6

0.73

0.79

g/l

0.41

148

1171

Other benign neoplasms of skin

369

3002

1.23

3.75

1.7

1.6

0.79

0.76

g/l

0.14

289

2313

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

232

1787

1.30

3.74

1.6

0.66

0.70

g/l

0.28

180

1394

Glaucoma-related operations

303

1.77

3.73

1.6

0.65

0.89

g/l

0.94

240

Diabetic retinopathy, excluding more controls

271

1179

1.29

3.73

1.4

1.7

0.72

0.77

g/l

0.18

190

886

Postprocedural musculoskeletal disorders, not elsewhere classified

448

1.62

3.71

1.3

1.7

0.69

0.79

g/l

0.57

355

Herpesviral keratitis and keratoconjunctivitis

260

1.83

3.70

1.9

1.7

1.52

0.81

g/l

0.67

209

Varicella [chickenpox], including avohilmo

433

1.63

3.70

1.3

1.7

0.84

0.82

g/l

0.03

351

Other salmonella infections

203

1.95

3.69

1.4

1.6

0.65

0.78

g/l

0.50

163

Congenital malformations of ovaries, fallopian tubes and broad ligaments

395

1.66

3.69

1.4

1.6

0.46

0.61

g/l

1.07

316

Congenital malformations of genital organs

110

748

1.47

3.68

1.4

1.7

0.55

0.68

g/l

0.98

602

Specific development disorders of scholastic skills

372

1.68

3.68

1.4

1.8

0.63

0.74

g/l

0.43

300

Cauda equina syndrome

2.53

3.68

1.2

1.8

0.69

0.76

g/l

0.11

Fall on and from stairs and steps

268

2108

1.28

3.67

1.6

0.90

0.77

g/l

0.61

207

1645

Mental and behavioural disorders due to opioids

283

1.79

3.66

1.5

2.0

0.51

0.80

g/l

1.45

219

Acute epiglottitis

2.58

3.66

2.0

2.1

0.77

0.89

g/l

0.17

Myeloproliferative diseases (CML excluded)

434

1.63

3.66

1.7

1.6

0.84

g/l

0.01

340

Other menopausal disorders

255

1099

1.30

3.66

1.7

1.5

0.66

0.64

g/l

0.09

197

848

Glaucoma secondary to other eye disorders

225

1.89

3.66

1.5

1.6

0.42

0.83

g/l

2.97

177

Malignant neoplasm of endocrine gland

489

1.59

3.65

1.8

1.6

0.74

0.78

g/l

0.12

385

Hyperaldosteronism

156

2.08

3.64

1.9

1.8

1.45

0.88

g/l

0.75

122

Other predominantly sexually transmitted diseases, not elsewhere classified

193

1456

1.33

3.63

1.6

0.66

0.70

g/l

0.30

155

1131

Speech disturbances, not elsewhere classified

521

1.57

3.63

1.9

1.5

0.83

g/l

0.00

408

Hyperfunction of pituitary gland

336

1.72

3.63

1.4

1.7

0.62

0.70

g/l

0.29

265

Spondylopathies in diseases classified elsewhere

2.81

3.62

1.3

1.9

0.67

1.06

g/l

0.60

Speech and linguistic disorders

110

724

1.47

3.61

1.3

1.8

0.55

0.79

g/l

3.44

588

Dislocation, sprain and strain of joint and ligaments of hip

212

1.91

3.60

1.3

1.7

0.66

0.89

g/l

0.95

169

Use of glatiramer acetate

111

2.30

3.59

1.4

1.6

0.66

0.61

g/l

0.08

Diphtheria

10.97

3.58

1.2

2.0

0.51

0.54

g/l

—

Other and unspecified nonscarring hair loss

3.13

3.57

1.3

1.4

0.43

0.50

g/l

—

Diphtheria, including avohilmo

10.82

3.57

1.2

2.0

0.51

0.54

g/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.89

3.57

1.2

1.4

0.33

0.67

g/l

—

Other disorders starting during childhood or adolescence

425

1.62

3.57

1.4

1.7

0.55

0.72

g/l

1.21

349

Impacted cerumen

108

742

1.47

3.55

1.5

1.6

0.77

0.82

g/l

0.19

589

Sixth [abducent] nerve palsy

192

1.95

3.55

1.7

1.8

0.53

0.84

g/l

1.72

153

Disorders of breast

510

3783

1.19

3.54

1.4

1.5

0.60

0.62

g/l

0.22

404

2944

Malignant neoplasm, without specification of site, including Hilmo

206

1.91

3.53

1.4

1.7

0.77

0.98

g/l

0.52

167

Left ventricular outflow tract obstruction (LVOTO), broad definition

117

818

1.44

3.53

1.7

0.94

0.82

g/l

0.39

656

Amputation of toe

392

1.65

3.52

1.3

1.6

1.12

0.90

g/l

0.23

307

Nonpyogenic thrombosis of intracranial venous system

2.69

3.52

1.4

1.3

0.50

0.69

g/l

0.67

Peripheral arterial reconstruction

132

942

1.41

3.52

1.5

1.7

1.08

0.96

g/l

0.19

733

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

566

1.53

3.51

1.3

1.8

0.70

0.80

g/l

0.43

442

Stroke, including SAH

606

3714

1.17

3.49

1.6

0.87

0.81

g/l

0.54

484

2842

Injuries to the elbow and forearm

793

5933

1.15

3.48

1.5

1.6

0.71

0.76

g/l

0.55

620

4640

Other specified congenital malformation syndromes affecting multiple systems

139

2.14

3.48

1.3

1.8

0.65

0.76

g/l

0.24

116

232

1547

1.29

3.47

1.4

1.6

0.82

0.88

g/l

0.24

172

1184

Wet age-related macular degeneration

124

845

1.42

3.47

1.6

0.92

0.88

g/l

0.08

666

Other facial nerve disorders

159

2.04

3.47

2.5

1.7

0.64

0.82

g/l

0.52

127

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

625

4162

1.17

3.47

1.5

0.67

0.68

g/l

0.13

472

3281

Entropion and trichiasis of eyelid

402

1.63

3.44

1.4

1.6

0.91

g/l

0.01

314

Melanocytic naevi of lower limb, including hip

297

1.74

3.41

1.9

1.7

0.75

g/l

0.00

233

Other disorders of choroid

2.62

3.41

1.6

1.8

0.64

0.80

g/l

0.25

Lactose intolerance

195

1.92

3.41

1.2

1.7

0.70

0.81

g/l

0.32

160

Other secondary gonarthrosis

336

1.68

3.36

1.7

0.93

0.78

g/l

0.29

270

Somnolence, stupor and coma

239

1.82

3.36

1.4

1.8

0.52

0.86

g/l

1.91

192

L01XX Other antineoplastic agents

314

1.70

3.33

1.3

1.7

0.56

0.91

g/l

2.65

248

Heart failure and hypertrophic cardiomyopathy

102

2.30

3.32

1.3

1.7

1.03

0.85

g/l

0.22

Bruxism

135

2.12

3.32

1.4

1.7

0.60

0.67

g/l

0.14

113

Pustular psoriasis

300

1.72

3.30

1.3

1.7

0.66

0.78

g/l

0.38

238

Blepharochalasis

261

2077

1.26

3.29

1.6

1.5

0.70

0.76

g/l

0.40

202

1599

Hallux rigidus

119

846

1.41

3.28

1.7

0.69

0.78

g/l

0.56

665

Thiazolidinediones

104

722

1.45

3.28

1.6

0.72

0.85

g/l

0.86

561

Perioral dermatitis

156

2.02

3.27

1.5

1.6

0.51

0.65

g/l

0.54

127

Benign neoplasm: Rectosigmoid junction

227

1.83

3.26

1.3

1.7

0.83

0.84

g/l

0.02

180

Secondary thrombocytopenia

2.50

3.25

1.8

0.16

0.88

g/l

3.08

Dermatitis due to ingested food

252

1.77

3.25

1.8

1.7

1.08

0.76

g/l

0.84

216

Left hemicolectomy

116

2.19

3.25

1.6

0.84

0.85

g/l

0.01

Kyphosis

2.55

3.24

1.3

1.7

0.70

0.87

g/l

0.34

Hypoglycaemia, other or unspecified

441

1.58

3.23

2.4

1.6

1.04

0.76

g/l

0.57

350

Molar incisor enamel hypoplasia

325

1.67

3.22

2.1

1.6

0.66

0.68

g/l

0.07

275

Alopecia areata

178

1.94

3.22

1.9

1.7

0.52

0.76

g/l

1.04

145

Other disorders of Eustachian tube

185

1.92

3.22

1.4

1.6

0.69

0.72

g/l

0.06

153

Oral leukoplakia, including avohilmo

164

1.98

3.22

1.3

1.8

0.63

0.89

g/l

0.70

131

Eating disorder

100

691

1.45

3.21

1.5

1.6

0.60

0.63

g/l

0.14

550

Open wound of head

573

4624

1.17

3.20

1.7

1.6

0.80

0.83

g/l

0.22

435

3571

Tobacco use

372

1.63

3.19

1.4

1.7

0.71

0.80

g/l

0.32

295

Carcinoma in situ of skin of upper limb, including shoulder

117

2.17

3.18

1.7

1.6

0.78

0.91

g/l

0.15

Psychotic depression

380

1.62

3.18

1.2

1.9

0.52

0.87

g/l

2.65

294

Malignant neoplasm of eye, brain and central nervous system

251

1.77

3.18

1.5

1.7

0.58

0.91

g/l

1.70

206

Pustulosis palmaris et plantaris

266

1.75

3.18

1.3

1.6

0.68

0.76

g/l

0.25

214

Eating disorders

114

809

1.42

3.17

1.4

1.6

0.58

0.64

g/l

0.41

637

Other congenital malformations of the digestive system

332

1.66

3.16

1.9

1.6

0.75

0.76

g/l

0.02

269

Localized skin eruption due to drugs and medicaments

2.60

3.16

1.9

2.0

0.45

0.85

g/l

1.09

Other congenital malformations of skin

274

1.74

3.16

1.4

1.7

0.80

0.74

g/l

0.12

220

Complications of genitourinary prosthetic devices, implants and grafts

124

2.12

3.16

1.5

1.3

0.77

0.72

g/l

0.11

102

Perineal laceration during delivery

101

1159

0.70

3.16

1.7

1.5

0.47

0.58

g/l

1.08

905

Insulin, fast-acting (human)

144

1065

1.36

3.15

1.5

1.6

0.75

0.78

g/l

0.06

114

832

Paraplegia, diplegia of upper limbs

131

2.10

3.15

1.4

1.8

0.58

0.85

g/l

0.84

106

Maltreatment syndromes

405

1.60

3.14

1.2

1.8

0.96

0.71

g/l

0.85

327

Primary gonarthrosis, bilateral

489

3477

1.18

3.13

1.5

1.6

0.76

0.81

g/l

0.55

401

2704

Psoriasis (vulgaris), strict definition

223

1.82

3.13

1.4

1.6

1.18

0.76

g/l

0.46

184

Hypertrophy of tongue papillae

2.38

3.11

1.8

1.7

0.99

0.81

g/l

0.21

Embedded teeth, including avohilmo

100

697

1.44

3.11

1.8

1.7

0.68

0.69

g/l

0.02

556

Fracture of skull and facial bones

225

1774

1.27

3.10

1.5

1.6

0.65

0.80

g/l

1.76

159

1379

Fracture of shoulder and upper arm

361

2990

1.21

3.10

1.5

1.6

0.69

0.78

g/l

1.01

283

2309

Occupational exposure to risk-factors

202

1.86

3.10

1.6

0.78

0.84

g/l

0.12

158

Other acquired deformities of musculoskeletal system and connective tissue

306

1.69

3.10

1.9

1.7

0.94

0.79

g/l

0.38

240

Unspecified urinary incontinence

542

1.50

3.09

1.4

1.5

0.66

0.76

g/l

0.47

406

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

247

1.76

3.05

1.4

1.8

0.64

0.72

g/l

0.20

197

Overexertion and strenuous or repetitive movements

107

758

1.42

3.05

1.2

1.7

0.85

0.82

g/l

0.05

591

Seborrhoeic dermatitis

675

1.45

3.05

1.3

1.6

0.69

0.81

g/l

0.75

535

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

10.94

3.04

1.6

0.52

0.57

g/l

—

Medial epicondylitis

225

1.80

3.04

1.5

1.7

0.68

0.80

g/l

0.41

178

Patellar tendinitis

113

2.16

3.03

1.7

2.1

0.76

0.88

g/l

0.19

Other epidermal thickening

270

1.72

3.03

1.5

1.7

0.56

0.86

g/l

1.51

225

Undefined dementia

418

0.48

3.03

1.3

1.4

1.09

0.86

g/l

0.20

325

Other specified disorders of muscle

147

2.00

3.01

1.4

1.8

0.54

0.84

g/l

1.13

119

Benign lipomatous neoplasm

286

2326

1.23

3.01

1.4

1.6

0.63

0.80

g/l

2.62

209

1807

Other articular cartilage disorders

120

2.11

3.00

2.1

0.88

0.92

g/l

0.06

Complications of other internal prosthetic devices, implants and grafts

204

1.83

3.00

2.1

1.4

0.87

0.72

g/l

0.19

162

Hypertrophic scar

363

1.61

2.99

1.6

1.7

0.60

0.75

g/l

0.71

288

Status epilepticus

197

1.85

2.99

1.4

1.7

0.67

0.84

g/l

0.44

159

Primary coxarthrosis, bilateral

247

1980

1.25

2.97

1.5

1.6

0.72

0.82

g/l

0.97

200

1511

Other diseases of spinal cord

169

1.92

2.97

1.3

1.8

0.56

0.80

g/l

1.00

142

Dysplasia of cervi uteri

213

1173

1.28

2.96

1.5

0.59

0.63

g/l

0.40

163

917

Congenital ovarian cysts

318

1.65

2.95

1.5

1.6

0.50

0.59

g/l

0.49

254

Female infertility, tubal origin

318

1.65

2.95

1.5

1.6

0.68

0.67

g/l

0.03

254

Alzheimer’s disease (Atypical or mixed)

468

0.50

2.94

1.1

1.6

0.84

0.92

g/l

0.11

367

Contusion of other and unspecified parts of foot

397

1.58

2.92

1.7

1.5

0.84

0.73

g/l

0.39

312

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

250

1.74

2.92

1.5

1.9

0.63

0.76

g/l

0.38

204

Other and unspecified mononeuropathies of lower limb

156

1.95

2.92

1.3

1.7

0.49

0.79

g/l

1.30

125

Other disorders of bone density and structure

149

1.97

2.92

1.5

1.8

0.50

0.78

g/l

1.08

118

Effects of foreign body entering through natural orifice

258

2084

1.24

2.91

1.4

1.7

0.70

0.83

g/l

1.51

186

1638

False labour

318

1619

1.22

2.89

1.4

1.5

0.59

g/l

0.04

244

1281

Respiratory conditions due to other external agents

102

2.19

2.89

1.7

0.81

0.83

g/l

0.02

Superficial injury of forearm

111

800

1.40

2.89

1.7

0.72

0.77

g/l

0.20

629

Coxarthrosis, primary

562

4035

1.16

2.89

1.4

1.6

0.75

0.81

g/l

0.64

461

3109

Organic, including symptomatic, mental disorders

332

2813

0.83

2.89

1.5

1.6

0.73

0.85

g/l

1.28

248

2156

Other disorders of pigmentation

274

1.70

2.89

1.5

1.7

0.62

0.79

g/l

0.82

218

Cardiac arrest

263

1.66

2.88

1.1

1.5

0.40

0.85

g/l

7.15

217

Ovarian dysfunction

543

1.48

2.88

1.7

1.6

0.40

0.57

g/l

2.24

429

Fracture of lower leg, including ankle

579

4936

1.15

2.87

1.5

1.6

0.77

g/l

0.06

465

3831

Amputation of foot

136

2.01

2.87

1.5

1.7

2.25

0.92

g/l

0.81

111

Congenital iodine-deficiency syndrome/hypothyroidism

143

1.98

2.86

2.0

1.8

0.66

0.84

g/l

0.38

125

Unspecified event, undetermined intent

165

1.91

2.83

1.3

1.7

0.75

0.76

g/l

0.03

140

Normotensive glaucoma

472

1.51

2.83

1.4

1.6

0.70

0.84

g/l

0.68

370

Other arterial embolism and thrombosis

123

2.06

2.83

2.1

1.6

1.47

0.81

g/l

0.45

Injury of muscle and tendon at forearm level

110

2.13

2.81

1.4

1.9

0.75

0.90

g/l

0.22

Retinal detachments and breaks

321

2662

1.21

2.81

1.8

1.6

0.83

g/l

0.04

258

2078

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

292

1.66

2.79

1.6

1.8

0.64

0.79

g/l

0.54

225

Pigmented purpuric dermatosis

2.37

2.79

1.1

1.7

0.49

0.83

g/l

0.85

Blood alcohol or alcohol intoxication level

159

1.91

2.78

1.2

1.7

0.73

g/l

0.00

131

Diabetic nephropathy, excluding more controls

146

897

1.33

2.78

1.4

1.8

0.71

0.82

g/l

0.67

116

673

Single spontaneous delivery

274

1774

0.81

2.78

1.6

1.5

0.64

0.62

g/l

0.13

198

1409

Tuberculosis of nervous system, including avohilmo

6.60

2.78

1.8

1.5

1.11

0.51

g/l

—

Tuberculosis of nervous system

6.60

2.78

1.8

1.5

1.11

0.51

g/l

—

Degenerative macular diseases

655

1.43

2.77

1.6

1.5

0.67

0.83

g/l

0.56

509

Emotional disorders and disorders of social functioning with onset specific to childhood

394

1.55

2.76

1.4

1.7

0.71

0.68

g/l

0.08

323

Hypertrophy of breast in women and men

203

1607

1.27

2.76

1.4

1.5

0.64

0.67

g/l

0.26

151

1242

Disorders of eyelid in diseases classified elsewhere

181

1.84

2.75

1.7

1.5

1.36

0.79

g/l

0.36

150

Endometriosis ASRM stages 3,4

217

1732

1.26

2.75

1.6

1.5

0.64

0.61

g/l

0.18

171

1329

Sudden idiopathic hearing loss

673

1.42

2.75

2.1

1.6

0.78

0.81

g/l

0.10

529

Viral agents as the cause of diseases classified to other chapters, including avohilmo

167

1.88

2.74

1.3

1.8

0.65

0.77

g/l

0.41

140

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.17

2.72

2.0

1.5

1.97

0.69

g/l

0.75

Alzheimer disease, excluding more controls

684

0.68

2.69

1.5

1.6

0.66

0.87

g/l

1.02

506

Leisure time condition

185

1453

1.28

2.69

1.9

1.6

0.73

0.78

g/l

0.28

135

1128

Anxious personality disorder

126

2.02

2.68

1.4

2.0

0.63

0.84

g/l

0.54

104

Postprocedural disorders of ear and mastoid process, not elsewhere classified

2.87

2.68

1.1

1.3

0.27

0.77

g/l

—

Oesophageal obstruction

161

1.88

2.67

1.2

1.5

0.84

0.92

g/l

0.17

127

Coarctation of the aorta

2.27

2.67

1.6

2.0

0.63

0.90

g/l

0.66

Essential (haemorrhagic) thrombocythaemia

205

1.77

2.67

1.3

1.7

0.92

0.96

g/l

0.08

168

Primary open-angle glaucoma, strict

209

1664

1.26

2.65

1.5

1.6

0.67

0.85

g/l

1.78

144

1275

Use of antiglaucoma preparations and miotics

383

1.55

2.64

1.4

1.5

0.67

0.85

g/l

0.62

301

Embedded and impacted teeth

298

2001

1.21

2.63

1.7

1.6

0.66

0.72

g/l

0.67

246

1576

Other acute skin changes due to ultraviolet radiation

184

1.81

2.62

1.7

1.6

0.68

0.76

g/l

0.23

145

Congenital malformations of the circulatory system

157

1177

1.30

2.61

1.6

1.7

0.74

0.79

g/l

0.26

124

937

Primary open-angle glaucoma

253

1986

1.23

2.61

1.5

1.6

0.68

0.84

g/l

1.78

178

1524

Excessive earwax

652

5207

1.14

2.61

1.8

1.6

0.73

0.80

g/l

1.18

481

4074

Other disorders of breast

136

1030

1.33

2.61

1.4

1.5

0.59

0.63

g/l

0.24

119

788

Redundant prepuce, phimosis and paraphimosis

214

1689

1.25

2.61

1.4

1.8

0.87

0.94

g/l

0.47

166

1326

Other congenital malformations of circulatory system

163

1.87

2.60

2.3

1.7

0.64

0.84

g/l

0.71

132

Dermatitis herpetiformis

107

2.09

2.60

1.7

0.91

0.80

g/l

0.22

Contact with other hot fluids

222

1.73

2.60

1.4

1.8

0.58

0.73

g/l

0.58

177

Carcinoma in situ of skin

466

1.49

2.58

2.2

1.5

0.99

0.81

g/l

0.39

361

Chalazion

115

852

1.36

2.57

1.7

1.6

0.71

0.76

g/l

0.27

664

Other and unspecified epidermal thickening

171

1.84

2.56

1.4

1.7

0.46

0.87

g/l

1.58

138

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

177

1392

1.28

2.56

1.6

0.86

0.79

g/l

0.27

145

1093

Assault

149

1147

1.31

2.56

1.4

1.7

0.74

0.79

g/l

0.29

115

900

Vestibular neuronitis

591

1.43

2.55

1.3

1.7

0.68

0.83

g/l

0.82

467

Corneal scars and opacities

164

1.85

2.55

2.1

1.8

0.69

0.83

g/l

0.41

131

Alzheimer’s disease (Early onset)

194

0.36

2.53

1.1

1.7

0.47

0.90

g/l

—

154

L02BA Anti-estrogens

1211

0.71

2.53

1.3

1.5

0.55

0.66

g/l

1.26

927

Acidosis

115

2.03

2.53

1.2

1.7

0.85

0.88

g/l

0.03

Secondary polycythaemia

136

1.94

2.52

2.1

1.7

0.92

0.81

g/l

0.18

110

Malignant neoplasm of oral cavity, including Hilmo

239

1.69

2.52

1.2

1.8

1.03

0.98

g/l

0.05

193

Volvulus

129

1.96

2.51

1.5

1.7

0.71

0.87

g/l

0.47

101

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

552

1.44

2.50

1.4

1.6

0.66

0.78

g/l

0.68

429

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

442

2561

1.17

2.49

1.7

1.6

0.77

0.83

g/l

0.51

354

2013

Other and unspecified injuries of ankle and foot

294

1.61

2.49

2.1

1.6

0.76

0.75

g/l

0.03

230

Endocrine disorders, other/unspecified

109

2.05

2.48

1.2

1.8

0.84

0.81

g/l

—

Vitreous haemorrhage

662

1.40

2.47

1.7

0.83

0.80

g/l

0.05

522

Disturbances of smell and taste

256

1.66

2.46

1.3

1.8

0.83

0.84

g/l

0.01

200

Dislocation, sprain and strain of joints and ligaments of head

303

1.60

2.46

1.5

1.8

0.57

0.74

g/l

0.84

238

Acute alcohol intoxication, ICD10

207

1668

1.25

2.46

1.6

1.7

0.81

0.82

g/l

0.03

154

1316

Superficial injury of shoulder and upper arm

123

929

1.33

2.43

1.7

0.64

0.80

g/l

1.58

104

735

Short stature, not elsewhere classified

203

1.72

2.42

1.4

1.7

0.49

0.74

g/l

1.69

180

156

1135

1.29

2.41

1.3

1.6

0.77

0.88

g/l

0.62

112

873

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

368

1.53

2.41

1.5

1.7

0.71

0.91

g/l

0.80

295

Arterial embolism and thrombosis of lower extremity artery

160

1.83

2.40

1.2

1.6

0.66

0.83

g/l

0.51

128

Schizoaffective disorder

591

0.60

2.39

1.0

1.8

0.43

0.75

g/l

3.68

464

Alzheimer’s disease (Late onset), excluding more controls

546

0.66

2.39

1.5

1.6

0.52

0.86

g/l

2.53

400

Injury of nerves at forearm level

2.18

2.37

1.6

2.0

0.35

0.84

g/l

1.93

Left bundle-branch block

402

1.50

2.36

1.5

1.6

0.86

0.87

g/l

0.02

317

Glucosamine medication

398

2725

1.17

2.35

1.4

1.6

0.75

0.81

g/l

0.56

300

2111

Infective bursitis

154

1.84

2.35

1.3

1.8

0.97

0.96

g/l

0.01

120

Benign neoplasm of urinary organs

275

1.61

2.35

1.8

1.6

0.67

0.90

g/l

0.56

213

Malignant neoplasm of prostate

148

1124

0.78

2.35

1.5

1.7

0.96

1.05

g/l

0.36

114

884

Other specified/unspecified deforming dorsopathies

2.07

2.33

1.2

1.9

0.49

0.90

g/l

1.27

Cholesteatoma of middle ear

268

1.62

2.33

2.2

1.6

0.51

0.81

g/l

1.62

214

Other malignant neoplasms of skin (=non-melanoma skin cancer)

417

2437

1.16

2.30

1.8

1.6

0.76

0.82

g/l

0.44

335

1906

Contraceptive management

456

2765

1.16

2.30

1.5

1.6

0.68

0.72

g/l

0.32

354

2164

Neuroendocrine tumor and carcinoma of small intestine

2.26

2.29

1.4

2.1

1.24

1.18

g/l

0.04

Endometriosis diagnosis and infertility diagnosis occurring together

113

852

1.33

2.29

1.5

0.63

0.62

g/l

0.07

661

Hypoplasia of dental enamel , including avohilmo

312

1.56

2.29

2.2

1.6

0.53

0.72

g/l

0.94

268

Other benign neoplasms of connective and other soft tissue

681

1.37

2.28

1.5

1.6

0.63

0.80

g/l

0.97

530

Melanocytic naevi of trunk

125

957

1.31

2.28

1.6

0.60

0.76

g/l

1.45

102

748

Tooth eruption problems

158

1203

1.27

2.28

1.7

0.70

0.71

g/l

0.03

126

969

Recurrent dislocation and subluxation of joint

488

1.44

2.27

1.6

1.7

0.68

0.81

g/l

0.65

375

Benign neoplasm of other and unspecified intrathoracic organs

2.32

2.27

2.0

1.9

0.65

0.88

g/l

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

414

1.48

2.27

1.4

1.7

0.51

0.90

g/l

3.75

333

Bicipital tendinitis

286

1.59

2.26

1.4

1.7

0.71

0.89

g/l

0.57

220

Muscle strain

186

1.74

2.25

1.3

1.7

1.03

0.91

g/l

0.15

148

Benign neoplasm: Skin, unspecified

255

1.62

2.25

1.2

1.6

0.55

0.82

g/l

1.49

202

Malignant neoplasm of skin, including Hilmo

497

2908

1.15

2.25

1.7

1.6

0.76

0.82

g/l

0.62

397

2280

L02BB Anti-androgens

482

0.58

2.25

2.1

1.5

1.17

1.05

g/l

0.20

374

Sequelae of cerebrovascular disease

299

2151

1.19

2.24

1.6

0.89

0.83

g/l

0.42

238

1640

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

453

3419

1.15

2.24

1.5

0.57

0.61

g/l

0.59

362

2682

D07AA Corticosteroids, weak (group I)

160

1266

1.27

2.23

1.5

1.6

0.78

0.73

g/l

0.24

128

1007

Myopia

139

1083

1.29

2.23

1.3

1.7

0.59

0.74

g/l

1.68

102

844

Acute alcohol intoxication

247

2051

1.21

2.22

1.6

1.7

0.79

0.86

g/l

0.42

185

1609

Lactose intolerance, other/unspecified

172

1.76

2.22

1.2

1.8

0.80

0.83

g/l

0.07

143

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

186

1231

1.25

2.21

1.3

1.6

0.70

0.87

g/l

1.35

133

943

Convergence insufficiency and excess

2.16

2.21

1.2

1.4

0.53

0.57

g/l

0.12

Dissociative [conversion] disorders

241

1.63

2.20

1.4

1.7

0.68

0.78

g/l

0.28

182

malignant neoplasm of male genital organs

159

1206

0.79

2.19

1.4

1.7

0.94

1.03

g/l

0.44

124

948

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.06

2.18

1.3

1.9

1.19

0.86

g/l

0.32

Scabies

353

1.51

2.18

1.6

1.7

0.66

0.79

g/l

0.52

279

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

568

1.40

2.17

1.6

1.7

0.68

0.81

g/l

0.77

435

Pediculosis, acariasis and other infestations

460

1.45

2.17

1.5

1.7

0.63

0.79

g/l

0.93

361

Other disorders of binocular movement

144

1.83

2.16

1.4

1.8

0.58

0.74

g/l

0.43

116

Colitis due to radiation

2.67

2.16

2.1

0.65

1.34

g/l

0.93

Fourth [trochlear] nerve palsy

123

1.89

2.13

1.9

1.6

0.61

0.83

g/l

0.69

Contact with and exposure to communicable diseases

330

2810

1.17

2.13

1.7

1.6

0.68

0.72

g/l

0.33

204

2234

Retinal vascular occlusion

664

1.36

2.12

1.7

1.6

0.85

0.86

g/l

0.04

511

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

123

1.89

2.12

2.4

1.8

0.68

0.91

g/l

0.50

Retinal vascular disorders

673

1.36

2.11

1.7

1.6

0.84

0.87

g/l

0.08

520

Other benign neoplasm of uterus: Other parts/unspecified

160

1.76

2.10

1.2

1.6

0.63

0.73

g/l

0.30

128

Early complications of trauma

292

1.55

2.09

1.4

1.8

0.49

0.85

g/l

1.63

233

!Aliquae complicationes praecoces traumatis

292

1.55

2.09

1.4

1.8

0.49

0.85

g/l

1.63

233

Other spirochaetal diseases

342

2939

1.17

2.09

1.6

0.74

0.75

g/l

0.06

287

2273

Macular hole

316

1.53

2.09

1.4

1.7

0.64

0.90

g/l

1.00

250

Graves disease, strict definition

102

770

1.33

2.08

1.6

0.79

0.68

g/l

0.48

605

Fitting and adjustment of other devices

304

2276

1.18

2.08

1.6

0.69

0.85

g/l

2.13

263

1731

Glaucoma suspect

328

2809

1.17

2.08

1.5

1.6

0.72

0.80

g/l

0.44

225

2188

Benign neoplasm of ovary

148

1174

1.27

2.07

1.2

1.5

0.68

0.66

g/l

0.04

112

893

Car occupant injured in other and unspecified transport accidents

191

1559

1.23

2.07

1.7

0.67

0.77

g/l

1.00

158

1223

Aortic valve malfunction, age under 60 years

745

1.34

2.07

1.7

0.98

0.83

g/l

0.47

597

Separation of retinal layers (serosa)

277

1.57

2.07

2.0

1.7

0.82

0.88

g/l

0.14

225

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

382

1.48

2.07

2.0

1.6

0.49

0.76

g/l

1.72

293

Other spirochaetal diseases, including avohilmo

345

2972

1.16

2.05

1.6

0.74

0.75

g/l

0.07

289

2298

Malignant neoplasm of mesothelium and soft tissue

207

1.66

2.05

1.3

1.8

0.72

0.93

g/l

0.54

167

Intentional self-harm by sharp object

185

1.70

2.02

1.3

1.8

0.80

0.74

g/l

0.13

147

Malignant neoplasm of prostate, including Hilmo

155

1143

0.80

2.02

1.5

1.7

0.97

1.04

g/l

0.33

119

899

Benign neoplasm of bone and articular cartilage

645

1.36

2.02

2.3

1.7

0.95

0.73

g/l

0.78

505

Embolic stroke

200

1.66

2.01

1.7

1.4

0.87

0.82

g/l

0.07

153

Other congenital malformations of skin, including avohilmo

611

1.37

2.01

1.3

1.6

0.81

0.72

g/l

0.28

480

Other maltreatment syndromes

232

1.61

2.00

1.3

1.8

0.69

0.78

g/l

0.25

188

Anomalies of pupillary function

126

1.85

2.00

1.2

1.7

0.57

0.73

g/l

0.46

102

Bursitis of shoulder

126

1.84

1.99

1.4

2.0

0.41

0.94

g/l

2.44

102

Malignant neoplasm of bladder, including Hilmo

587

1.37

1.98

2.0

1.7

0.91

0.93

g/l

0.05

469

Other specified/unspecified disorders of bone/cartilage

156

1.75

1.97

1.7

1.6

1.00

0.73

g/l

0.21

127

Other specified disorders of kidney and ureter

194

1.67

1.97

1.7

0.67

0.80

g/l

0.32

156

Anorexia (incl.atypical)

411

1.44

1.96

1.2

1.7

0.46

0.66

g/l

1.81

313

Macular pucker

127

997

1.28

1.96

2.0

1.6

0.75

0.86

g/l

0.71

762

Exposure to other and unspecified forces of nature

2.51

1.96

1.5

2.1

0.78

0.98

g/l

0.25

Additional codes for the location of defect, injury or illness

387

1.46

1.95

1.6

0.69

0.78

g/l

0.25

308

Primary hyperparathyroidism

701

1.33

1.94

1.6

0.89

0.75

g/l

0.32

529

Sequelae of injuries of lower limb

719

1.33

1.93

1.4

1.6

0.68

0.77

g/l

0.43

567

Gonarthrosis, primary, with knee surgery

527

3646

1.13

1.92

1.5

1.6

0.77

0.81

g/l

0.34

410

2827

Alzheimer’s disease (Early onset), excluding more controls

164

0.40

1.91

1.1

1.4

0.47

0.82

g/l

—

123

Anankastic personality disorder

275

1.54

1.90

1.3

1.7

0.68

0.75

g/l

0.22

214

Alzheimer’s disease (Atypical or mixed), excluding more controls

307

0.58

1.90

1.1

1.5

0.84

0.95

g/l

0.14

226

Inflammatory diseases of prostate (prostatitis)

113

878

1.29

1.90

1.5

1.8

0.90

1.01

g/l

0.45

692

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.36

1.90

1.4

2.1

0.31

1.01

g/l

—

Pilonidal cyst

704

1.33

1.90

1.4

1.7

0.69

0.80

g/l

0.57

561

Sequelae of injuries of neck and trunk

181

1.67

1.89

1.7

1.6

1.26

0.77

g/l

0.82

147

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.74

1.89

1.3

1.2

1.35

0.56

g/l

—

Chromosomal abnormalities, not elsewhere classified

181

1.68

1.89

1.5

1.6

0.71

0.67

g/l

0.05

152

Myocardial infarction, with ST-elevation

129

1020

1.27

1.88

1.6

1.7

0.81

0.94

g/l

0.39

804

Hyperprolactinaemia

236

1.58

1.88

1.4

1.8

0.66

0.73

g/l

0.19

186

Benign neoplasm of other and unspecified sites

197

1.64

1.88

1.3

1.7

0.72

0.83

g/l

0.25

159

Superficial injury of thorax

143

1146

1.25

1.87

1.8

1.6

0.71

0.80

g/l

0.45

105

907

Other and unspecified trigeminal disorders

1.96

1.86

1.7

1.4

1.08

0.52

g/l

1.28

Dyshidrosis [pompholyx]

2.05

1.86

1.1

1.8

0.36

0.73

g/l

—

Other and unspecified injuries of shoulder and upper arm

213

1.61

1.86

1.3

1.8

0.84

0.86

g/l

0.04

169

Procedures for purposes other than remedying health state

144

1.76

1.86

1.6

0.91

0.78

g/l

0.23

119

Moderate visual impairment, binocular

129

1.80

1.86

1.6

1.5

1.34

0.75

g/l

0.32

103

Contusion of ankle

293

1.51

1.85

1.7

0.73

0.78

g/l

0.10

232

Other puerperal infections

603

1.35

1.85

1.4

1.6

0.67

0.57

g/l

0.58

477

Periodontal disease, other/unspecified

167

1.69

1.85

1.4

1.6

0.55

0.81

g/l

0.81

137

Injury of muscle and tendon at shoulder and upper arm level

339

2945

1.15

1.84

1.6

1.7

0.74

0.87

g/l

1.52

261

2278

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

152

1229

1.24

1.84

1.6

0.92

0.77

g/l

0.59

124

970

Sequelae of infectious and parasitic diseases

493

1.39

1.84

1.5

1.7

0.65

0.80

g/l

0.85

387

Varicose veins

553

3734

1.12

1.83

1.6

1.5

0.79

0.76

g/l

0.17

405

2920

Retinal haemorrhage

130

1.79

1.82

1.3

1.9

0.67

0.87

g/l

0.46

105

Melanoma in situ

246

1.56

1.82

1.6

1.7

0.69

0.91

g/l

0.66

193

Hypotension due to drugs

2.08

1.82

1.3

1.8

0.46

0.95

g/l

—

Pregnancy with abortive outcome

644

3018

1.11

1.82

1.5

0.61

0.62

g/l

0.03

501

2343

Emotional disorders starting during childhood or adolescence

381

1.44

1.82

1.3

1.7

0.61

0.67

g/l

0.31

314

Varicose veins of other sites

435

1.41

1.82

1.8

1.7

0.97

0.86

g/l

0.21

350

Impacted teeth

216

1552

1.20

1.82

1.7

0.67

0.71

g/l

0.35

180

1225

Alcoholic gastritis

2.03

1.81

1.1

1.3

0.83

g/l

—

Foreign body in respiratory tract

352

1.46

1.81

1.4

1.7

0.61

0.80

g/l

0.94

285

Other sexually transmitted chlamydial diseases

495

1.38

1.80

1.3

1.8

0.68

g/l

0.02

375

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

572

1.35

1.79

1.4

1.7

0.79

0.91

g/l

0.31

449

Sequelae of infectious and parasitic diseases, including avohilmo

504

1.38

1.79

1.6

1.7

0.64

0.81

g/l

0.96

394

malignant neoplasm of male genital organs, including Hilmo

168

1231

0.82

1.79

1.5

1.7

0.95

1.03

g/l

0.39

131

962

Delivery

290

1779

0.86

1.78

1.6

1.5

0.65

0.62

g/l

0.23

215

1413

Sequelae of injuries of upper limb

764

1.30

1.78

1.4

1.7

0.70

0.80

g/l

0.45

601

Crushed, pushed or stepped on by crowd or human stampede

634

1.33

1.77

1.3

1.7

0.64

0.74

g/l

0.67

504

Allergic contact dermatitis due to drugs in contact with skin

124

1.79

1.77

1.4

1.8

0.67

0.80

g/l

0.29

Benign neoplasm: Anus and anal canal

154

1.70

1.77

2.1

1.7

0.88

g/l

0.01

124

Hypermetropia

539

1.36

1.77

1.4

1.6

0.62

0.77

g/l

0.95

431

Melanocytic naevi, other sites/unspecified

609

1.34

1.75

1.5

1.6

0.49

0.74

g/l

1.65

473

Gonococcal infection

201

1.61

1.75

1.4

2.1

0.79

0.89

g/l

0.21

165

Alcohol dependence

247

2104

1.18

1.75

1.4

1.7

0.78

0.87

g/l

0.75

182

1648

Malignant neoplasm of head and neck, including Hilmo

583

1.34

1.75

1.2

1.7

0.89

g/l

0.01

462

Injury of muscle and tendon at lower leg level

149

1211

1.24

1.74

1.8

1.7

0.73

0.86

g/l

0.68

119

947

Bacterial meningitis

217

1.58

1.74

1.9

1.8

0.89

0.88

g/l

0.02

170

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

241

1.55

1.74

1.6

1.7

0.80

0.75

g/l

0.12

193

Corns and callosities

422

1.41

1.74

1.2

1.6

0.52

0.83

g/l

3.29

338

Other benign neoplasms of uterus

241

1.55

1.73

1.2

1.5

0.65

0.70

g/l

0.20

192

Presence of other devices

192

1575

1.20

1.73

1.6

0.79

0.82

g/l

0.11

153

1256

Malignant neoplasm of oral cavity

178

1.64

1.73

1.2

1.7

0.76

0.97

g/l

0.52

145

All dysplastic lesions of the vulva

290

1.50

1.73

1.4

1.6

0.80

0.64

g/l

0.43

234

Malignant neoplasm of bronchus and lung, including Hilmo

157

1068

1.23

1.73

1.2

1.6

0.70

0.87

g/l

1.13

109

830

Early lumbar disc prolapse, operated

750

1.30

1.73

1.3

1.7

0.57

0.81

g/l

3.23

587

Carcinoma in situ of other and unspecified digestive organs

258

1.52

1.71

2.0

1.7

1.23

0.97

g/l

0.36

202

Bitten or struck by other mammals

118

937

1.27

1.71

1.4

1.6

0.62

0.71

g/l

0.53

735

Arthropod-borne viral fevers and viral haemorrhagic fevers

665

1.32

1.69

1.7

1.6

0.71

0.81

g/l

0.37

523

Specific development disorders of speech and language

458

1.38

1.69

1.3

1.8

0.58

0.77

g/l

1.51

373

Injuries involving multiple body regions

243

1.53

1.69

1.3

1.7

0.91

0.79

g/l

0.28

196

In situ neoplasms

359

3155

1.14

1.68

1.7

1.6

0.80

0.73

g/l

0.50

267

2442

736

1.30

1.68

1.2

1.5

0.51

0.58

g/l

0.54

574

Gestational [pregnancy-induced] hypertension

244

2081

1.17

1.67

1.5

0.61

0.60

g/l

0.08

194

1621

Diabetic nephropathy

148

1193

1.23

1.67

1.4

1.7

0.71

0.80

g/l

0.59

118

894

Postmenopausal atrophic vaginitis

212

969

1.20

1.66

1.8

1.4

0.64

0.66

g/l

0.13

174

745

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.96

1.66

1.3

1.7

0.68

0.61

g/l

0.12

Injury of muscle and tendon at wrist and hand level

132

1066

1.24

1.66

1.5

1.7

0.62

0.81

g/l

1.59

851

Haemangioma, any site

607

1.32

1.65

2.0

1.6

0.64

0.74

g/l

0.67

470

Autism spe, excluding more controls

173

1.63

1.64

1.4

1.8

0.50

0.71

g/l

1.50

138

Pregnancy hypertension

402

3183

1.13

1.64

1.5

0.58

0.60

g/l

0.15

324

2490

Premature rupture of membranes

148

1284

0.82

1.63

1.5

0.64

0.60

g/l

0.26

107

1014

Infectious mononucleosis

678

1.30

1.63

1.9

1.7

0.57

0.71

g/l

1.05

533

Infectious mononucleosis, including avohilmo

678

1.30

1.63

1.9

1.7

0.57

0.71

g/l

1.05

533

Malignant neoplasm of urinary organs, including Hilmo

661

1.31

1.62

1.3

1.7

0.78

0.89

g/l

0.32

523

Dependent personality disorder

113

1.79

1.61

1.5

1.9

0.98

0.89

g/l

0.08

Acne conglobata

2.56

1.61

1.0

1.3

0.67

0.75

g/l

—

Cerebral aneurysm, nonruptured

593

1.32

1.59

1.4

1.5

0.65

0.73

g/l

0.41

453

LSIL lesion of the cervix uteri, vagina or vulva

139

1135

1.23

1.59

1.5

0.64

0.62

g/l

0.07

112

880

Foreign body entering into or through eye or natural orifice

603

1.32

1.57

1.4

1.6

0.72

0.81

g/l

0.42

484

Pregnancy examination and test

157

800

1.22

1.57

1.6

0.57

0.56

g/l

0.07

127

634

Malignant neoplasm of skin

455

2751

1.12

1.57

1.7

1.6

0.74

0.83

g/l

0.86

364

2157

Carcinoid syndrome

2.31

1.57

1.4

2.0

1.29

1.05

g/l

—

Other disorders of the genitourinary system

102

806

1.27

1.56

1.4

1.5

0.67

0.74

g/l

0.33

607

Melanoma in situ of other and unspecified parts of face

2.14

1.56

1.2

1.9

0.42

0.98

g/l

—

Haemangioma and lymphangioma, any site

674

1.30

1.56

1.9

1.6

0.67

0.73

g/l

0.30

526

Benign neoplasm: Long bones of lower limb

232

1.52

1.55

2.3

1.7

0.90

0.81

g/l

0.19

184

Hypertrophy of breast

168

1402

1.20

1.55

1.5

0.58

0.62

g/l

0.32

126

1082

Gonococcal infection, including avohilmo

224

1.53

1.55

1.4

2.1

0.79

0.90

g/l

0.25

179

Delirium, not induced by alcohol and other psychoactive substances

708

1.29

1.54

1.5

1.6

0.64

0.89

g/l

1.61

551

Viral haemorrhagic fevers, not elsewhere classified/unspecified

536

1.33

1.54

1.8

1.6

0.73

0.82

g/l

0.26

421

Lyme disease

331

2915

1.14

1.53

1.6

0.73

0.75

g/l

0.14

280

2256

Lyme disease, including avohilmo

331

2915

1.14

1.53

1.6

0.73

0.75

g/l

0.14

280

2256

Superficial injury of neck

138

1.69

1.53

1.1

1.8

0.51

0.72

g/l

0.67

113

Calcific tendinitis of shoulder

357

1.41

1.52

1.2

1.6

0.59

0.82

g/l

1.38

276

Polycystic ovarian syndrome

391

1.39

1.52

1.3

1.6

0.35

0.60

g/l

3.97

302

Abnormal findings in secretions and smears from cervix uteri vagina vulva

490

3244

1.11

1.52

1.5

0.60

g/l

0.03

381

2554

Malignant neoplasm of head and neck

468

1.35

1.51

1.2

1.6

1.00

0.89

g/l

0.17

368

Delivery, wide proxy

229

1418

0.85

1.51

1.6

1.5

0.68

0.62

g/l

0.36

176

1112

Other disorders of penis

748

1.27

1.50

2.2

1.8

0.92

0.95

g/l

0.10

601

Crossbite

559

1.31

1.50

1.5

1.7

0.82

0.80

g/l

0.04

462

Cystic kidney disease

202

1.55

1.49

1.3

1.8

0.58

0.81

g/l

0.88

162

Malignant neoplasm of bladder

283

1.45

1.49

2.2

1.7

0.94

1.08

g/l

0.26

224

Exposure to other and unspecified animate mechanical forces

235

1.50

1.48

1.5

1.7

0.57

0.73

g/l

0.70

194

Sequelae of injuries of head

377

1.39

1.47

1.4

1.7

0.60

0.82

g/l

1.22

296

Injury of eye and orbit

143

1183

1.21

1.46

1.4

1.7

0.70

0.79

g/l

0.76

107

924

Malignant neoplasm of stomach, including Hilmo

268

1.46

1.4

1.7

0.60

0.97

g/l

2.01

216

Congenital deformities of hip, including avohilmo

140

1.66

1.45

1.7

1.5

0.62

0.52

g/l

0.31

115

Carcinoma in situ of breast, intraductal

568

0.70

1.45

1.2

1.5

0.67

0.65

g/l

0.05

432

Spirochaetal infections, other/unspecified, including avohilmo

332

2938

1.13

1.45

1.6

0.73

0.75

g/l

0.14

281

2268

Single delivery by forceps and vacuum extractor

110

814

0.80

1.45

1.4

1.5

0.66

0.58

g/l

0.64

665

Hyperosmolality and hypernatraemia

1.99

1.44

1.8

1.9

1.85

0.84

g/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

220

1.51

1.44

1.6

1.8

0.66

0.88

g/l

0.56

182

Non-small cell lung cancer, adenocarcinoma

303

1.43

1.42

1.1

1.7

0.59

0.99

g/l

2.46

237

Open wound of forearm

728

1.27

1.42

1.3

1.7

0.70

0.83

g/l

0.75

574

Chronic viral hepatitis

405

1.37

1.42

1.3

1.8

0.81

0.83

g/l

0.05

318

Basal cell carcinoma, including Hilmo

408

2470

1.12

1.42

1.8

1.6

0.74

0.83

g/l

0.79

328

1936

Juvenile osteochondrosis

221

1.51

1.42

1.8

1.9

0.75

0.79

g/l

0.08

183

Failed attempted abortion

1.88

1.41

1.7

1.5

0.30

0.53

g/l

—

Assault by bodily force

667

1.28

1.41

1.4

1.7

0.75

0.77

g/l

0.07

526

Congenital deformities of hip

126

1.68

1.40

1.7

1.5

0.62

0.48

g/l

0.38

105

Use of rivastigmine

780

0.75

1.39

1.4

1.6

0.77

0.87

g/l

0.25

599

Pediculosis, acariasis and other infestations, including avohilmo

180

1529

1.18

1.39

1.6

0.73

0.75

g/l

0.15

145

1209

Nontoxic multinodular goitre

152

1272

1.20

1.39

1.5

0.68

0.70

g/l

0.12

118

978

142

1.63

1.39

1.4

1.6

0.50

0.62

g/l

0.32

106

Certain conditions originating in the perinatal period

632

1.27

1.38

1.3

1.7

0.61

0.77

g/l

0.96

524

Inflammatory disease of cervix uteri

373

1.37

1.38

1.3

1.4

0.82

0.67

g/l

0.41

288

Benign thyroid growths and nodules

277

2261

1.14

1.36

1.8

1.5

0.76

0.70

g/l

0.33

213

1763

Malignant neoplasm of respiratory system and intrathoracic organs

153

1063

1.20

1.35

1.2

1.6

0.74

0.87

g/l

0.71

109

829

Other secondary coxarthrosis

199

1.52

1.35

1.6

1.7

0.96

0.83

g/l

0.15

155

Major anomalies of jaw size

183

1.54

1.35

1.5

1.7

0.78

0.76

g/l

0.05

149

Injury of intra-abdominal organs

159

1.59

1.35

1.4

1.9

0.98

0.82

g/l

0.33

128

Diffuse brain injury

199

1.52

1.35

1.1

1.6

0.73

0.83

g/l

0.23

161

Malignant neoplasm of breast, HER-negative

118

1376

0.82

1.34

1.4

1.5

0.62

0.68

g/l

0.42

1068

Congenital malformations of great arteries

196

1.52

1.34

1.6

1.8

0.68

0.78

g/l

0.23

168

Recurrent and persistent haematuria

2.07

1.34

1.0

1.4

0.57

0.66

g/l

—

Other and unspecified vascular occlusions

487

1.32

1.34

1.9

1.6

0.92

0.87

g/l

0.09

383

Foreign body in ear

136

1.64

1.33

1.2

1.7

0.40

0.74

g/l

1.03

113

Hydrocele

744

1.25

1.33

1.9

1.8

0.76

0.99

g/l

1.27

590

Other abnormal findings in urine

1.83

1.32

2.1

1.4

1.33

0.76

g/l

—

Cystic kidney disease, including avohilmo

217

1.49

1.31

1.3

1.7

0.69

0.79

g/l

0.26

176

Preterm labour and delivery

238

2078

1.15

1.30

1.5

0.53

0.60

g/l

0.73

176

1623

Basal cell carcinoma

387

2368

1.12

1.29

1.8

1.6

0.75

0.82

g/l

0.59

311

1848

Injury of nerves at ankle and foot level

2.04

1.29

1.2

2.0

0.28

0.88

g/l

—

Open wound of abdomen, lower back and pelvis

218

1.48

1.29

1.2

1.9

0.76

0.85

g/l

0.19

171

Disorders of speech understanding and production

329

1.38

1.28

1.4

1.8

0.82

0.76

g/l

0.13

279

Mental and behavioural disorders due to cannabinoids

227

1.47

1.27

1.3

2.0

0.61

0.76

g/l

0.43

185

Hyperplasia of prostate

305

1520

1.13

1.27

1.6

1.7

0.88

0.97

g/l

0.63

240

1187

Fracture of femur

197

1532

1.16

1.26

1.5

1.6

0.69

0.83

g/l

1.56

155

1171

Injury of muscle and tendon at hip and thigh level

804

1.24

1.26

1.6

1.7

0.77

0.82

g/l

0.17

630

Leiomyoma of uterus

601

3094

1.09

1.25

1.6

1.4

0.63

0.62

g/l

0.04

457

2431

Carcinoma in situ of colon

171

1.53

1.24

1.4

1.7

1.11

0.91

g/l

0.25

140

Status post-ami

179

1163

1.17

1.23

1.4

1.7

0.93

0.97

g/l

0.13

153

907

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

329

1.37

1.23

1.5

0.76

0.74

g/l

0.06

255

Open wound of hip and thigh

229

1.45

1.22

1.4

1.8

0.76

0.72

g/l

0.06

184

Other appendicitis

610

1.27

1.22

1.3

1.7

0.62

0.77

g/l

0.72

477

Foreign body on external eye

143

1208

1.19

1.22

1.3

1.7

0.78

0.85

g/l

0.40

103

959

Benign mammary dysplasia

116

962

1.21

1.4

1.5

0.59

0.67

g/l

0.62

725

Mental disorders, not otherwise specified

620

1.26

1.21

1.5

1.7

0.62

0.72

g/l

0.56

484

Benign neoplasm: Choroid

409

1.33

1.20

1.4

1.6

1.05

0.79

g/l

0.23

326

Inguinal hernia

552

3366

1.09

1.19

1.8

1.6

0.95

0.84

g/l

0.96

426

2583

Disorders of synovium and tendon in diseases classified elsewhere

109

1.67

1.19

1.4

1.9

1.25

0.82

g/l

0.50

Contact with heat and hot substances

401

1.33

1.19

1.4

1.7

0.66

0.81

g/l

0.49

322

Other orthopaedic follow-up care

349

1.35

1.19

1.2

1.8

0.65

0.86

g/l

0.94

271

Other acquired deformities of ankle and foot

2.13

1.19

1.4

1.6

0.51

0.46

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

281

1.40

1.19

1.3

1.8

0.64

0.82

g/l

0.54

227

Primary ovarian failure

125

1.62

1.18

2.0

1.6

0.39

0.64

g/l

0.98

101

Other fall from one level to another

218

1908

1.14

1.18

1.6

1.7

0.89

0.80

g/l

0.40

174

1506

Schizophrenia, schizotypal and delusional disorders

246

2782

0.88

1.18

1.3

1.6

0.67

0.76

g/l

0.86

179

2155

Conotruncal defects

110

1.66

1.17

1.3

1.5

0.74

0.67

g/l

0.09

Schizophrenia or delusion

245

2769

0.88

1.16

1.3

1.6

0.67

0.76

g/l

0.85

178

2145

Obstructed labour due to maternal pelvic abnormality

135

1142

1.19

1.15

1.4

1.5

0.55

0.62

g/l

0.64

116

883

Use of fingolimod

1.93

1.13

1.1

1.3

0.17

0.45

g/l

—

Ectopic pregnancy

159

1366

1.17

1.13

1.5

0.61

0.62

g/l

0.08

123

1060

Non-small cell lung cancer, including Hilmo

106

824

1.21

1.12

1.2

1.7

0.78

0.84

g/l

0.23

644

HSIL lesion of the vagina

1.72

1.12

1.7

1.6

0.36

0.60

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

135

1.57

1.12

1.4

1.8

0.48

0.80

g/l

1.13

109

Hereditary corneal dystrophies

192

1.47

1.12

2.1

1.8

0.83

0.87

g/l

0.07

149

Intermittent heterotropia

440

1.30

1.11

1.4

1.7

0.59

0.75

g/l

0.80

348

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

406

1.31

1.11

1.5

1.7

0.60

0.78

g/l

0.98

321

Fracture of forearm

559

4636

1.08

1.11

1.4

1.6

0.72

0.74

g/l

0.17

436

3619

Behavioural disorders, excluding more controls

135

1.56

1.11

1.6

1.8

0.96

0.75

g/l

0.19

110

Congenital malformations of the nervous system

168

1.50

1.10

1.3

1.8

1.34

0.73

g/l

0.88

139

Asymptomatic human immunodeficiency virus [HIV] infection status

1.99

1.10

1.3

1.8

0.57

0.74

g/l

—

Coxarthrosis, primary, with hip surgery

391

3298

1.10

1.4

1.6

0.70

0.82

g/l

1.59

317

2535

Other blood glucose lowering drugs, excl. Insulins

121

1019

1.19

1.10

1.3

1.5

0.69

0.87

g/l

1.49

777

Malignant neoplasm of ovary, including Hilmo

375

0.69

1.09

1.6

0.96

0.67

g/l

0.18

291

Pregnancy, childbirth and the puerperium

196

1172

0.87

1.09

1.5

0.62

0.65

g/l

0.20

152

913

Lichen sclerosus et atrophicus

792

1.22

1.09

1.8

1.5

0.74

0.72

g/l

0.07

603

Malignant neoplasm of breast, ER-negative, including Hilmo

133

1458

0.85

1.08

1.4

1.5

0.59

0.67

g/l

0.66

106

1134

Astigmatism

487

1.28

1.07

1.3

1.7

0.47

0.80

g/l

3.09

386

Disorder of external ear, unspecified

211

1.43

1.06

1.7

1.6

0.65

0.77

g/l

0.29

172

Other conjunctival vascular disorders and cysts

137

1.55

1.06

1.6

1.8

0.51

0.86

g/l

1.29

112

Traumatic subdural haemorrhage

700

1.22

1.05

1.5

1.6

0.77

0.89

g/l

0.51

534

Wide developmental disorders, excluding more controls

240

1.39

1.04

1.4

1.8

0.51

0.73

g/l

1.72

194

Sequelae of other and unspecified infectious and parasitic diseases

402

1.30

1.04

1.5

1.7

0.61

0.79

g/l

0.94

317

Malignant neoplasm of ovary

288

0.66

1.03

1.7

1.6

0.35

0.71

g/l

2.03

225

Retinoschisis and retinal cysts

122

1.57

1.03

2.1

1.6

1.35

0.84

g/l

0.36

Foreign body or object entering through skin

456

1.28

1.02

1.4

1.7

0.52

0.81

g/l

2.79

364

Other degenerative diseases of the nervous system

215

1385

1.13

1.01

1.5

1.6

0.61

0.84

g/l

3.01

164

1061

Congenital malformations of heart and great arteries

124

1024

1.18

1.01

1.4

1.7

0.75

0.79

g/l

0.18

821

Prepatellar bursitis

273

1.36

1.01

1.2

1.8

0.77

0.94

g/l

0.57

219

Atlantoaxial subluxation

2.03

1.01

1.1

1.4

0.53

0.72

g/l

—

Benign neoplasm of brain and other parts of central nervous system

404

1.29

1.00

1.4

1.7

0.81

0.80

g/l

0.02

319

Transient global amnesia

585

0.77

1.00

1.8

1.6

0.57

0.84

g/l

1.69

448

Focal epilepsy

189

1662

1.14

1.00

1.5

1.6

0.71

0.79

g/l

0.52

145

1311

Non-small cell lung cancer

549

1.25

1.00

1.2

1.7

0.63

0.91

g/l

2.55

426

Foreign body in alimentary tract

352

1.31

0.99

1.5

1.7

0.72

0.83

g/l

0.34

280

Right hemicolectomy

301

1.33

0.97

1.4

1.6

0.92

0.85

g/l

0.18

236

Anisometropia and aniseikonia

199

1.42

0.96

1.3

1.7

0.60

0.82

g/l

0.62

161

Congenital deformities of feet, including avohilmo

276

1.35

0.96

1.5

1.7

0.84

0.75

g/l

0.24

222

Benign neoplasm: Skin of trunk

276

1.35

0.96

2.1

1.7

0.67

0.83

g/l

0.35

224

LSIL lesion of the cervix uteri

107

906

1.18

0.95

1.5

0.61

0.60

g/l

0.04

709

Isolated patent ductus arteriosus

1.67

0.95

1.5

0.77

0.60

g/l

—

Early syphilis

1.73

0.93

2.3

2.2

0.72

0.99

g/l

0.38

Urethral stricture

312

1.32

0.93

1.3

1.5

0.95

0.93

g/l

0.06

254

Laparoscopic right hemicolectomy

321

1.31

0.93

1.5

1.6

0.92

0.88

g/l

0.09

253

Other specified and unspecified strabismus

1.69

0.92

1.5

1.3

0.45

0.65

g/l

—

Carcinoma in situ of cervix uteri

776

0.81

0.91

1.6

0.65

0.59

g/l

0.23

612

Convergent concomitant strabismus

455

1.26

0.91

1.7

1.8

0.91

0.76

g/l

0.20

362

Focal epilepsy, strict definition

171

1506

1.14

0.91

1.5

1.6

0.68

0.79

g/l

0.88

132

1181

Abscess of Bartholin gland

176

1.43

0.91

1.2

1.6

0.32

0.62

g/l

2.23

142

Impotence

384

1.28

0.91

1.5

1.6

1.06

1.04

g/l

0.04

300

Other and unspecified injuries of wrist and hand

270

1.34

0.91

1.3

1.8

0.81

0.83

g/l

0.03

220

L01XE Protein kinase inhibitors

305

1.32

0.90

1.4

1.7

0.94

0.87

g/l

0.10

242

Retinal breaks without detachment

138

1199

1.15

0.90

2.2

1.6

0.86

0.82

g/l

0.15

110

942

Infections of genitourinary tract in pregnancy

673

1.21

0.90

1.4

1.6

0.56

0.63

g/l

0.47

516

Toxic effects of substances chiefly nonmedicinal as to source

105

894

1.18

0.89

1.8

1.6

0.64

0.76

g/l

0.87

702

Combinations of oral blood glucose lowering drugs

236

2123

1.11

0.89

1.8

1.6

0.82

0.90

g/l

0.44

185

1642

Family history of other conditions

111

1.55

0.88

1.4

2.1

0.40

0.81

g/l

1.31

Other and unspecified injuries of head

502

1.24

0.88

1.3

1.6

0.89

0.83

g/l

0.14

392

Pyoderma

111

1.54

0.88

1.0

1.6

0.73

0.74

g/l

0.01

Malignant neoplasm of testis, including Hilmo

103

1.57

0.88

2.3

2.1

0.85

1.11

g/l

0.44

Enterobiasis

2.04

0.88

1.8

1.4

0.29

0.71

g/l

—

Periapical abscess

467

4338

1.08

0.88

1.5

1.6

0.69

0.80

g/l

1.60

355

3402

Use of interferon beta-1a

161

1.44

0.87

1.4

1.6

0.40

0.64

g/l

0.75

126

Follow-up examination after treatment for malignant neoplasms

449

1.25

0.87

1.2

1.5

0.70

0.90

g/l

1.03

310

Long labour

181

1726

0.89

0.87

1.5

0.72

0.58

g/l

1.11

151

1350

Mumps, including avohilmo

180

0.61

0.86

1.1

1.7

0.53

0.76

g/l

—

139

Scabies, including avohilmo

148

1297

1.14

0.86

1.7

1.6

0.77

0.75

g/l

0.12

117

1024

Lesion of plantar nerve

379

1.27

0.85

1.6

0.72

0.74

g/l

0.04

292

Other sexually transmitted chlamydial diseases, including avohilmo

797

1.18

0.85

1.4

1.7

0.65

0.67

g/l

0.08

616

Post-traumatic wound infection, not elsewhere classified

179

1.41

0.84

1.1

1.8

0.38

0.90

g/l

4.01

141

Fracture of neck

353

1.28

0.84

1.2

1.7

0.60

0.91

g/l

1.70

277

Traumatic subarachnoid haemorrhage

179

1.40

0.84

1.2

1.4

0.85

0.76

g/l

0.22

140

Pedestrian injured in transport accident

479

1.24

0.83

1.5

1.7

0.79

g/l

0.01

379

Bulimia nervosa (incl. atypical)

231

1.35

0.83

1.3

1.7

0.71

0.58

g/l

0.50

172

Complications of the puerperium, not elsewhere classified

301

1.30

0.83

1.5

1.6

0.55

0.58

g/l

0.09

238

Impacted maxillary molar

480

1.23

0.82

1.8

1.6

0.62

0.61

g/l

0.05

376

Complications of labour and delivery

592

3081

1.07

0.82

1.5

0.64

0.60

g/l

0.44

464

2402

Keratoconus

155

1.43

0.81

1.4

1.9

0.88

0.80

g/l

0.17

127

Polymorphous light eruption

1.72

0.81

1.1

1.3

0.42

0.52

g/l

—

Malignant melanoma, including Hilmo

131

1145

1.15

0.81

1.5

1.6

0.59

0.83

g/l

3.11

100

891

Congenital malformations of eye, ear, face and neck

481

1.23

0.81

1.3

1.6

0.83

0.71

g/l

0.30

384

Focal epilepsy, mode (most common among epilepsy diagnosis)

160

1418

1.13

0.80

1.6

0.71

0.78

g/l

0.43

127

1108

Assault by blunt object

114

1.51

0.80

1.7

2.0

0.72

0.88

g/l

0.24

Benign neoplasm: Skin of upper limb, including shoulder

114

1.50

0.80

1.9

1.7

0.46

0.72

g/l

0.48

Syndactyly, including avohilmo

0.00

0.80

0.0

1.4

—

0.61

—

Mental and behavioural disorders due to hallucinogens

1.84

0.79

1.2

1.8

1.61

0.74

g/l

—

Transient synovitis

1.68

0.79

1.4

2.3

0.70

0.88

g/l

—

Other and unspecified corneal deformities and disorders

199

1.36

0.78

1.6

1.7

0.77

0.80

g/l

0.06

161

Malignant neoplasm of brain

199

1.36

0.78

1.3

1.7

0.56

0.87

g/l

1.25

164

Inguinal or femoral hernia, bilateral

684

1.19

0.78

1.6

1.18

0.91

g/l

0.52

542

Complications predominantly related to the puerperium

239

2171

1.10

0.78

1.5

1.6

0.59

0.62

g/l

0.23

186

1694

Glaucoma, exfoliation

492

1.22

0.78

1.6

0.77

0.88

g/l

0.38

388

Slow fetal growth and fetal malnutrition

1.69

0.78

1.9

1.7

0.36

0.64

g/l

0.88

Labour and delivery complicated by umbilical cord complications

340

1.27

0.77

1.3

1.6

0.54

0.62

g/l

0.46

265

Abnormal findings on antenatal screening of mother

639

0.81

0.77

1.6

1.7

0.52

0.59

g/l

0.22

511

All dysplastic lesions of the cervix uteri, vagina or vulva

270

2407

1.10

0.77

1.5

0.62

0.59

g/l

0.22

212

1885

174

1.39

0.77

2.2

1.8

0.63

0.80

g/l

0.38

141

Mumps

174

0.63

0.77

1.1

1.7

0.53

0.76

g/l

—

138

Unspecified lump in breast

132

1160

1.14

0.77

1.5

0.61

0.65

g/l

0.26

101

882

Non-seminoma of testis, including Hilmo

1.78

0.77

1.3

0.81

0.85

g/l

—

Polycystic ovarian syndrome, broad definition

843

1.17

0.76

1.4

1.6

0.53

0.59

g/l

0.33

671

Parkinson's disease

910

0.84

0.76

2.2

1.5

0.55

0.89

g/l

4.39

702

Parkinson's disease, including avohilmo

953

0.85

0.76

2.1

1.5

0.54

0.90

g/l

5.13

733

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

149

1.42

0.76

1.3

1.7

0.40

0.71

g/l

1.66

125

Other disorders of iris and ciliary body

166

1.39

0.76

1.5

1.6

0.53

0.80

g/l

1.02

131

Other disorders of cornea

687

1.18

0.75

1.7

1.6

0.77

0.79

g/l

0.07

538

Inguinal hernia, bilateral

678

1.18

0.75

1.6

1.20

0.90

g/l

0.57

539

Other vitreous opacities

253

1.31

0.75

1.5

1.7

0.55

0.83

g/l

1.16

204

Malignant neoplasm of bronchus and lung

127

931

1.14

0.75

1.2

1.6

0.73

0.87

g/l

0.70

732

Non-small cell lung cancer, adenocarcinoma, helper endpoint

342

1.26

0.74

1.1

1.7

0.59

0.90

g/l

1.72

272

Benign leiomyoma with endometriosis

121

1061

1.14

0.74

1.5

0.62

0.67

g/l

0.23

805

Lesion of radial nerve

219

1.33

0.73

2.4

1.7

1.26

0.78

g/l

0.63

172

Pedal cyclist injured in noncollision transport accidents

959

0.85

0.73

1.6

0.65

0.77

g/l

0.94

750

Seminoma of testis, including Hilmo

1.62

0.73

3.1

2.3

0.97

1.13

g/l

—

Sequelae of other accidents

1.53

0.72

1.2

1.8

0.56

0.83

g/l

—

Malignant neoplasm of testis

1.53

0.72

2.5

2.2

0.87

1.10

g/l

0.33

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.63

0.72

2.2

1.7

1.69

0.94

g/l

—

Struck by thrown, projected or falling objec

398

1.24

0.72

1.5

1.8

0.76

0.81

g/l

0.18

314

Alcohol withdrawal state with delirium

471

1.21

0.71

1.4

1.7

0.97

0.92

g/l

0.10

376

Persistent delusional disorders

500

0.80

0.71

1.1

1.7

0.59

0.80

g/l

1.08

393

Serous carcinoma of ovary, including Hilmo

193

0.67

0.69

1.3

1.8

0.34

0.73

g/l

—

156

Carcinoma in situ of other and unspecified genital organs

118

1.45

0.69

1.9

1.6

0.32

0.63

g/l

—

Granulomatous disorders of skin and subcutaneous tissue

152

1.39

0.69

1.8

1.7

0.45

0.80

g/l

1.30

126

Use of galantamine

331

0.75

0.69

1.3

1.5

0.73

0.94

g/l

0.56

256

Contact with machinery

796

1.16

0.69

1.3

1.7

0.66

0.92

g/l

1.89

637

Motorcycle rider injured in other and unspecified transport accidents

464

1.21

0.69

1.6

1.7

0.63

0.82

g/l

0.93

368

Diabetes mellitus in pregnancy

304

1783

1.08

0.69

1.4

1.5

0.57

0.60

g/l

0.23

249

1418

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

602

1.18

0.68

1.4

1.5

0.60

0.63

g/l

0.13

478

Other and unspecified disease of Bartholin gland

144

1.40

0.68

1.1

1.6

0.57

0.67

g/l

0.29

120

Aneurysms, operations, SAH

127

1128

1.13

0.66

1.5

0.65

0.77

g/l

0.97

101

866

Malignant neoplasm of stomach

232

1.30

0.66

1.4

1.7

0.65

0.98

g/l

1.35

190

Pathological resorption of teeth

259

1.28

0.65

2.0

1.7

0.80

0.73

g/l

0.15

207

Bicornuate uterus

1.61

0.65

1.0

1.3

0.21

0.47

g/l

—

Cervical polyps

642

1.17

0.65

1.4

1.5

0.57

0.66

g/l

0.52

502

Contact with sharp glass

286

1.26

0.65

1.4

1.9

0.66

0.78

g/l

0.27

228

Unspecified abortion

340

1.24

0.65

1.6

1.5

0.52

0.64

g/l

0.64

257

Autism spe

216

1.30

0.63

1.4

1.7

0.50

0.67

g/l

1.08

176

Injury of other and unspecified intrathoracic organs

406

1.21

0.62

1.3

1.7

0.75

0.86

g/l

0.32

324

malignant neoplasm of female genital organs

985

0.87

0.62

1.3

1.5

0.48

0.70

g/l

2.84

754

HSIL lesion of the cervix uteri

138

1535

0.90

0.61

1.5

0.63

0.61

g/l

0.10

104

1199

Malignant melanoma

114

1012

1.13

0.61

1.6

0.59

0.82

g/l

2.87

793

Polyhydramnios

334

0.78

0.60

1.6

0.74

0.60

g/l

0.29

261

Alzheimer’s disease (undefined), excluding more controls

0.00

0.60

0.0

1.4

—

1.08

—

Malignant neoplasm of rectum, including Hilmo

737

0.85

0.60

1.4

1.6

0.89

0.87

g/l

0.02

572

Caught, crushed, jammed or pinched in or between objects

399

1.21

0.59

1.8

1.7

0.68

0.80

g/l

0.48

312

malignant neoplasm of female genital organs, including Hilmo

106

1138

0.89

0.59

1.3

1.5

0.69

g/l

0.02

871

Spontaneous abortion

421

2653

1.06

0.59

1.3

1.5

0.62

0.61

g/l

0.16

336

2072

Anomalies of dental arch relationship, including avohilmo

196

1623

1.09

0.59

1.4

1.6

0.69

0.74

g/l

0.32

152

1287

Use of cabergoline

1.47

0.58

1.2

1.8

0.52

0.77

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

622

1.16

0.58

1.2

1.6

0.48

0.64

g/l

1.26

470

Toxic effect of ethanol

282

1.25

0.58

2.9

1.8

0.70

0.78

g/l

0.20

228

Mental retardation, excluding more controls

255

1.25

0.57

1.5

2.0

0.65

0.87

g/l

0.56

211

Conduct disorder

158

1.34

0.57

1.6

1.7

0.96

0.71

g/l

0.23

129

Multiple delivery

669

0.85

0.57

1.8

1.4

0.49

0.57

g/l

0.54

548

Cysts of oral region, not elsewhere classified

401

1.20

0.57

1.9

1.7

0.80

0.82

g/l

0.04

320

Obstructed labour due to malposition and malpresentation of fetus

176

1781

0.91

0.57

1.4

1.5

0.67

0.58

g/l

0.61

140

1402

Left ventricular outflow tract obstruction, narrow definition

374

1.21

0.57

1.5

1.7

0.88

0.81

g/l

0.17

294

Orchitis and epididymitis

624

1.16

0.56

1.6

1.8

0.88

0.98

g/l

0.31

494

Diabetic retinopathy

315

1826

1.07

0.56

1.4

1.7

0.73

0.77

g/l

0.17

222

1395

Car occupant injured in noncollision transport accident

239

1.26

0.55

1.2

1.9

0.71

0.84

g/l

0.33

190

Other inflammation of vagina/vulva

257

1.25

0.55

1.6

1.7

0.48

0.61

g/l

0.82

205

Benign neoplasm of other and unspecified female genital organs

248

1.25

0.55

1.5

1.7

0.63

0.70

g/l

0.18

201

Diabetic maculopathy

107

901

1.12

0.55

1.5

1.7

0.93

0.79

g/l

0.23

683

Postpartum care and examination

700

0.89

0.55

1.5

1.6

0.62

0.57

g/l

0.18

553

Peripheral retinal degeneration

177

1.31

0.55

1.4

1.6

0.37

0.81

g/l

2.48

142

Rubella [German measles]

249

1.25

0.54

2.4

1.8

1.05

0.98

g/l

0.11

196

Rubella [German measles], including avohilmo

249

1.25

0.54

2.4

1.8

1.05

0.98

g/l

0.11

196

Autism

222

1.27

0.54

1.4

1.7

0.50

0.70

g/l

1.42

178

Conductive hearing loss, unspecified

571

1.16

0.54

1.5

1.6

0.76

0.79

g/l

0.08

451

Other and unspecified disorders of adult personality and behaviour

1.55

0.53

1.2

1.5

0.36

0.61

g/l

—

Varus deformity, not elsewhere classified

1.46

0.53

1.7

2.1

0.74

0.73

g/l

—

Type 1 diabetes, strict (exclude DM2)

832

1.13

0.53

1.5

1.8

0.69

0.75

g/l

0.22

672

Amblyopia ex anopsia

277

1.23

0.52

1.8

1.7

0.87

0.73

g/l

0.20

224

Type 1 diabetes, definitions combined

833

1.13

0.52

1.5

1.7

0.69

0.74

g/l

0.20

673

Femoral hernia

214

1.27

0.52

2.0

1.5

0.56

0.77

g/l

0.80

177

Unspecified maternal hypertension

1.46

0.52

1.3

1.4

0.61

0.53

g/l

0.27

Colon adenocarcinoma

685

1.14

0.52

1.9

1.7

0.97

0.87

g/l

0.27

529

Malignant neoplasm of colon, including Hilmo

123

1107

1.11

0.51

1.7

1.6

1.03

0.87

g/l

0.61

849

Benign neoplasm of thyroid gland

197

1.27

0.51

2.4

1.6

0.84

0.81

g/l

0.04

159

Short Achilles tendon (acquired)

135

1.34

0.51

2.1

1.9

1.50

0.94

g/l

—

111

Secondary parkinsonism+Parkinsonism in other disease

145

0.69

0.50

1.9

1.7

0.73

0.82

g/l

—

117

Benign neoplasm: Skin of other and unspecified parts of face

659

1.14

0.50

1.6

0.81

0.79

g/l

0.05

517

Melanocytic naevi of other and unspecified parts of face

398

1.18

0.50

2.0

1.5

0.86

0.72

g/l

0.25

310

Burn and corrosion of trunk

198

1.27

0.49

1.2

1.8

0.60

0.82

g/l

1.03

161

Complications following abortion and ectopic and molar pregnancy

198

1.27

0.49

1.4

1.6

0.73

0.64

g/l

0.17

150

Otorrhagia

1.57

0.49

1.4

1.5

0.33

0.63

g/l

—

540

0.85

0.49

1.2

1.6

1.12

0.90

g/l

0.60

429

Parkinson's disease, strict definition

816

0.88

0.48

2.3

1.5

0.55

0.89

g/l

4.09

631

Pre-eclampsia or poor fetal growth

271

2533

1.07

0.47

1.4

1.5

0.59

0.60

g/l

0.02

214

1984

Contact with blunt object, undetermined intent

1.47

0.47

1.3

2.1

0.51

0.95

g/l

—

Meningococcal infection

1.47

0.47

1.1

1.3

0.70

0.66

g/l

—

Meningococcal infection, including avohilmo

1.47

0.47

1.1

1.3

0.70

0.66

g/l

—

Clear cell adenocarcinoma of kidney

254

1.22

0.47

1.6

1.7

1.00

0.98

g/l

0.02

206

Generalized epilepsy, mode (most common among epilepsy diagnosis)

209

1.25

0.46

1.3

1.7

0.65

0.79

g/l

0.35

169

Marfan's syndrome

1.44

0.46

1.1

1.5

0.60

0.54

g/l

—

Undescended testis, unilateral

1.44

0.46

1.5

1.6

1.27

0.86

g/l

0.49

Aggressive periodontitis

138

1.31

0.45

1.4

1.7

0.43

0.83

g/l

1.51

112

Xanthelasma of eyelid

1.41

0.45

1.1

2.0

0.51

0.99

g/l

—

Other noninflammatory disorders of cervix uteri

283

1.20

0.45

1.8

1.5

0.71

0.72

g/l

0.02

218

Malignant neoplasm of brain, including Hilmo

283

1.20

0.45

1.3

1.8

0.52

0.89

g/l

2.36

232

Nontoxic goitre/thyroid nodule

235

2203

1.07

0.44

1.8

1.5

0.71

0.69

g/l

0.14

182

1681

Malignant neoplasm of colon

894

1.11

0.44

1.8

1.6

0.97

0.85

g/l

0.47

689

Maternal care related to the fetus and amniotic cavity and possible delivery problems

417

2326

1.05

0.44

1.5

0.65

0.59

g/l

0.67

343

1837

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

114

1038

1.10

0.44

1.4

1.6

0.60

0.80

g/l

1.85

812

Malignant neoplasm of tonsil and base of tongue, including Hilmo

130

1.31

0.44

1.1

1.6

0.49

0.93

g/l

1.64

105

Congenital malformations of aortic and mitral valves

312

1.19

0.43

1.5

1.7

0.92

0.83

g/l

0.19

248

Renal cell carcinoma of kidney

128

0.70

0.43

1.4

1.5

0.60

0.99

g/l

—

103

Cyst of Bartholin Gland

248

1.21

0.43

1.7

0.60

0.64

g/l

0.08

198

Bacterial sepsis of newborn

1.42

0.42

1.4

1.7

0.91

0.56

g/l

—

Tooth agenesis EXCLUDE clefts and syndromes

316

0.82

0.42

1.6

1.8

0.48

0.73

g/l

1.16

262

Primary angle-closure glaucoma

221

1.23

0.42

2.9

1.7

0.66

0.87

g/l

0.40

175

Benign neoplasm: Kidney

203

1.24

0.42

1.6

1.7

0.73

0.88

g/l

0.19

160

Type1 diabetes, definitions combined, early onset

582

0.87

0.42

1.6

1.8

0.74

0.70

g/l

0.10

470

Traumatic ischaemia of muscle

1.36

0.42

1.8

0.91

0.82

g/l

—

Postpartum haemorrhage due to retained placenta

985

0.90

0.42

1.4

1.5

0.66

0.61

g/l

0.28

774

Noise effects on inner ear

272

0.81

0.41

1.5

1.7

0.80

0.91

g/l

0.18

214

Traumatic amputation of wrist and hand

272

0.81

0.41

1.6

1.8

0.78

0.94

g/l

0.34

216

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

605

0.87

0.41

1.4

1.6

0.98

0.89

g/l

0.12

469

Chondrosarcoma

0.00

0.41

0.0

3.6

—

1.12

—

Use of biperiden

348

0.83

0.41

1.1

1.7

0.82

0.83

g/l

0.03

279

Liposarcoma, including Hilmo

1.36

0.41

1.4

2.4

0.78

1.14

g/l

—

Accidental poisoning by and exposure to pesticides

0.00

0.41

0.0

1.5

—

0.69

—

Other osteochondropathies

520

1.14

0.41

1.6

0.71

0.80

g/l

0.41

405

Malignant neoplasm of rectum

583

0.87

0.41

1.5

1.6

0.83

0.90

g/l

0.11

452

HSIL lesion of the cervix uteri, vagina or vulva

156

1680

0.93

0.40

1.4

1.5

0.61

g/l

0.01

120

1310

Pedestrian injured in collision with pedal cycle

186

1.24

0.40

1.3

1.7

1.07

0.82

g/l

0.35

152

Nontoxic single thyroid nodule

464

1.14

0.40

1.9

1.6

0.63

0.75

g/l

0.50

361

Other mental disorders due to brain damage and dysfunction and to physical disease

710

1.11

0.40

1.3

1.6

0.63

0.87

g/l

2.40

555

Retinal detachment with retinal break

853

1.10

0.40

1.8

1.6

0.90

0.86

g/l

0.08

665

Other specified disorders of external ear

223

1.21

0.39

1.4

1.6

0.81

0.85

g/l

0.08

173

Labour and delivery complicated by fetal stress [distress]

194

1348

0.93

0.39

1.4

1.5

0.60

0.56

g/l

0.25

152

1066

Puerperal sepsis

101

921

1.10

0.39

1.6

1.5

0.59

0.65

g/l

0.43

705

Type 1 diabetes, strict definition

706

0.89

0.39

1.5

1.8

0.72

0.71

g/l

0.01

570

Other disorders of breast and lactation associated with childbirth

106

1.33

0.39

1.2

1.4

0.52

0.46

g/l

—

Injury of nerves at wrist and hand level

251

1.20

0.39

1.4

1.8

0.53

0.89

g/l

2.02

204

Other and unspecified nonorganic psychotic disorders

158

1697

0.93

0.39

1.3

1.6

0.67

0.77

g/l

0.73

113

1313

Behavioural disorders

169

1.25

0.39

1.6

0.96

0.72

g/l

0.22

143

Non-small cell lung cancer, squamous

187

1.23

0.39

1.4

1.5

0.70

1.03

g/l

1.36

144

Pedal cyclist injured in transport accident

181

1934

0.93

0.39

1.7

1.6

0.67

0.77

g/l

1.03

145

1521

Torsion of testis

151

1.26

0.38

1.5

1.9

2.44

0.80

g/l

0.56

121

Medical treatment for female infertility

187

1735

1.07

0.38

1.5

0.53

0.60

g/l

0.72

152

1363

Calculus of lower urinary tract

280

1.18

0.37

1.5

1.7

0.52

0.96

g/l

2.44

224

Overjet

223

0.80

0.37

1.8

1.6

0.76

0.68

g/l

0.16

190

Liveborn infants according to place of birth

1.29

0.37

1.0

1.6

0.63

0.49

g/l

—

Other superficial injuries of ankle and foot

1.47

0.36

3.3

1.4

0.77

0.67

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

364

0.85

0.36

1.3

1.7

0.65

0.74

g/l

0.27

294

Manic episode

180

1.23

0.36

1.7

1.9

0.86

0.87

g/l

0.02

141

Prominent ears

0.64

0.36

1.4

1.6

1.52

0.69

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.32

0.36

1.5

2.0

1.03

0.80

g/l

—

Liposarcoma

1.44

0.36

1.0

2.2

0.51

1.07

g/l

—

Malignant melanoma of skin

775

0.90

0.35

1.7

1.6

0.54

0.83

g/l

3.29

607

Memory loss

508

1.12

0.35

1.8

1.5

0.74

0.84

g/l

0.34

399

Dislocation, sprain and strain of joints and ligaments of elbow

499

1.12

0.34

1.7

1.8

0.64

0.77

g/l

0.84

403

Postpartum haemorrhage

207

1807

0.94

0.34

1.5

0.61

0.57

g/l

0.36

161

1421

Maternal care for cervical incompetence

232

0.82

0.33

1.4

1.6

0.69

0.66

g/l

0.05

188

Burn and corrosion of wrist and hand

256

1.18

0.33

1.7

1.9

0.59

0.79

g/l

0.86

207

Hydatidiform mole

0.69

0.33

1.3

1.5

0.93

0.51

g/l

—

Burns and corrosions

126

1173

1.08

0.33

1.6

1.7

0.63

0.79

g/l

1.45

914

Other disorders of amniotic fluid and membranes

104

1085

0.92

0.32

1.7

1.6

0.60

0.61

g/l

0.05

856

Divergent concomitant strabismus

560

0.89

0.32

1.8

1.7

0.81

0.76

g/l

0.06

438

Malignant neoplasm of kidney, except renal pelvis

512

1.11

0.32

1.4

1.7

0.89

0.92

g/l

0.05

400

Inflammatory disorders of breast

446

1.12

0.31

1.6

1.5

0.58

0.57

g/l

0.04

345

All dysplastic lesions of the cervix uteri

228

2134

1.05

0.31

1.4

1.5

0.61

0.59

g/l

0.10

173

1681

Open bite

456

1.12

0.31

1.5

1.7

0.87

0.74

g/l

0.30

368

Abnormal spermatozoa

820

0.91

0.31

1.5

1.7

1.31

0.99

g/l

0.57

647

Otosclerosis

475

1.12

0.31

1.2

1.7

0.74

0.77

g/l

0.07

371

Benign neoplasm: Parathyroid gland

1.30

0.30

1.0

1.9

0.39

0.88

g/l

—

Toxic effect of contact with venomous animals

296

1.15

0.30

1.2

1.6

0.56

0.79

g/l

1.60

234

Melanoma in situ of trunk

1.30

0.30

1.8

1.7

0.72

0.90

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

372

1.13

0.30

1.5

0.70

0.73

g/l

0.08

286

Personal history of malignant neoplasm

582

1.10

0.29

1.5

1.6

0.65

0.72

g/l

0.29

467

Vascular syndromes of brain in cerebrovascular disorders

222

1.17

0.29

1.3

1.5

0.78

0.88

g/l

0.30

176

Other abnormal products of conception

295

1854

1.04

0.29

1.6

1.5

0.56

0.59

g/l

0.32

230

1464

Sulfonylureas

204

1704

0.95

0.29

1.3

1.6

0.80

0.90

g/l

0.64

163

1296

Diabetic retinopathy, strict definition

143

1194

1.06

0.29

1.5

1.8

0.88

0.80

g/l

0.16

898

Adenocarcinoma and papilloma adenocarcinoma of rectum

576

0.90

0.28

1.4

1.7

0.96

0.89

g/l

0.10

448

Schizophrenia or delusion, excluding more controls

245

2313

1.05

0.28

1.3

1.7

0.67

0.79

g/l

1.26

178

1797

Tibial collateral bursitis [Pellegrini-Stieda]

1.30

0.28

1.0

2.3

0.41

1.05

g/l

—

Intracerebral haemorrhage

699

1.09

0.28

1.4

1.5

0.90

0.84

g/l

0.21

540

Mandibular retrognathia

507

1.10

0.27

1.4

1.7

0.52

0.71

g/l

1.24

404

Fall on and from ladder

499

1.10

0.27

1.6

1.7

1.05

0.89

g/l

0.43

401

Benign neoplasm: Skin of lower limb, including hip

168

1.19

0.27

1.8

1.7

0.61

0.82

g/l

0.51

133

Lesion of sciatic nerve

196

1.18

0.27

1.7

1.14

0.92

g/l

0.21

157

Generalized epilepsy

300

1.14

0.26

1.5

1.7

0.74

0.77

g/l

0.07

241

Universal erythroderma, KELA reimbursement

1.28

0.26

1.2

1.8

0.57

0.91

g/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.69

0.26

1.8

1.3

0.90

0.53

g/l

—

Femoral hernia, unilateral

141

1.21

0.26

2.4

1.6

0.73

0.80

g/l

—

117

Inguinal of femoral hernia, unilateral

141

1.21

0.26

2.4

1.6

0.73

0.80

g/l

—

117

Inguinal hernia, unilateral

141

1.21

0.26

2.4

1.6

0.73

0.80

g/l

—

117

Mental and behavioural disorders associated with the puerperium

0.66

0.26

1.8

1.4

0.90

0.55

g/l

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

176

1623

1.05

0.25

1.3

1.6

0.84

0.86

g/l

0.05

130

1261

Contact with nonpowered hand tool

301

1.13

0.25

1.5

1.7

0.73

0.89

g/l

0.61

238

Malignant neoplasm of urinary organs

559

1.09

0.25

1.4

1.7

0.87

0.93

g/l

0.11

437

Early lumbar disc prolapse operation

100

936

1.07

0.25

1.4

1.7

0.62

0.78

g/l

1.22

733

LeFortI or BSSO operation

298

0.87

0.25

1.3

1.7

0.52

0.73

g/l

0.90

234

Open wound of thorax

105

1.24

0.25

2.1

1.7

1.34

0.85

g/l

0.75

Bilateral sagittal split ramus osteotomy operation

244

0.86

0.24

1.3

1.8

0.47

0.75

g/l

1.18

191

Postpartum hemorraghe, all women as controls

207

2107

0.96

0.24

1.5

0.61

0.59

g/l

0.17

161

1659

Supervision of high-risk pregnancy

180

1031

1.05

0.24

1.7

1.5

0.63

0.58

g/l

0.29

148

813

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

106

1.23

0.23

1.5

1.9

1.03

0.79

g/l

—

Parkinson's disease, strict definition, excluding more controls

623

1.08

0.23

2.3

1.5

0.55

0.88

g/l

3.49

465

Outcome of delivery

128

830

0.95

0.23

1.4

1.5

0.58

0.57

g/l

0.07

118

653

Postpartum haemorrhage due to anatomy

774

0.93

0.23

1.7

1.5

0.63

0.57

g/l

0.32

611

Other disorders of male genital organs

285

1.13

0.22

2.0

1.7

0.83

0.93

g/l

0.25

232

Burn and corrosion of hip and lower limb, except ankle and foot

153

1.18

0.22

1.8

1.7

1.11

0.76

g/l

0.40

122

Focal brain injury

362

1.11

0.22

1.5

0.78

0.85

g/l

0.20

291

Benign neoplasm of breast

826

1.07

0.22

1.5

0.92

0.63

g/l

0.72

632

Wide developmental disorders

304

1.12

0.21

1.4

1.6

0.51

0.67

g/l

1.11

252

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.5

—

0.48

—

Burns and corrosions of external body surface, specified by site

895

1.06

0.21

1.5

1.6

0.69

0.79

g/l

0.57

702

Kela-code for severe mental illness

309

3188

0.97

0.21

1.3

1.6

0.64

0.76

g/l

1.84

237

2460

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

1.8

—

0.68

—

Carcinoma in situ of oral cavity

0.00

0.21

0.0

4.2

—

1.52

—

Placenta praevia

335

1.11

0.20

1.5

1.6

0.63

g/l

0.01

259

Mental and behavioural disorders due to use of other stimulants, including caffeine

221

1.13

0.20

1.2

1.9

0.88

0.80

g/l

0.13

176

Pedal cyclist injured in collision with pedestrian or animal

1.23

0.20

1.5

1.4

0.50

0.68

g/l

—

Cerebral atherosclerosis

1.22

0.20

1.3

1.9

1.16

1.08

g/l

—

severe traumatic brain injury, does not include concussion

160

1533

1.04

0.20

1.4

1.6

0.75

0.89

g/l

1.04

120

1194

Pre-eclampsia

170

1633

1.04

0.19

1.5

0.58

0.62

g/l

0.20

137

1263

Pre-eclampsia or eclampsia

183

1761

1.04

0.19

1.5

0.58

0.62

g/l

0.26

150

1364

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

414

1.09

0.19

1.5

1.7

0.73

0.81

g/l

0.26

327

Crowding of teeth, including avohilmo

648

1.06

0.18

1.4

1.7

0.54

0.77

g/l

2.50

524

Unspecified mental disorder

370

3609

1.03

0.17

1.4

1.6

0.63

0.76

g/l

2.34

286

2803

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.75

0.17

1.8

1.4

0.90

0.53

g/l

—

Acute and transient psychotic disorders

947

0.95

0.17

1.3

1.7

0.74

0.76

g/l

0.07

735

Migraine with aura, drug-induced

1.16

0.16

2.6

1.8

0.51

0.68

g/l

—

1.16

0.16

1.9

1.8

0.23

0.84

g/l

—

Hydrocephalus

412

0.92

0.16

1.8

1.6

0.87

g/l

0.00

329

Deep bite

104

872

1.05

0.16

1.5

1.7

0.64

0.77

g/l

1.26

705

Other and/or unspecified nontoxic goitre

506

1.07

0.15

2.5

1.6

0.87

0.73

g/l

0.55

388

Maternal care for other known or suspected fetal problems

211

1284

1.03

0.15

1.3

1.5

0.65

0.58

g/l

0.64

164

1026

Other complications of labour and delivery, not elsewhere classified

839

1.05

0.15

1.3

1.6

0.59

g/l

0.01

656

Use of disulfiram, acamprosate or naltrexone

713

1.05

0.14

1.3

1.7

0.71

0.87

g/l

0.79

566

Spermatocele

469

1.07

0.14

1.6

1.7

0.81

1.02

g/l

0.51

366

Maternal care for known or suspected malpresentation of fetus

152

1121

0.97

0.14

1.4

1.6

0.50

0.58

g/l

1.20

120

891

Bicuspidal aortic valve syndrome

256

1.10

0.14

1.6

1.7

1.03

0.81

g/l

0.48

206

Cellulitis of external ear

1.19

0.14

2.6

1.8

0.83

0.73

g/l

—

Presbyopia

656

1.05

0.13

1.4

1.6

0.66

0.80

g/l

0.63

512

Colorectal adenocarcinoma

128

1219

1.04

0.13

1.7

0.97

0.88

g/l

0.29

940

Other deformities of toe(s)

199

1.11

0.13

1.0

1.8

0.66

0.78

g/l

0.24

153

Retained placenta and membranes, without haemorrhage

912

1.04

0.13

1.5

0.64

0.62

g/l

0.07

697

Accidental poisoning by and exposure to alcohol

113

1.15

0.13

1.9

1.8

0.50

0.80

g/l

—

Subarachnoid haemorrhage

612

0.95

0.13

1.8

1.5

0.74

0.79

g/l

0.19

465

Pedal cyclist injured in other and unspecified transport accidents

887

0.96

0.13

1.6

0.66

0.77

g/l

0.81

695

Nontraumatic intracranial haemmorrhage

130

1261

1.03

0.11

1.6

0.80

0.83

g/l

0.12

115

962

Malignant neoplasm of corpus uteri, including Hilmo

504

1.05

0.11

1.2

1.6

0.57

0.69

g/l

0.62

379

Parkinson's disease, excluding more controls

681

1.04

0.10

2.2

1.6

0.55

0.91

g/l

4.37

515

Congenital varicose veins

1.11

0.10

1.8

1.6

0.45

0.65

g/l

—

Poor fetal growth

1021

0.97

0.09

1.3

1.6

0.60

0.59

g/l

0.05

810

Dementia in other diseases classified elsewhere

252

1.07

0.09

1.3

1.5

0.52

0.86

g/l

1.85

201

Non-small cell lung cancer, squamous, helper endpoint

213

1.08

0.09

1.4

1.6

0.70

0.95

g/l

0.99

170

Contact with other sharp object(s)

563

0.96

0.09

1.5

1.7

0.65

0.77

g/l

0.60

441

Tarsal tunnel syndrome

1.05

0.08

1.0

1.8

1.68

0.70

g/l

—

Maternal care for known or suspected abnormality of pelvic organs

216

1431

1.02

0.08

1.4

1.5

0.60

0.59

g/l

0.05

164

1124

Other and unspecified mononeuropathies of upper limb

185

1.08

0.08

1.4

1.7

1.05

0.75

g/l

0.26

148

Mental retardation, wide definition

345

0.95

0.08

1.5

1.6

0.65

0.77

g/l

0.26

287

Erectile dysfunction

480

1.04

0.08

1.8

1.6

1.17

0.95

g/l

0.47

381

Other congenital malformations of male genital organs

0.83

0.07

1.2

1.6

1.20

0.76

g/l

—

Twin gestation

702

0.97

0.07

1.6

0.57

0.62

g/l

0.26

548

Type 1 diabetes, strict definition, subgroup 1

588

1.04

0.07

1.5

1.7

0.67

0.71

g/l

0.09

476

Open wound of shoulder and upper arm

118

1.10

0.07

1.2

1.8

0.67

0.82

g/l

—

Congenital malformations of cardiac septa

514

1.04

0.07

1.3

1.7

0.66

0.78

g/l

0.48

425

Pedestrian injured in collision with car, pick-up truck or van

138

1.09

0.06

1.5

1.7

0.69

0.71

g/l

—

111

Vascular dementia

392

0.96

0.06

1.8

1.5

0.74

0.93

g/l

1.02

301

Male infertility

374

1.04

0.06

1.3

1.8

0.89

0.92

g/l

0.08

293

Family history of malignant neoplasm

869

1.02

0.06

1.3

1.6

0.52

0.70

g/l

1.93

694

Colon adenocarcinoma, helper endpoint

760

1.03

0.06

1.9

1.6

0.97

0.86

g/l

0.33

588

Antenatal screening

197

1087

1.01

0.05

1.4

1.5

0.57

g/l

0.01

172

856

Acute appendicitis, with complications

149

1513

0.98

0.05

1.8

1.6

0.64

0.82

g/l

1.63

115

1198

Other obstructed labour

544

1.03

0.05

1.3

1.5

0.66

0.62

g/l

0.16

425

Thyrotoxicosis with toxic multinodular goitre

356

1.04

0.05

1.8

1.7

0.98

0.81

g/l

0.21

280

Postpartum hemorraghe, parous women as controls

207

1750

0.99

0.04

1.5

0.61

0.58

g/l

0.26

161

1375

Ill-defined and unknown causes of mortality

524

0.97

0.04

1.1

1.6

0.85

0.88

g/l

0.08

420

Other ill-defined and unspecified causes of mortality

467

1.03

0.04

1.1

1.6

0.91

0.88

g/l

0.06

370

Antepartum haemorrhage, not elsewhere classified

704

0.98

0.04

1.3

1.6

0.45

0.61

g/l

1.53

559

Colorectal cancer, including Hilmo

175

1648

0.99

0.03

1.6

1.7

0.92

0.89

g/l

0.08

134

1283

Ectropion of eyelid

161

1.06

0.03

1.3

1.5

0.88

1.06

g/l

0.31

128

Use of levodopa decarboxylase inhibitor

793

0.98

0.03

2.4

1.5

0.60

0.89

g/l

2.86

613

Mandibular retrognathia AND surgery (BSSO)

181

1.05

0.03

1.3

1.8

0.49

0.75

g/l

0.88

145

Failed induction of labour

449

1.02

0.03

1.8

1.6

0.49

0.58

g/l

0.35

353

Supervision of normal pregnancy

183

1053

0.99

0.02

1.3

1.5

0.60

0.57

g/l

0.29

150

833

Gestational diabetes (for exclusion)

326

2254

0.99

0.02

1.3

1.5

0.58

0.59

g/l

0.08

262

1782

Other lesions of median nerve

133

1.05

0.01

1.1

1.7

0.34

0.80

g/l

—

110

Maternal care for known or suspected fetal abnormality and damage

134

1127

1.01

0.01

1.5

1.6

0.62

0.61

g/l

0.08

114

887

Multiple gestation

727

0.99

0.01

1.6

0.56

0.62

g/l

0.30

570

Colorectal cancer

155

1493

1.00

0.00

1.6

1.7

0.95

0.88

g/l

0.23

121

1151

Atrial septal defect

284

0.98

0.00

1.3

1.7

0.61

0.77

g/l

0.52

240

Atrial septal defect, secundum type

225

0.97

0.00

1.1

1.7

0.34

0.72

g/l

3.29

187

Septal defects

495

0.99

0.00

1.3

1.7

0.64

0.76

g/l

0.52

416

Coronary artery bypass grafting

148

1101

1.00

0.00

2.0

1.6

0.79

1.02

g/l

1.64

115

858

Myocardial infarction, unclassifiable

120

1076

1.00

0.00

1.5

1.6

0.84

0.92

g/l

0.32

832

Distal bite

322

1.02

0.00

1.5

1.7

0.72

0.77

g/l

0.11

265

Malignant melanoma of skin, including Hilmo

945

0.99

0.00

1.6

0.57

0.82

g/l

3.00

740

Benign neoplasm: Larynx

176

1.02

0.00

1.7

1.6

0.71

0.77

g/l

0.16

141

Single delivery by caesarean section

171

974

1.00

0.00

1.6

1.5

0.71

0.58

g/l

1.01

132

799

Mental retardation

330

0.99

0.00

1.5

1.7

0.65

0.74

g/l

0.19

278

Malignant neoplasm of corpus uteri

449

1.00

0.00

1.1

1.6

0.56

0.70

g/l

0.79

346

Pedal cyclist injured in collision with motor vehicle

207

1.01

0.00

2.0

1.8

1.01

0.82

g/l

0.33

166

Assault by unspecified means

155

1.03

0.00

1.8

1.06

0.81

g/l

0.29

121

Burns and corrosions of multiple and unspecified body regions

155

0.97

0.00

1.0

1.8

0.56

0.83

g/l

—

125

Localized hypertrichosis

0.00

0.0

1.8

—

0.74

—

Rhabdomyosarcoma

0.00

0.0

1.0

—

0.69

—

Congenital malposition of the kidney

0.00

0.0

1.0

—

0.81

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

0.75

—

Use of pergolide

0.00

0.0

1.5

—

0.52

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.1

—

0.71

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.93

0.00

1.4

0.75

0.52

g/l

—

Toxic effect of metals

0.00

0.0

2.2

—

0.94

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

1.4

—

0.74

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

1.3

—

0.55

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.6

—

0.61

—

Benign neoplasm: Cornea

0.00

-0.00

0.0

1.4

—

0.73

—

Amputation of ankle

0.00

-0.00

0.0

1.2

—

0.71

—

Other and unspecified injuries of forearm

0.98

-0.00

1.0

2.2

0.26

0.93

g/l

—

Other congenital malformations of male genital organs, including avohilmo

0.88

-0.00

1.1

1.5

1.03

0.75

g/l

—

Forearm

0.00

-0.00

0.0

2.0

—

0.83

—

Lichen nitidus

0.00

-0.00

0.0

1.1

—

0.61

—

Other sudden death, cause unknown

0.00

-0.00

0.0

1.3

—

0.64

—

Hereditary erythropoietic porphyria

0.00

-0.00

0.0

1.4

—

0.40

—

Exposure to noise

0.00

-0.00

0.0

1.0

—

0.49

—

Rhabdomyosarcoma, including Hilmo

0.00

-0.00

0.0

1.0

—

0.75

—

Defects in glycoprotein degradation

0.00

-0.00

0.0

1.6

—

0.57

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.4

—

0.56

—

Alcoholic myopathy

0.00

-0.00

0.0

1.5

—

0.72

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.6

—

0.57

—

Seminoma of testis

0.96

-0.00

4.6

2.4

1.22

1.12

g/l

—

Abnormalities of forces of labour

840

1.00

-0.00

1.3

1.5

0.56

0.60

g/l

0.26

656

Thyrotoxicosis with toxic single thyroid nodule

1.02

-0.00

2.0

1.4

0.85

0.59

g/l

—

Hypotony of eye

0.00

-0.00

0.0

1.2

—

0.79

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

0.83

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

1.8

—

0.53

—

Birth asphyxia

1.00

-0.00

1.0

1.6

0.38

0.64

g/l

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.8

—

0.54

—

Delta-beta thalassaemia

0.00

-0.00

0.0

1.2

—

0.61

—

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.4

—

0.45

—

Classical phenylketonuria

0.00

-0.00

0.0

1.2

—

1.11

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.4

—

0.78

—

Carcinoma in situ of lip

0.00

-0.00

0.0

1.2

—

0.66

—

Carcinoma in situ of penis

0.00

-0.00

0.0

5.4

—

2.36

—

Legal intervention

0.00

-0.00

0.0

1.8

—

0.54

—

Peutz-Jeghers syndrome

0.00

-0.00

0.0

1.8

—

0.65

—

Victim of lightning

0.00

-0.00

0.0

1.5

—

0.51

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 4 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS